3.1.3.3 Acidosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11731570&form=6&db=m Cytochalasin D reduces Ca2+ currents via cofilin-activated depolymerization of F-actin in guinea-pig cardiomyocytes. unassigned - 3.1.3.3 Acne Vulgaris http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31414709&form=6&db=m Evaluation of PSP technique including dot peeling, subcision and intradermal injection of PRP in the treatment of atrophic post-acne scars. therapeutic application,unassigned 4,0 3.1.3.3 aconitate hydratase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12105325&form=6&db=m Brain aconitase activity is not decreased in progressive supranuclear palsy. causal interaction,ongoing research,unassigned 4,1,0 3.1.3.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9326431&form=6&db=m Long-term perspective on the prevalent-cohort biases in studies of human immunodeficiency virus progression. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Acquired Immunodeficiency Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10449111&form=6&db=m Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Acute Kidney Injury http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25705419&form=6&db=m A validation of presepsin levels in kidney dysfunction patients: four case reports. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,4,1 3.1.3.3 Acute Kidney Injury http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30673037&form=6&db=m Rectal ulcer due to Kayexalate deposition - an unusual case. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=212173&form=6&db=m Human colon tumors: enzymic and histological characteristics. causal interaction,unassigned 1,0 3.1.3.3 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31784034&form=6&db=m Positive Resection Margins Detected by Standardized Study of a Pancreaticoduodenectomy Sample: Is There Any Real Impact on Long-term Survival? causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32666331&form=6&db=m Pulmonary sclerosing pneumocytoma with mediastinal lymph node metastasis: a case report. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Adenocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34430194&form=6&db=m A case of pulmonary sclerosing pneumocytoma diagnosed preoperatively using transbronchial cryobiopsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Adenoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1455310&form=6&db=m Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures. diagnostic usage,ongoing research,unassigned 3,4,0 3.1.3.3 Adenoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25921430&form=6&db=m Pituitary tumors contain a side population with tumor stem cell-associated characteristics. causal interaction,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Adenoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27784967&form=6&db=m Interendoscopist variability in proximal colon polyp detection is twice higher for serrated polyps than adenomas. causal interaction,therapeutic application,unassigned 1,3,0 3.1.3.3 Adenoma, Pleomorphic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19507761&form=6&db=m Pleomorphic adenoma: extracapsular dissection versus partial superficial parotidectomy with facial nerve dissection. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,2,0 3.1.3.3 Agnosia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964698&form=6&db=m Cognitive disturbances in progressive supranuclear palsy. unassigned - 3.1.3.3 Agraphia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23665607&form=6&db=m Profile of children with poor school performance in Mumbai. causal interaction,unassigned 1,0 3.1.3.3 Akinetic Mutism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1520562&form=6&db=m [The thalamic changes in progressive supranuclear palsy] causal interaction,unassigned 4,0 3.1.3.3 Akinetic Mutism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25997420&form=6&db=m Vascular Parkinsonism: deconstructing a syndrome. causal interaction,unassigned 3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1321966&form=6&db=m Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles. therapeutic application,unassigned 1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1473314&form=6&db=m Progressive supranuclear palsy with widespread cerebral lesions. causal interaction,diagnostic usage,unassigned 3,4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1704110&form=6&db=m Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging. causal interaction,unassigned 4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2169789&form=6&db=m [An autopsy case of postencephalitic parkinsonism: investigation on neurofibrillary tangles in comparison with those in progressive supranuclear palsy] causal interaction,unassigned 1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2891795&form=6&db=m Brain somatostatin concentrations do not decrease in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,2,4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3185956&form=6&db=m Antigenic characteristics of neurofibrillary tangles in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3379428&form=6&db=m The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3631916&form=6&db=m Loss of pedunculopontine neurons in progressive supranuclear palsy. unassigned - 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4090942&form=6&db=m Substructure of 20 nm filaments of progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6637400&form=6&db=m Neuronal loss in the basal nucleus of Meynert in progressive supranuclear palsy. unassigned - 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7187969&form=6&db=m [Sleep in progressive supranuclear palsy] diagnostic usage,unassigned 1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964683&form=6&db=m The neuropathology of progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964685&form=6&db=m Neurofibrillary pathology in progressive supranuclear palsy (PSP). causal interaction,unassigned 1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7969952&form=6&db=m Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8208392&form=6&db=m Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8627344&form=6&db=m Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. diagnostic usage,ongoing research,unassigned 1,3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8937777&form=6&db=m Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9700707&form=6&db=m Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease. causal interaction,unassigned 4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10482263&form=6&db=m Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease. diagnostic usage,ongoing research,unassigned 3,4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10525997&form=6&db=m Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. causal interaction,unassigned 3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10580705&form=6&db=m Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10888369&form=6&db=m Lipoperoxidation is selectively involved in progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11193178&form=6&db=m Molecular genetics of chromosome 17 tauopathies. causal interaction,unassigned 4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11601500&form=6&db=m Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,4,4,1 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11960887&form=6&db=m Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12071638&form=6&db=m Argyrophilic grain disease is a sporadic 4-repeat tauopathy. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12200627&form=6&db=m Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. causal interaction,unassigned 3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12220379&form=6&db=m Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders. causal interaction,ongoing research,unassigned 3,4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12410387&form=6&db=m Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains. ongoing research,unassigned 2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12566927&form=6&db=m Role of serine/threonine protein phosphatase in Alzheimer's disease. causal interaction,ongoing research,unassigned 4,2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15641585&form=6&db=m Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies. unassigned - 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16691119&form=6&db=m Lewy bodies in progressive supranuclear palsy represent an independent disease process. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16938018&form=6&db=m Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration. causal interaction,unassigned 1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17010515&form=6&db=m No evidence of CRHR1 gene involvement in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17085483&form=6&db=m Haplotype-specific expression of exon 10 at the human MAPT locus. causal interaction,unassigned 3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17178818&form=6&db=m The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17320831&form=6&db=m Tau and saitohin gene expression pattern in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 4,3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17347250&form=6&db=m Rates of cerebral atrophy differ in different degenerative pathologies. causal interaction,unassigned 4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17357802&form=6&db=m Phosphorylation and cleavage of tau in non-AD tauopathies. causal interaction,unassigned 3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17483697&form=6&db=m Muscarinic receptors in the thalamus in progressive supranuclear palsy and other neurodegenerative disorders. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,2,1 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17709155&form=6&db=m Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17721707&form=6&db=m Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18315566&form=6&db=m Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats. diagnostic usage,unassigned 1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18362099&form=6&db=m Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18971445&form=6&db=m Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19308965&form=6&db=m An association study of common variation at the MAPT locus with late-onset Alzheimer's disease. causal interaction,unassigned 3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21245475&form=6&db=m Applause sign: is it really specific for Parkinsonian disorders? Evidence from cortical dementias. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21741294&form=6&db=m Cytokine expression and microglial activation in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21987561&form=6&db=m [Progressive nonfluent aphasia]. unassigned - 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23242279&form=6&db=m Essential tremor followed by progressive supranuclear palsy: postmortem reports of 11 patients. causal interaction,unassigned 2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23300100&form=6&db=m [The genetics of corticobasal syndrome]. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24169076&form=6&db=m C9orf72 repeat expansions are restricted to the ALS-FTD spectrum. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24252572&form=6&db=m The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease. causal interaction,unassigned 4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26227957&form=6&db=m An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome. causal interaction,unassigned 3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26823029&form=6&db=m Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases. diagnostic usage,unassigned 3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27526039&form=6&db=m Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27797445&form=6&db=m Tau imaging with [(18) F]THK-5351 in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,3,1 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28409749&form=6&db=m The Role of Stress as a Risk Factor for Progressive Supranuclear Palsy. causal interaction,unassigned 3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28510312&form=6&db=m The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28653647&form=6&db=m Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29181488&form=6&db=m Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies. diagnostic usage,therapeutic application,unassigned 1,2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29254665&form=6&db=m Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29278274&form=6&db=m The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29282336&form=6&db=m CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP. causal interaction,unassigned 2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29293892&form=6&db=m Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29339765&form=6&db=m Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29973911&form=6&db=m Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31155302&form=6&db=m Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,2,2 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31656263&form=6&db=m [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report]. unassigned - 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31695675&form=6&db=m Frontrunner in Translation: Progressive Supranuclear Palsy. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31837067&form=6&db=m Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders. causal interaction,ongoing research,unassigned 1,2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32108694&form=6&db=m Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome: A 11C-Pyridinyl-Butadienyl-Benzothiazole 3 PET Pilot Study. diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32293067&form=6&db=m Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,2,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32416639&form=6&db=m Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32754109&form=6&db=m PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33165511&form=6&db=m Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33459709&form=6&db=m Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice. causal interaction,unassigned 1,0 3.1.3.3 Amnesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25732053&form=6&db=m Progressive Supranuclear Palsy: What do we know About it? causal interaction,unassigned 3,0 3.1.3.3 Amyotrophic Lateral Sclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8363349&form=6&db=m Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels. unassigned - 3.1.3.3 Amyotrophic Lateral Sclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11912113&form=6&db=m Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,1,1 3.1.3.3 Amyotrophic Lateral Sclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16736722&form=6&db=m Progress in clinical neurosciences: Frontotemporal dementia-pick's disease. unassigned - 3.1.3.3 Amyotrophic Lateral Sclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24252572&form=6&db=m The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease. causal interaction,unassigned 4,0 3.1.3.3 Amyotrophic Lateral Sclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30089514&form=6&db=m Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases. unassigned - 3.1.3.3 Amyotrophic Lateral Sclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31267304&form=6&db=m Under-recognized primary spontaneous pneumothorax in ALS: a multicenter retrospective study. causal interaction,unassigned 3,0 3.1.3.3 Aneurysm http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15037703&form=6&db=m Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm. diagnostic usage,therapeutic application,unassigned 1,2,0 3.1.3.3 Aneurysm http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15452329&form=6&db=m Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm. diagnostic usage,therapeutic application,unassigned 1,2,0 3.1.3.3 Aneurysm http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15457585&form=6&db=m Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm. diagnostic usage,therapeutic application,unassigned 1,2,0 3.1.3.3 Aneurysm http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21387699&form=6&db=m [A case of a syndrome resembling PSP after aortic arch replacement under deep hypothermic circulatory arrest]. therapeutic application,unassigned 1,0 3.1.3.3 Angina, Stable http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30392496&form=6&db=m The role of polysaccharide peptide of Ganoderma lucidum as a potent antioxidant against atherosclerosis in high risk and stable angina patients. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,2,0 3.1.3.3 Anhedonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20046384&form=6&db=m Major depressive disorder preceding the onset of progressive supranuclear palsy. causal interaction,ongoing research,unassigned 2,2,0 3.1.3.3 Anhedonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24814140&form=6&db=m Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting. therapeutic application,unassigned 1,0 3.1.3.3 Anhedonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31743601&form=6&db=m Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism. unassigned - 3.1.3.3 Anosmia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12111470&form=6&db=m Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. unassigned - 3.1.3.3 Anosmia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20209627&form=6&db=m Hyposmia in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,1,2 3.1.3.3 Anosmia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33755262&form=6&db=m Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,3,0 3.1.3.3 Anovulation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9328231&form=6&db=m A single dose of mifepristone induces ovulation in pseudopregnant rats. therapeutic application,unassigned 2,0 3.1.3.3 Anthracosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16627865&form=6&db=m Fluorescein-enhanced Autofluorescence Thoracoscopy in Patients with Primary Spontaneous Pneumothorax and Normal Subjects. causal interaction,unassigned 1,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964698&form=6&db=m Cognitive disturbances in progressive supranuclear palsy. unassigned - 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10525996&form=6&db=m Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. therapeutic application,unassigned 1,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16401843&form=6&db=m Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. diagnostic usage,ongoing research,therapeutic application,unassigned 4,1,1,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18362099&form=6&db=m Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,2,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19323870&form=6&db=m Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy. unassigned - 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21524271&form=6&db=m The overlapping syndromes of the pick complex. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21887521&form=6&db=m Extrapyramidal syndromes in frontotemporal degeneration. diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24368882&form=6&db=m A case of atypical progressive supranuclear palsy. therapeutic application,unassigned 1,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24759627&form=6&db=m Family history of frontotemporal lobar degeneration in Asia - an international multi-center research. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24814140&form=6&db=m Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting. therapeutic application,unassigned 1,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25732053&form=6&db=m Progressive Supranuclear Palsy: What do we know About it? causal interaction,unassigned 3,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26247320&form=6&db=m Frontal dynamic aphasia in progressive supranuclear palsy: Distinguishing between generation and fluent sequencing of novel thoughts. unassigned - 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28386688&form=6&db=m Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28510312&form=6&db=m The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29254097&form=6&db=m Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31603934&form=6&db=m Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,3,0 3.1.3.3 Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33662165&form=6&db=m First symptom guides diagnosis and prognosis in neurodegenerative diseases-a retrospective study of autopsy proven cases. causal interaction,unassigned 1,0 3.1.3.3 Aphasia, Broca http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18989114&form=6&db=m Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,2,0 3.1.3.3 Aphasia, Primary Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12669238&form=6&db=m Progressive supranuclear palsy presenting with primary progressive aphasia--clinicopathological report of an autopsy case. causal interaction,unassigned 1,0 3.1.3.3 Aphasia, Primary Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15178937&form=6&db=m Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,1,0 3.1.3.3 Aphasia, Primary Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15651349&form=6&db=m [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis] diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Aphasia, Primary Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16938018&form=6&db=m Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration. causal interaction,unassigned 1,0 3.1.3.3 Aphasia, Primary Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21817180&form=6&db=m [A 62-year-old Woman Presenting with Progressive Nonfluent Aphasia, Apraxia of Eyelid Opening, Supranuclear Gaze Palsy, and Asymmetric Rigidity]. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Aphasia, Primary Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31321513&form=6&db=m Language impairment in progressive supranuclear palsy and corticobasal syndrome. diagnostic usage,unassigned 3,0 3.1.3.3 Apnea http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11788135&form=6&db=m Effects of neural drives on breathing in the awake state in humans. therapeutic application,unassigned 1,0 3.1.3.3 Apraxia, Ideomotor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9055799&form=6&db=m Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Apraxia, Ideomotor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9520011&form=6&db=m Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,3,0 3.1.3.3 Apraxia, Ideomotor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10449111&form=6&db=m Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Apraxia, Ideomotor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10525996&form=6&db=m Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. therapeutic application,unassigned 1,0 3.1.3.3 Apraxia, Ideomotor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11054490&form=6&db=m Somatosensory evoked potentials in progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Apraxia, Ideomotor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14598093&form=6&db=m Distal-proximal differences in limb apraxia in corticobasal degeneration but not progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Apraxia, Ideomotor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15699373&form=6&db=m Limb apraxia in corticobasal degeneration and progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 2,3,0 3.1.3.3 Apraxia, Ideomotor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16093226&form=6&db=m Limb apraxia and cognitive impairment in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,4,0 3.1.3.3 Apraxia, Ideomotor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25088758&form=6&db=m Cognitive dysfunction associated with falls in progressive supranuclear palsy. diagnostic usage,unassigned 1,0 3.1.3.3 Apraxia, Ideomotor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30989369&form=6&db=m Motor, cognitive and behavioral differences in MDS PSP phenotypes. causal interaction,diagnostic usage,ongoing research,unassigned 2,3,2,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1301327&form=6&db=m [A case of progressive supranuclear palsy presenting mouth opening difficulty with tonic contraction of the orbicularis oris muscle] causal interaction,unassigned 3,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964698&form=6&db=m Cognitive disturbances in progressive supranuclear palsy. unassigned - 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9055799&form=6&db=m Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9294327&form=6&db=m [Progressive supranuclear palsy with macular degeneration--report of three cases] causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11441873&form=6&db=m [A 68-year-old man with speech disturbance as the initial symptom followed by bradykinesia and dementia. Clinical conference] diagnostic usage,therapeutic application,unassigned 2,2,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15699373&form=6&db=m Limb apraxia in corticobasal degeneration and progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 2,3,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15834857&form=6&db=m Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. unassigned - 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15930045&form=6&db=m Apraxia in movement disorders. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16092076&form=6&db=m Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16093226&form=6&db=m Limb apraxia and cognitive impairment in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,4,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17578939&form=6&db=m Long-term locomotor training for gait and balance in a patient with mixed progressive supranuclear palsy and corticobasal degeneration. diagnostic usage,therapeutic application,unassigned 1,2,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18989114&form=6&db=m Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,2,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20610990&form=6&db=m Neuropathology of variants of progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21690028&form=6&db=m [Progressive supranuclear palsy: what's new?]. diagnostic usage,therapeutic application,unassigned 3,3,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21887521&form=6&db=m Extrapyramidal syndromes in frontotemporal degeneration. diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22181323&form=6&db=m Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. unassigned - 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24368882&form=6&db=m A case of atypical progressive supranuclear palsy. therapeutic application,unassigned 1,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28725681&form=6&db=m Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,2,2 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31321513&form=6&db=m Language impairment in progressive supranuclear palsy and corticobasal syndrome. diagnostic usage,unassigned 3,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31333840&form=6&db=m How to spot ocular abnormalities in progressive supranuclear palsy? A practical review. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33045651&form=6&db=m The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33719524&form=6&db=m Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Apraxias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33744691&form=6&db=m Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Arthritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31081461&form=6&db=m Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. therapeutic application,unassigned 1,0 3.1.3.3 Arthritis, Psoriatic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31081461&form=6&db=m Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. therapeutic application,unassigned 1,0 3.1.3.3 Astrocytoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29594248&form=6&db=m Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma. diagnostic usage,ongoing research,therapeutic application,unassigned 1,3,3,0 3.1.3.3 Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2087284&form=6&db=m Modification of phenyl saligenin phosphate-induced delayed effects by calcium channel blockers: in vivo and in vitro electrophysiological assessment. diagnostic usage,unassigned 3,0 3.1.3.3 Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2558427&form=6&db=m Effect of verapamil on organophosphorus-induced delayed neuropathy in hens. unassigned - 3.1.3.3 Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3341034&form=6&db=m Types of adrenocorticoids and their effect on organophosphorus-induced delayed neuropathy in chickens. therapeutic application,unassigned 1,0 3.1.3.3 Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19778211&form=6&db=m Effects of organophosphate phenyl saligenin phosphate and polyether carboxylic ionophore lasalocid on motor nerve conduction velocity, neuropathy target esterase enzyme activity, and clinical ataxia in chickens. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,1,2,1 3.1.3.3 Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28725681&form=6&db=m Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,2,2 3.1.3.3 Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31847511&form=6&db=m Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,4,0 3.1.3.3 Atherosclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26124939&form=6&db=m The reduction of aorta histopathological images through inhibition of reactive oxygen species formation in hypercholesterolemia rattus norvegicus treated with polysaccharide peptide of Ganoderma lucidum. unassigned - 3.1.3.3 Atherosclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30392496&form=6&db=m The role of polysaccharide peptide of Ganoderma lucidum as a potent antioxidant against atherosclerosis in high risk and stable angina patients. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,2,0 3.1.3.3 Atherosclerosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32031980&form=6&db=m Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Atrial Fibrillation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25593058&form=6&db=m Alterations in the interactome of serine/threonine protein phosphatase type-1 in atrial fibrillation patients. unassigned - 3.1.3.3 Atrial Fibrillation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27430328&form=6&db=m Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,1 3.1.3.3 Atrial Fibrillation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28461795&form=6&db=m Prolonged Sinus Pauses upon Termination of Paroxysmal Atrial Fibrillation: Abnormal Right Atrial Electrophysiologic and Electroanatomic Findings. diagnostic usage,unassigned 2,0 3.1.3.3 Atrial Fibrillation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31735079&form=6&db=m Risk stratification model for post-stroke pneumonia in patients with acute ischemic stroke. diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Atrial Fibrillation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33761707&form=6&db=m Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Autoimmune Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18957170&form=6&db=m Polysaccharopeptide mimics ciclosporin-mediated Th1/Th2 cytokine balance for suppression of activated human T cell proliferation by MAPKp38 and STAT5 pathways. diagnostic usage,unassigned 3,0 3.1.3.3 Autoimmune Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20663037&form=6&db=m Regulatory properties of polysaccharopeptide derived from Coriolus versicolor and its combined effect with ciclosporin on the homeostasis of human lymphocytes. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Autoimmune Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28390965&form=6&db=m Autoantibodies, detection methods and panels for diagnosis of Sjögren's syndrome. causal interaction,unassigned 1,0 3.1.3.3 Azotemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7325431&form=6&db=m Relationship of selected clinical renal function tests to glomerular filtration rate and renal blood flow in cats. diagnostic usage,unassigned 3,0 3.1.3.3 Bacterial Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19483002&form=6&db=m Plasmatocyte-spreading peptide (PSP) plays a central role in insect cellular immune defenses against bacterial infection. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Bacterial Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31421036&form=6&db=m Clinical application of presepsin as diagnostic biomarker of infection: overview and updates. causal interaction,ongoing research,therapeutic application,unassigned 3,1,4,0 3.1.3.3 Basal Ganglia Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6107328&form=6&db=m Progressive supranuclear palsy: clinico-pathological and biochemical studies. causal interaction,unassigned 1,0 3.1.3.3 Basal Ganglia Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6609939&form=6&db=m CT findings in progressive supranuclear palsy. diagnostic usage,unassigned 4,0 3.1.3.3 Basal Ganglia Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17709155&form=6&db=m Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,2,0 3.1.3.3 Biliary Fistula http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7991190&form=6&db=m [Benign obstruction of the common bile duct: what is the current role of transduodenal sphincteroplasty?] therapeutic application,unassigned 4,0 3.1.3.3 Birt-Hogg-Dube Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18505456&form=6&db=m Mutation analysis of the FLCN gene in Chinese patients with sporadic and familial isolated primary spontaneous pneumothorax. causal interaction,unassigned 4,0 3.1.3.3 Blepharospasm http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2215950&form=6&db=m Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. causal interaction,unassigned 2,0 3.1.3.3 Blepharospasm http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964695&form=6&db=m Eyelid motor abnormalities in progressive supranuclear palsy. therapeutic application,unassigned 2,0 3.1.3.3 Blepharospasm http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31333840&form=6&db=m How to spot ocular abnormalities in progressive supranuclear palsy? A practical review. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1485007&form=6&db=m Value of computer tomography in the detection of bullae and blebs in patients with primary spontaneous pneumothorax. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7597609&form=6&db=m One hundred consecutive cases of video-assisted thoracoscopic surgery for primary spontaneous pneumothorax. therapeutic application,unassigned 3,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10735663&form=6&db=m Videothoracoscopic treatment of primary spontaneous pneumothorax: a 6-year experience. therapeutic application,unassigned 3,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10936128&form=6&db=m Can CT scanning be used to select patients with unilateral primary spontaneous pneumothorax for bilateral surgery? causal interaction,therapeutic application,unassigned 3,2,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14752638&form=6&db=m Results of thoracoscopic pleural abrasion for primary spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14974660&form=6&db=m Video-assisted thoracoscopic suture closure of blebs to treat primary spontaneous pneumothorax. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15359923&form=6&db=m Alveolar epithelial permeability in patients with primary spontaneous pneumothorax as determined by Tc-99m DTPA aerosol scintigraphy. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,4,3,1 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15657874&form=6&db=m A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15767109&form=6&db=m Primary spontaneous pneumothorax in children: the role of CT in guiding management. diagnostic usage,unassigned 3,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16261980&form=6&db=m Physical fitness after apical resection for the treatment of primary spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 3,2,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16376095&form=6&db=m Video-assisted thoracoscopic surgery for primary spontaneous pneumothorax: clinicopathological correlation. ongoing research,therapeutic application,unassigned 1,4,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17943610&form=6&db=m Video-assisted extrathoracic bleb excision: An ultra-minithoracotomy for primary spontaneous pneumothorax. diagnostic usage,unassigned 1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18381810&form=6&db=m Video-assisted thoracoscopic surgery (VATS) for bilateral primary spontaneous pneumothorax. causal interaction,unassigned 3,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19651381&form=6&db=m Evidence-based management of paediatric primary spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 3,2,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19936978&form=6&db=m Efficacy of blebs detection for preventive surgery in children's idiopathic spontaneous pneumothorax. diagnostic usage,therapeutic application,unassigned 3,4,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22785214&form=6&db=m Role of Blebs and Bullae Detected by High-Resolution Computed Tomography and Recurrent Spontaneous Pneumothorax. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23775414&form=6&db=m Natural Course of Spontaneous Pneumothorax without Bullae or Blebs under High-Resolution Computed Tomography. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24284502&form=6&db=m What Factors Predict Recurrence after an Initial Episode of Primary Spontaneous Pneumothorax in Children? diagnostic usage,unassigned 3,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25015539&form=6&db=m Vascular-penetration defect detected in parietal pleura of primary spontaneous pneumothorax. diagnostic usage,unassigned 1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25391893&form=6&db=m Simultaneous Bilateral Video-Assisted Thoracoscopic Surgery for the Treatment of Primary Spontaneous Pneumothorax. ongoing research,therapeutic application,unassigned 3,1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26104239&form=6&db=m Relationship between postoperative bulla neogenesis at the staple line and the resected lung volume in primary spontaneous pneumothorax. unassigned - 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26113675&form=6&db=m ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 1,4,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26665105&form=6&db=m Outcomes of Contralateral Bullae in Primary Spontaneous Pneumothorax. diagnostic usage,unassigned 2,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26669786&form=6&db=m First Episode of Spontaneous Pneumothorax: CT-based Scoring to Select Patients for Early Surgery. unassigned - 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26875751&form=6&db=m The Presence of a Reticulated Trabecula-Like Structure Increases the Risk for the Recurrence of Primary Spontaneous Pneumothorax after Thoracoscopic Bullectomy. diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28088269&form=6&db=m Association of MMP-2 and MMP-9 expression with recurrences in primary spontaneous pneumothorax. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,1,2 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28099064&form=6&db=m Surgical Intervention for Primary Spontaneous Pneumothorax in Pediatric Population: When and Why? diagnostic usage,therapeutic application,unassigned 2,3,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28149562&form=6&db=m Correlation of matrix metalloproteinase-2 and -9 expression with recurrences in primary spontaneous pneumothorax patients. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,2,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28149563&form=6&db=m Association between postoperative bulla neogenesis at the staple line and resected lung weight for primary spontaneous pneumothorax: a retrospective study using the inverse-probability of treatment weighted method in patients grouped according to age. unassigned - 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28205019&form=6&db=m A deep azygoesophageal recess may increase the risk of secondary spontaneous pneumothorax. diagnostic usage,unassigned 1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29707314&form=6&db=m Influence of lung resection volume on risk of primary spontaneous pneumothorax recurrence. unassigned - 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29707331&form=6&db=m Expression of TGF-beta receptor 1 and Smads in the tissues of primary spontaneous pneumothorax. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,3,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30416793&form=6&db=m Comparison of additional minocycline versus iodopovidone pleurodesis during video-assisted thoracoscopic bleb resection for primary spontaneous pneumothorax: a propensity score-matched analysis. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30615303&form=6&db=m New insights and improved strategies for the management of primary spontaneous pneumothorax. causal interaction,unassigned 1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30674336&form=6&db=m Neo-generation of neogenetic bullae after surgery for spontaneous pneumothorax in young adults: a prospective study. therapeutic application,unassigned 1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30971282&form=6&db=m Unilateral single-port thoracoscopic surgery for bilateral pneumothorax or pulmonary bullae. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,1,2,4 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31089446&form=6&db=m Do Blebs or Bullae on High-Resolution Computed Tomography Predict Ipsilateral Recurrence in Young Patients at the First Episode of Primary Spontaneous Pneumothorax? unassigned - 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31993738&form=6&db=m Primary spontaneous pneumothorax in children: factors predicting recurrence and contralateral occurrence. ongoing research,therapeutic application,unassigned 1,1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32030229&form=6&db=m Contralateral bulla neogenesis associated with postoperative recurrences of primary spontaneous pneumothorax in young patients. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32040606&form=6&db=m Severity of Pectus Excavatum is a Risk Factor for Primary Spontaneous Pneumothorax. causal interaction,diagnostic usage,unassigned 3,1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32328783&form=6&db=m Should We Consider the Resected Lung Volume in Primary Spontaneous Pneumothorax? ongoing research,unassigned 2,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33032044&form=6&db=m Metachronous recurrent pediatric primary spontaneous pneumothorax: A case presentation and literature review. causal interaction,unassigned 1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33717565&form=6&db=m Uniportal approach as an alternative to the three-portal approach to video-assisted thoracic surgery for primary spontaneous pneumothorax. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33885029&form=6&db=m Is it a myth to perform blind apical wedge resection in primary spontaneous pneumothorax surgery to improve recurrence rates? therapeutic application,unassigned 1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34123633&form=6&db=m High-Resolution CT Following Primary Spontaneous Pneumothorax in Adolescents: Useful Tool or Wasted Radiation? causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,1,3 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34217255&form=6&db=m Male adolescents with contralateral blebs undergoing surgery for primary spontaneous pneumothorax may benefit from simultaneous contralateral blebectomies. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Blister http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34304085&form=6&db=m Bilateral primary spontaneous pneumothorax with multiple bleb performed by VATS and wedge resection: A rare case in Indonesian adult and review article. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Bone Diseases, Metabolic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27293836&form=6&db=m Abnormal bone mineral density and bone turnover marker expression profiles in patients with primary spontaneous pneumothorax. diagnostic usage,ongoing research,unassigned 4,1,0 3.1.3.3 Bone Resorption http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20805334&form=6&db=m Role of Porphyromonas gingivalis phosphoserine phosphatase enzyme SerB in inflammation, immune response, and induction of alveolar bone resorption in rats. causal interaction,ongoing research,unassigned 1,2,0 3.1.3.3 Bone Resorption http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27293836&form=6&db=m Abnormal bone mineral density and bone turnover marker expression profiles in patients with primary spontaneous pneumothorax. diagnostic usage,ongoing research,unassigned 4,1,0 3.1.3.3 Botulism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8319395&form=6&db=m [Clinical analysis of paralytic shellfish poisoning following ingestion of oysters] causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Bradycardia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24996551&form=6&db=m Perinatal and infant outcomes of prenatal diagnosis of heterotaxy syndrome (asplenia and polysplenia). diagnostic usage,unassigned 3,0 3.1.3.3 Brain Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2357154&form=6&db=m Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. causal interaction,unassigned 1,0 3.1.3.3 Brain Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20669302&form=6&db=m Typical cerebral metabolic patterns in neurodegenerative brain diseases. diagnostic usage,unassigned 1,0 3.1.3.3 Brain Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25997420&form=6&db=m Vascular Parkinsonism: deconstructing a syndrome. causal interaction,unassigned 3,0 3.1.3.3 Brain Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32585946&form=6&db=m Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies. therapeutic application,unassigned 1,0 3.1.3.3 Brain Injuries http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29497398&form=6&db=m Cerebrospinal Fluid Presepsin As a Marker of Nosocomial Infections of the Central Nervous System: A Prospective Observational Study. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Brain Injuries, Traumatic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29973911&form=6&db=m Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Brain Ischemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7990846&form=6&db=m Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. diagnostic usage,therapeutic application,unassigned 2,3,0 3.1.3.3 Brain Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31365504&form=6&db=m Diagnostic value of radiolabeled amino acid PET for detection of pseudoprogression of brain tumor after treatment: a meta-analysis. diagnostic usage,therapeutic application,unassigned 1,4,0 3.1.3.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2541019&form=6&db=m Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. unassigned - 3.1.3.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8959327&form=6&db=m Cell cycle-independent regulation of p21Waf1/Cip1 and retinoblastoma protein during okadaic acid-induced apoptosis is coupled with induction of Bax protein in human breast carcinoma cells. ongoing research,therapeutic application,unassigned 3,1,0 3.1.3.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12021784&form=6&db=m Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. causal interaction,unassigned 1,0 3.1.3.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12723750&form=6&db=m Polysaccharide peptide mediates apoptosis by up-regulating p21 gene and down-regulating cyclin D1 gene. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12881376&form=6&db=m The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation. causal interaction,diagnostic usage,ongoing research,unassigned 3,1,1,0 3.1.3.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12888371&form=6&db=m The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18292947&form=6&db=m Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,4 3.1.3.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22605639&form=6&db=m Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening. diagnostic usage,unassigned 1,0 3.1.3.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26462835&form=6&db=m Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway. causal interaction,ongoing research,therapeutic application,unassigned 3,4,4,0 3.1.3.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28439535&form=6&db=m A murine preclinical syngeneic transplantation model for breast cancer precision medicine. causal interaction,therapeutic application,unassigned 1,3,0 3.1.3.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29654756&form=6&db=m PPM1B depletion in U2OS cells supresses cell growth through RB1-E2F1 pathway and stimulates bleomycin-induced cell death. unassigned - 3.1.3.3 Breast Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32763584&form=6&db=m Anti- RI antibody associated progressive supranuclear palsy like presentation in a patient with breast carcinoma. diagnostic usage,unassigned 4,0 3.1.3.3 Bronchiectasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32913868&form=6&db=m Multifocal neuroendocrine cell hyperplasia accompanied by tumorlet formation and pulmonary sclerosing pneumocytoma: A case report. causal interaction,unassigned 3,0 3.1.3.3 Bronchiolitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30615303&form=6&db=m New insights and improved strategies for the management of primary spontaneous pneumothorax. causal interaction,unassigned 1,0 3.1.3.3 Bronchitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31030754&form=6&db=m Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,1,1 3.1.3.3 Bulbar Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1308417&form=6&db=m [Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of a case and review of the literature] causal interaction,unassigned 4,0 3.1.3.3 Bulbar Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3315157&form=6&db=m Progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9125847&form=6&db=m [Minisatellite instability induced by okadaic acid] therapeutic application,unassigned 1,0 3.1.3.3 Carcinogenesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25382183&form=6&db=m Phosphatase Wip1 as a new therapeutic target for intestinal ischemia-reperfusion injury. therapeutic application,unassigned 1,0 3.1.3.3 Carcinoid Tumor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33725576&form=6&db=m 68Ga-DOTATATE-avid pulmonary sclerosing pneumocytoma in a man of North African descent: Case report, imaging findings and pathology. unassigned - 3.1.3.3 Carcinoid Tumor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34430194&form=6&db=m A case of pulmonary sclerosing pneumocytoma diagnosed preoperatively using transbronchial cryobiopsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2721044&form=6&db=m Early progressive supranuclear palsy: pathology and clinical presentation. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2882044&form=6&db=m Enzyme pathology of human mesotheliomas. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,1,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10636884&form=6&db=m Serine/threonine protein phosphatase type 1gamma1 is required for the completion of cytokinesis in human A549 lung carcinoma cells. ongoing research,unassigned 4,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11467773&form=6&db=m Differences in association of the serine/threonine protein phosphatase PP-2A with microtubules of metastatic and nonmetastatic tumor cells. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,2,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12133545&form=6&db=m Radical resection of gastric carcinoma with pancreas and spleen preservation and functional cleaning of lymph nodes. causal interaction,therapeutic application,unassigned 3,2,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12914669&form=6&db=m Inducible expression of catalytically active type 1 serine/threonine protein phosphatase in a human carcinoma cell line. diagnostic usage,ongoing research,therapeutic application,unassigned 1,4,1,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16201166&form=6&db=m [Resection of gastric carcinoma with preserving of the spleen and pancreas and functional clearance lymph nodes of the spleen hillus and splenic artery] causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16524888&form=6&db=m Dihydroxyphenylethanol induces apoptosis by activating serine/threonine protein phosphatase PP2A and promotes the endoplasmic reticulum stress response in human colon carcinoma cells. causal interaction,ongoing research,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19626897&form=6&db=m [A fluorescent dye method based on changes in membrane potential for detecting PSP toxins in shellfish] ongoing research,unassigned 2,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23324392&form=6&db=m Enhancing the utility of Proteomics Signature Profiling (PSP) with Pathway Derived Subnets (PDSs), performance analysis and specialised ontologies. ongoing research,therapeutic application,unassigned 3,1,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27318371&form=6&db=m Paraneoplastic syndrome mimicking progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32184379&form=6&db=m FLCN-regulated miRNAs suppressed reparative response in cells and pulmonary lesions of Birt-Hogg-Dubé syndrome. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33357311&form=6&db=m [Analysis of Clinical Characteristics of 35 Cases ?of Pulmonary Sclerosing Pneumocytoma]. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,1,0 3.1.3.3 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11577990&form=6&db=m Recombinant expression of perchloric acid-soluble protein reduces cell proliferation. ongoing research,unassigned 4,0 3.1.3.3 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12939504&form=6&db=m Down regulation of a novel protein, PSP, in rat hepatoma cdRLh 84-beared tumor. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,4,0 3.1.3.3 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25793315&form=6&db=m cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. causal interaction,unassigned 3,0 3.1.3.3 Carcinoma, Lewis Lung http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11467773&form=6&db=m Differences in association of the serine/threonine protein phosphatase PP-2A with microtubules of metastatic and nonmetastatic tumor cells. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,2,0 3.1.3.3 Carcinoma, Non-Small-Cell Lung http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23324392&form=6&db=m Enhancing the utility of Proteomics Signature Profiling (PSP) with Pathway Derived Subnets (PDSs), performance analysis and specialised ontologies. ongoing research,therapeutic application,unassigned 3,1,0 3.1.3.3 Carcinoma, Non-Small-Cell Lung http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30977310&form=6&db=m Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 3.1.3.3 Carcinoma, Renal Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32184379&form=6&db=m FLCN-regulated miRNAs suppressed reparative response in cells and pulmonary lesions of Birt-Hogg-Dubé syndrome. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Carcinoma, Small Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27318371&form=6&db=m Paraneoplastic syndrome mimicking progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Carcinoma, Squamous Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33357311&form=6&db=m [Analysis of Clinical Characteristics of 35 Cases ?of Pulmonary Sclerosing Pneumocytoma]. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,1,0 3.1.3.3 Carcinoma, Transitional Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19626897&form=6&db=m [A fluorescent dye method based on changes in membrane potential for detecting PSP toxins in shellfish] ongoing research,unassigned 2,0 3.1.3.3 Cardiomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12063245&form=6&db=m Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Cardiomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12554096&form=6&db=m The role of modulatory calcineurin-interacting proteins in calcineurin signaling. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Cardiomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14623295&form=6&db=m Structures of calcineurin and its complexes with immunophilins-immunosuppressants. therapeutic application,unassigned 1,0 3.1.3.3 Cardiomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16126726&form=6&db=m The essential role of MEKK3 signaling in angiotensin II-induced calcineurin/nuclear factor of activated T-cells activation. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Cardiomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16402360&form=6&db=m Functional and phenotypic relevance of differentially expressed proteins in calcineurin mutants of Caenorhabditis elegans. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Cardiomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16415348&form=6&db=m Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Cardiomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29926425&form=6&db=m Four and a half LIM domain protein signaling and cardiomyopathy. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28726657&form=6&db=m ECHOCARDIOGRAPHIC CHARACTERISTICS OF DIFFERENT WHO/ISH CARDIOVASCULAR DISEASE RISK GROUPS. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Cardiovascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33776440&form=6&db=m A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study. unassigned - 3.1.3.3 Cardiovascular Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31421036&form=6&db=m Clinical application of presepsin as diagnostic biomarker of infection: overview and updates. causal interaction,ongoing research,therapeutic application,unassigned 3,1,4,0 3.1.3.3 Cataract http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6630889&form=6&db=m [Experimental study of changes in the pressure of the posterior segment of the eye under general anesthesia. Consequences for surgery of the anterior segment] therapeutic application,unassigned 1,0 3.1.3.3 Cellulitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29222939&form=6&db=m Which outcomes are reported in cellulitis trials? Results of a review of outcomes included in cellulitis trials and a patient priority setting survey. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19412943&form=6&db=m Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20086286&form=6&db=m The linear vestibulo-ocular reflex, locomotion and falls in neurological disorders. therapeutic application,unassigned 1,0 3.1.3.3 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22883477&form=6&db=m Deterioration of horizontal saccades in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,2,3,1 3.1.3.3 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24529226&form=6&db=m Cerebellar dentate nucleus in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 3,4,0 3.1.3.3 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26138942&form=6&db=m When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. unassigned - 3.1.3.3 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27861346&form=6&db=m Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia: Case report. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27915581&form=6&db=m FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28386688&form=6&db=m Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28415165&form=6&db=m Progressive Supranuclear Gaze Palsy with Predominant Cerebellar Ataxia: A Case Series with Videos. causal interaction,diagnostic usage,unassigned 2,3,0 3.1.3.3 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29191439&form=6&db=m Effects of cerebellar neuromodulation in movement disorders: A systematic review. therapeutic application,unassigned 1,0 3.1.3.3 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31847511&form=6&db=m Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,4,0 3.1.3.3 Cerebellar Ataxia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31865188&form=6&db=m Differences in cerebellar perfusion between Parkinson's disease and multiple system atrophy. diagnostic usage,unassigned 2,0 3.1.3.3 Cerebellar Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31552724&form=6&db=m Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes. diagnostic usage,therapeutic application,unassigned 3,2,0 3.1.3.3 Cerebellar Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33632587&form=6&db=m Deciphering the saccade velocity profile of progressive supranuclear palsy: A sign of latent cerebellar/brainstem dysfunction? causal interaction,diagnostic usage,ongoing research,unassigned 3,1,1,0 3.1.3.3 Cerebral Amyloid Angiopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3561771&form=6&db=m Progressive supranuclear palsy and a multi-infarct state. unassigned - 3.1.3.3 Cerebral Cortical Thinning http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31641878&form=6&db=m 18F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Cerebral Cortical Thinning http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33854426&form=6&db=m Integrated 18F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Cerebral Infarction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2178061&form=6&db=m Multi-infarct progressive supranuclear palsy--case report. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Cerebral Infarction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30365125&form=6&db=m Protective effect of polysaccharide peptide on cerebral ischemia?reperfusion injury in rats. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,4,0 3.1.3.3 Cerebral Infarction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33761707&form=6&db=m Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Cerebrovascular Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964687&form=6&db=m Vascular progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,3,0 3.1.3.3 Cerebrovascular Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12784275&form=6&db=m Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study. diagnostic usage,unassigned 2,0 3.1.3.3 Cerebrovascular Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17010515&form=6&db=m No evidence of CRHR1 gene involvement in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Cerebrovascular Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32125724&form=6&db=m Copathology in Progressive Supranuclear Palsy: Does It Matter? causal interaction,unassigned 2,0 3.1.3.3 Cerebrovascular Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33967937&form=6&db=m Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Cholangiocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28540797&form=6&db=m Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Cholera http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1658015&form=6&db=m Regulation of the transmodulated epidermal growth factor receptor by cholera toxin and the protein phosphatase inhibitor okadaic acid. causal interaction,ongoing research,therapeutic application,unassigned 1,4,2,0 3.1.3.3 Chronic Traumatic Encephalopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28653647&form=6&db=m Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Chronic Traumatic Encephalopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31695675&form=6&db=m Frontrunner in Translation: Progressive Supranuclear Palsy. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Colitis, Ulcerative http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31081461&form=6&db=m Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. therapeutic application,unassigned 1,0 3.1.3.3 Colonic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10896920&form=6&db=m Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers. ongoing research,therapeutic application,unassigned 2,1,0 3.1.3.3 Colonic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28805452&form=6&db=m Birt-Hogg-Dube Syndrome with a Novel Mutation in the FLCN Gene. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15657874&form=6&db=m A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27349874&form=6&db=m Inhibition of phosphoserine phosphatase enhances the anticancer efficacy of 5-fluorouracil in colorectal cancer. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,3,0 3.1.3.3 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28476802&form=6&db=m Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,2,1 3.1.3.3 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29307989&form=6&db=m Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Communicable Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32333860&form=6&db=m Presepsin in risk stratification of SARS-CoV-2 patients. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Complex Regional Pain Syndromes http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33469900&form=6&db=m Poststroke Pain. causal interaction,unassigned 1,0 3.1.3.3 Confusion http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8628467&form=6&db=m Limited usefulness of electroconvulsive therapy in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,2 3.1.3.3 Confusion http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14673883&form=6&db=m Health-related quality of life in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Confusion http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20972003&form=6&db=m PATH47 Slow saccades in bulbar-onset motor neuron disease. unassigned - 3.1.3.3 Confusion http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32831405&form=6&db=m qPCR assays for Alexandrium fundyense and A. ostenfeldii (Dinophyceae) identified from Alaskan waters and a review of species-specific Alexandrium molecular assays. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Congenital Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16941460&form=6&db=m Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,1,1 3.1.3.3 Congenital Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17072698&form=6&db=m Anesthetic management of a patient with progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Congenital Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29351696&form=6&db=m Risk of Primary Spontaneous Pneumothorax According to Chest Configuration. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Congenital Abnormalities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32362539&form=6&db=m A meta-analysis of the pros and cons of partial superficial parotidectomy versus superficial parotidectomy for the treatment of benign parotid neoplasms. causal interaction,therapeutic application,unassigned 1,4,0 3.1.3.3 Contracture http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26589312&form=6&db=m Novel Report of Phosphoserine Phosphatase Deficiency in an Adult with Myeloneuropathy and Limb Contractures. causal interaction,unassigned 4,0 3.1.3.3 Contracture http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26888760&form=6&db=m Erratum to: Novel Report of Phosphoserine Phosphatase Deficiency in an Adult with Myeloneuropathy and Limb Contractures. causal interaction,unassigned 4,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8673495&form=6&db=m What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features? causal interaction,ongoing research,unassigned 1,4,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8761994&form=6&db=m Cortical ballooned neurons in progressive supranuclear palsy. unassigned - 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8841954&form=6&db=m Structural basis of dementia in neurodegenerative disorders. causal interaction,unassigned 1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8937777&form=6&db=m Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9055798&form=6&db=m Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9194894&form=6&db=m Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy. unassigned - 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9577667&form=6&db=m [Progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10378376&form=6&db=m Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10718204&form=6&db=m Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 1,3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11217688&form=6&db=m [A 57-year-old woman with progressive disturbance of gait and mental deterioration] causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11441873&form=6&db=m [A 68-year-old man with speech disturbance as the initial symptom followed by bradykinesia and dementia. Clinical conference] diagnostic usage,therapeutic application,unassigned 2,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11940310&form=6&db=m [The application of Gallyas-Braak stainings in pathologic diagnosis of neurodegenerative diseases] diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12084445&form=6&db=m Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. unassigned - 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12410387&form=6&db=m Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains. ongoing research,unassigned 2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15178937&form=6&db=m Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15641585&form=6&db=m Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies. unassigned - 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16033782&form=6&db=m The evolution and pathology of frontotemporal dementia. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16157754&form=6&db=m Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16823854&form=6&db=m Unexpected abundance of pathological tau in progressive supranuclear palsy white matter. unassigned - 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16897134&form=6&db=m Neuroimaging of PD, PSP, CBD and MSA-PET and SPECT studies. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16987883&form=6&db=m Untangling the tau gene association with neurodegenerative disorders. causal interaction,unassigned 4,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17080728&form=6&db=m Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies. ongoing research,unassigned 2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17709155&form=6&db=m Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18267272&form=6&db=m MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice. diagnostic usage,therapeutic application,unassigned 2,3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18315566&form=6&db=m Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats. diagnostic usage,unassigned 1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18971445&form=6&db=m Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18972544&form=6&db=m Applause sign in Parkinsonian disorders and Huntington's disease. diagnostic usage,ongoing research,therapeutic application,unassigned 4,4,3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18989114&form=6&db=m Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19099114&form=6&db=m Clinical features of dystonia in atypical parkinsonism. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19647470&form=6&db=m Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical parkinsonian disorders. causal interaction,unassigned 3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20610990&form=6&db=m Neuropathology of variants of progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20847421&form=6&db=m A combination of CSF tau ratio and midsaggital midbraintopons atrophy for the early diagnosis of progressive supranuclear palsy. ongoing research,unassigned 1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21690028&form=6&db=m [Progressive supranuclear palsy: what's new?]. diagnostic usage,therapeutic application,unassigned 3,3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21817180&form=6&db=m [A 62-year-old Woman Presenting with Progressive Nonfluent Aphasia, Apraxia of Eyelid Opening, Supranuclear Gaze Palsy, and Asymmetric Rigidity]. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22488922&form=6&db=m Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22556362&form=6&db=m Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. causal interaction,unassigned 3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22862741&form=6&db=m Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies. causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23432126&form=6&db=m Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. causal interaction,unassigned 1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23436751&form=6&db=m Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23603177&form=6&db=m The Value of GRE, ADC and Routine MRI in Distinguishing Parkinsonian Disorders. diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24041972&form=6&db=m Microtubule-associated protein tau genetic variations are uncommon cause of frontotemporal dementia in south India. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24366105&form=6&db=m Unilateral perseveration. causal interaction,therapeutic application,unassigned 2,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24566396&form=6&db=m Neuronal correlates of clinical asymmetry in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 2,3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24759627&form=6&db=m Family history of frontotemporal lobar degeneration in Asia - an international multi-center research. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26227957&form=6&db=m An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome. causal interaction,unassigned 3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26439704&form=6&db=m The Relationship Between Development of Neuronal and Astrocytic Tau Pathologies in Subcortical Nuclei and Progression of Argyrophilic Grain Disease. therapeutic application,unassigned 1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26823029&form=6&db=m Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases. diagnostic usage,unassigned 3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26980757&form=6&db=m Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations. ongoing research,unassigned 1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27061067&form=6&db=m Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27411806&form=6&db=m MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome. diagnostic usage,ongoing research,unassigned 4,3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27553513&form=6&db=m Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseases. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27709685&form=6&db=m Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27774334&form=6&db=m Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28179466&form=6&db=m Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28207803&form=6&db=m Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms. diagnostic usage,therapeutic application,unassigned 2,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28256434&form=6&db=m Pathologic correlates of supranuclear gaze palsy with parkinsonism. causal interaction,unassigned 3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28386688&form=6&db=m Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28500752&form=6&db=m Which ante mortem clinical features predict progressive supranuclear palsy pathology? causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28510312&form=6&db=m The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28906054&form=6&db=m Neuropathological comorbidity associated with argyrophilic grain disease. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30348994&form=6&db=m APOE ?2 is associated with increased tau pathology in primary tauopathy. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30894142&form=6&db=m Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation. diagnostic usage,unassigned 3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30989369&form=6&db=m Motor, cognitive and behavioral differences in MDS PSP phenotypes. causal interaction,diagnostic usage,ongoing research,unassigned 2,3,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31155302&form=6&db=m Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,2,2 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31319800&form=6&db=m Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report. diagnostic usage,unassigned 2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31414383&form=6&db=m CSF sAPP? and sAPP? levels in Alzheimer's Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis. causal interaction,unassigned 4,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31416793&form=6&db=m Profound degeneration of wake-promoting neurons in Alzheimer's disease. unassigned - 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31506735&form=6&db=m Late-onset Niemann-Pick disease type C overlapping with frontotemporal dementia syndromes: a case report. diagnostic usage,unassigned 3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31552724&form=6&db=m Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes. diagnostic usage,therapeutic application,unassigned 3,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31621617&form=6&db=m Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study. unassigned - 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31656263&form=6&db=m [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report]. unassigned - 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31695675&form=6&db=m Frontrunner in Translation: Progressive Supranuclear Palsy. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31779824&form=6&db=m Progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31837067&form=6&db=m Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders. causal interaction,ongoing research,unassigned 1,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31999351&form=6&db=m Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32075473&form=6&db=m Progressive supranuclear palsy presenting with hyperkinetic movement disorder and hemiplegic dystonia: a case report. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32389545&form=6&db=m Is brain perfusion a differentiating feature in the comparison of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)? diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33125873&form=6&db=m High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies. ongoing research,unassigned 1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33581485&form=6&db=m Association of PSP phenotypes with survival: A brain-bank study. diagnostic usage,unassigned 3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33714084&form=6&db=m A novel diagnostic marker for progressive supranuclear palsy targeting atrophy of the subthalamic nucleus. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34062646&form=6&db=m Environmental Risk Factors for Progressive Supranuclear Palsy. causal interaction,diagnostic usage,unassigned 3,1,0 3.1.3.3 Corticobasal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34398211&form=6&db=m Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study. ongoing research,unassigned 1,0 3.1.3.3 Cough http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27424849&form=6&db=m Cough reflex attenuation and swallowing dysfunction in sub-acute post-stroke patients: prevalence, risk factors, and clinical outcome. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Cough http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29221270&form=6&db=m Analysis of the clinical differentiation of pulmonary sclerosing pneumocytoma and lung cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,3 3.1.3.3 Cough http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32311952&form=6&db=m Comparison of tracheal intubation with controlled ventilation and laryngeal mask airway with spontaneous ventilation for thoracoscopic bullectomy. diagnostic usage,therapeutic application,unassigned 1,3,0 3.1.3.3 Cough http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32687232&form=6&db=m The Role of Vocal Fold Bowing on Cough and Swallowing Dysfunction in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,2,1 3.1.3.3 Cough http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33515312&form=6&db=m Immediate Effects of Sensorimotor Training in Airway Protection (smTAP) on Cough Outcomes in Progressive Supranuclear Palsy: A Feasibility Study. causal interaction,ongoing research,therapeutic application,unassigned 3,3,4,0 3.1.3.3 Cough http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34173683&form=6&db=m Sensorimotor Cough Dysfunction Is Prevalent and Pervasive in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,3,1 3.1.3.3 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32333860&form=6&db=m Presepsin in risk stratification of SARS-CoV-2 patients. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33322095&form=6&db=m How Have Public Safety Personnel Seeking Digital Mental Healthcare Been Affected by the COVID-19 Pandemic? An Exploratory Mixed Methods Study. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 COVID-19 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33972808&form=6&db=m Periphery-aware COVID-19 diagnosis with contrastive representation enhancement. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Craniocerebral Trauma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8710069&form=6&db=m Follow-up study of risk factors in progressive supranuclear palsy. unassigned - 3.1.3.3 Creutzfeldt-Jakob Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15142229&form=6&db=m Creutzfeldt-Jakob disease presenting as progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Creutzfeldt-Jakob Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23300100&form=6&db=m [The genetics of corticobasal syndrome]. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Crohn Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31081461&form=6&db=m Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. therapeutic application,unassigned 1,0 3.1.3.3 Cross Infection http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10876895&form=6&db=m [The use of data on the composition and drug resistance of the causative agents of suppuration in a retrospective analysis of the epidemiological situation in a hospital] diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,1,0 3.1.3.3 Cysts http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10858525&form=6&db=m Saxitoxin and neosaxitoxin as toxic principles of Alexandrium andersoni (Dinophyceae) from the Gulf of Naples, Italy. ongoing research,unassigned 1,0 3.1.3.3 Cysts http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11024496&form=6&db=m Determination of paralytic shellfish toxins in Portuguese shellfish by automated pre-column oxidation. unassigned - 3.1.3.3 Cysts http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19651381&form=6&db=m Evidence-based management of paediatric primary spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 3,2,0 3.1.3.3 Cysts http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21658755&form=6&db=m Source and profile of paralytic shellfish poisoning toxins in shellfish in Daya Bay, South China Sea. causal interaction,unassigned 3,0 3.1.3.3 Cysts http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26398834&form=6&db=m Promoter methylation is not associated with FLCN irregulation in lung cyst lesions of primary spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Cysts http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28040101&form=6&db=m Termination of a toxic Alexandrium bloom with hydrogen peroxide. unassigned - 3.1.3.3 Cysts http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28690476&form=6&db=m Dynamics of Alexandrium fundyense blooms and shellfish toxicity in the Nauset Marsh System of Cape Cod (Massachusetts, USA). causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Cysts http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31194169&form=6&db=m Pulmonary sclerosing pneumocytoma demonstrating intratumoral hematoma. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1566133&form=6&db=m Low body weight in Parkinson's disease. diagnostic usage,unassigned 2,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8648326&form=6&db=m Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,4,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9159726&form=6&db=m Comparison of swallowing function in Parkinson's disease and progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,3,2 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9190099&form=6&db=m Dysphagia in progressive supranuclear palsy: radiologic features. causal interaction,unassigned 2,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11176964&form=6&db=m Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. causal interaction,diagnostic usage,therapeutic application,unassigned 2,2,3,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11332186&form=6&db=m [An assessment of dysphagia using videofluorography in Parkinson's disease and progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14673883&form=6&db=m Health-related quality of life in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18158316&form=6&db=m Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. unassigned - 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20629130&form=6&db=m Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,1,4 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21387699&form=6&db=m [A case of a syndrome resembling PSP after aortic arch replacement under deep hypothermic circulatory arrest]. therapeutic application,unassigned 1,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25253555&form=6&db=m Orofaryngeale slikstoornissen bij neurodegeneratieve aandoeningen. causal interaction,ongoing research,unassigned 1,2,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27424849&form=6&db=m Cough reflex attenuation and swallowing dysfunction in sub-acute post-stroke patients: prevalence, risk factors, and clinical outcome. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28250027&form=6&db=m Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28702192&form=6&db=m Freezing of gait is an early clinical feature of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28799303&form=6&db=m Clinical Profile of Dysphagia in Patients with Parkinson's Disease, Progressive Supranuclear Palsy and Multiple System Atrophy. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28918891&form=6&db=m Case diagnosis and characterization of suspected paralytic shellfish poisoning in Alaska. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,1,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29457122&form=6&db=m A case of spinal anesthesia in a patient with progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31676923&form=6&db=m Dysphagia in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,1,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31796642&form=6&db=m Natural clinical course of progressive supranuclear palsy in Chinese patients in Hong Kong. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32959131&form=6&db=m Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,1,0 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33761707&form=6&db=m Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Deglutition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34054712&form=6&db=m Usefulness of the Neutrophil-to-Lymphocyte Ratio as a Predictor of Pneumonia and Urinary Tract Infection Within the First Week After Acute Ischemic Stroke. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Dehydration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25462971&form=6&db=m Contribution of arbuscular mycorrhizal fungi and/or bacteria to enhancing plant drought tolerance under natural soil conditions: effectiveness of autochthonous or allochthonous strains. unassigned - 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1308417&form=6&db=m [Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of a case and review of the literature] causal interaction,unassigned 4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1520562&form=6&db=m [The thalamic changes in progressive supranuclear palsy] causal interaction,unassigned 4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1827513&form=6&db=m Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. diagnostic usage,unassigned 2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1837977&form=6&db=m Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2676308&form=6&db=m [Palilalia associated with progressive supranuclear palsy] causal interaction,unassigned 2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2721044&form=6&db=m Early progressive supranuclear palsy: pathology and clinical presentation. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3315157&form=6&db=m Progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6107328&form=6&db=m Progressive supranuclear palsy: clinico-pathological and biochemical studies. causal interaction,unassigned 1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7501785&form=6&db=m Psychiatric symptoms in progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7644044&form=6&db=m The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7799001&form=6&db=m The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7955710&form=6&db=m [Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 2,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964698&form=6&db=m Cognitive disturbances in progressive supranuclear palsy. unassigned - 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8301879&form=6&db=m Concentration of neural thread protein in cerebrospinal fluid from progressive supranuclear palsy and Parkinson's disease. causal interaction,unassigned 3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8370199&form=6&db=m [Event-related potentials in progressive supranuclear palsy] causal interaction,unassigned 4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8710069&form=6&db=m Follow-up study of risk factors in progressive supranuclear palsy. unassigned - 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8780065&form=6&db=m Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8928621&form=6&db=m Progressive supranuclear palsy: a clinicopathological study of 21 cases. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8937777&form=6&db=m Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9014435&form=6&db=m [Progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9055798&form=6&db=m Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9125748&form=6&db=m [A 85-year-old woman with the onset of progressive gait disturbance at 80 years of the age] diagnostic usage,therapeutic application,unassigned 3,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9294327&form=6&db=m [Progressive supranuclear palsy with macular degeneration--report of three cases] causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9546292&form=6&db=m Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9577667&form=6&db=m [Progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9779658&form=6&db=m Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9877531&form=6&db=m Clinical and genetic aspects of progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10218631&form=6&db=m Progressive supranuclear palsy with dementia: cortical pathology. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10388790&form=6&db=m Clinical genetics of familial progressive supranuclear palsy. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10417247&form=6&db=m Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. unassigned - 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10522887&form=6&db=m Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10824455&form=6&db=m Visual event-related potentials in progressive supranuclear palsy. unassigned - 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10852537&form=6&db=m Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,1,3 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10967656&form=6&db=m [An autopsy case of corticobasal degeneration without prominent cortical pathology--an imitator of progressive supranuclear palsy] diagnostic usage,ongoing research,unassigned 1,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11032614&form=6&db=m Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11054490&form=6&db=m Somatosensory evoked potentials in progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11217688&form=6&db=m [A 57-year-old woman with progressive disturbance of gait and mental deterioration] causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11699567&form=6&db=m Progressive supranuclear palsy on Guam. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11912113&form=6&db=m Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,1,1 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12071638&form=6&db=m Argyrophilic grain disease is a sporadic 4-repeat tauopathy. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12584413&form=6&db=m Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. causal interaction,unassigned 4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14502669&form=6&db=m Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. diagnostic usage,unassigned 3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15641585&form=6&db=m Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies. unassigned - 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15651349&form=6&db=m [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis] diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15754175&form=6&db=m Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study. diagnostic usage,ongoing research,unassigned 4,3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15788542&form=6&db=m Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,1,1 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16015014&form=6&db=m Natural history of progressive supranuclear palsy: a clinicopathologic study from a population of brain donors. causal interaction,unassigned 3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16033782&form=6&db=m The evolution and pathology of frontotemporal dementia. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16093225&form=6&db=m Cognitive and behavioral aspects of PSP since Steele, Richardson and Olszewski's description of PSP 40 years ago and Albert's delineation of the subcortical dementia 30 years ago. therapeutic application,unassigned 1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16093226&form=6&db=m Limb apraxia and cognitive impairment in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16093228&form=6&db=m Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17097770&form=6&db=m Voxel-based morphometry in autopsy proven PSP and CBD. unassigned - 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17178818&form=6&db=m The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17483697&form=6&db=m Muscarinic receptors in the thalamus in progressive supranuclear palsy and other neurodegenerative disorders. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,2,1 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17534953&form=6&db=m Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17675576&form=6&db=m Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of parkinsonism-dementia complex of Guam but not alzheimer's disease or progressive supranuclear palsy. causal interaction,ongoing research,therapeutic application,unassigned 3,2,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17709155&form=6&db=m Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18315566&form=6&db=m Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats. diagnostic usage,unassigned 1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18691446&form=6&db=m Differentiation of PA from early PSP with different patterns of symptoms and CBF reduction. unassigned - 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18971445&form=6&db=m Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18989114&form=6&db=m Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18992014&form=6&db=m Progressive supranuclear palsy combined with Alzheimer's disease: A clinicopathological study of two autopsy cases. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19458322&form=6&db=m Familial aggregation of parkinsonism in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19733862&form=6&db=m Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. therapeutic application,unassigned 1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20129321&form=6&db=m Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis. causal interaction,therapeutic application,unassigned 1,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20477368&form=6&db=m Diagnostic potential of saccadometry in progressive supranuclear palsy. diagnostic usage,therapeutic application,unassigned 3,3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20482608&form=6&db=m Familial aggregation in Progressive Supranuclear Palsy and Corticobasal Syndrome. diagnostic usage,unassigned 2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20512649&form=6&db=m Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20625759&form=6&db=m Familial aggregation in atypical Parkinson's disease: a case control study in multiple system atrophy and progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 4,2,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20798538&form=6&db=m Obsessive-compulsive behavior as a symptom of dementia in progressive supranuclear palsy. causal interaction,unassigned 2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21035623&form=6&db=m YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. causal interaction,unassigned 2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21420891&form=6&db=m Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP? causal interaction,diagnostic usage,ongoing research,unassigned 1,3,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21447110&form=6&db=m Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,2,4 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21856424&form=6&db=m Post mortem cerebrospinal fluid ?-synuclein levels are raised in multiple system atrophy and distinguish this from the other ?-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. unassigned - 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22347799&form=6&db=m Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22862741&form=6&db=m Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies. causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24041972&form=6&db=m Microtubule-associated protein tau genetic variations are uncommon cause of frontotemporal dementia in south India. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24086739&form=6&db=m A Novel MAPT Mutation, G55R, in a Frontotemporal Dementia Patient Leads to Altered Tau Function. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24575030&form=6&db=m Brain dopamine transporter binding and glucose metabolism in progressive supranuclear palsy-like creutzfeldt-jakob disease. causal interaction,unassigned 2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25253555&form=6&db=m Orofaryngeale slikstoornissen bij neurodegeneratieve aandoeningen. causal interaction,ongoing research,unassigned 1,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25501556&form=6&db=m Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25732053&form=6&db=m Progressive Supranuclear Palsy: What do we know About it? causal interaction,unassigned 3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26823029&form=6&db=m Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases. diagnostic usage,unassigned 3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26980757&form=6&db=m Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations. ongoing research,unassigned 1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27495201&form=6&db=m Diagnostic Approach to Atypical Parkinsonian Syndromes. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27915581&form=6&db=m FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28064358&form=6&db=m Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series. diagnostic usage,unassigned 4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28702192&form=6&db=m Freezing of gait is an early clinical feature of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28754841&form=6&db=m In vivo retention of (18)F-AV-1451 in corticobasal syndrome. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,3,1 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28881351&form=6&db=m Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,2,1 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29111000&form=6&db=m Natural history and predictors of survival in progressive supranuclear palsy. diagnostic usage,unassigned 4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29307562&form=6&db=m Anti-inflammatory drug use and progressive supranuclear palsy. causal interaction,unassigned 1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29339765&form=6&db=m Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29621183&form=6&db=m Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models. causal interaction,unassigned 4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30084194&form=6&db=m Patient and Public Involvement in Identifying Dementia Research Priorities. therapeutic application,unassigned 1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30989369&form=6&db=m Motor, cognitive and behavioral differences in MDS PSP phenotypes. causal interaction,diagnostic usage,ongoing research,unassigned 2,3,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31155302&form=6&db=m Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,2,2 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31333840&form=6&db=m How to spot ocular abnormalities in progressive supranuclear palsy? A practical review. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31414383&form=6&db=m CSF sAPP? and sAPP? levels in Alzheimer's Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis. causal interaction,unassigned 4,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31432258&form=6&db=m Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31433871&form=6&db=m Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,4,1 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31506735&form=6&db=m Late-onset Niemann-Pick disease type C overlapping with frontotemporal dementia syndromes: a case report. diagnostic usage,unassigned 3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31779824&form=6&db=m Progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31837067&form=6&db=m Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders. causal interaction,ongoing research,unassigned 1,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32220093&form=6&db=m Progressive Supranuclear Palsy and Statin Use. diagnostic usage,unassigned 2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32341240&form=6&db=m Alpha-synuclein Levels in the Differential Diagnosis of Lewy Bodies Dementia and Other Neurodegenerative Disorders: A Meta-analysis. diagnostic usage,unassigned 2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32408893&form=6&db=m It takes two to tango: carers' reflections on their participation and the participation of people with dementia in the James Lind Alliance process. causal interaction,ongoing research,therapeutic application,unassigned 3,1,2,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32416639&form=6&db=m Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32651138&form=6&db=m Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32731191&form=6&db=m Understanding the relationship between freezing of gait and other progressive supranuclear palsy features. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33385754&form=6&db=m Disease course and treatment patterns in progressive supranuclear palsy: A real-world study. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34002893&form=6&db=m ?-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease. diagnostic usage,ongoing research,unassigned 1,2,0 3.1.3.3 Demyelinating Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11442435&form=6&db=m Abnormal signals on proton density-weighted MRI of the superior cerebellar peduncle in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 2,3,4,0 3.1.3.3 Demyelinating Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28367478&form=6&db=m Central hypoventilation in progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 1,3,0 3.1.3.3 Depression, Postpartum http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23469738&form=6&db=m Supporting women with perinatal mental health problems: the role of the voluntary sector. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8501356&form=6&db=m Serum pancreatic stone protein in pancreatic diseases. causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27799841&form=6&db=m Optimizing insulin initiation in primary care: the Diabetes CoStars patient support program. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30426692&form=6&db=m Polygonatum sibiricum polysaccharide potentially attenuates diabetic retinal injury in a diabetic rat model. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31432066&form=6&db=m Antidiabetic activity of a polysaccharide-protein complex from Asian Clam (Corbicula fluminea) in streptozotoxin-induced diabetic rats and its underlying mechanism. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,1,0 3.1.3.3 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32031980&form=6&db=m Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33363351&form=6&db=m Black soybean tempeh and purple sweet potato improve sperm quality in streptozotocin-induced diabetic rats. unassigned - 3.1.3.3 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33967937&form=6&db=m Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27799841&form=6&db=m Optimizing insulin initiation in primary care: the Diabetes CoStars patient support program. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8189325&form=6&db=m Immunological characterization of pancreatic stone protein in human urine. unassigned - 3.1.3.3 Diabetic Nephropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9678681&form=6&db=m Urinary excretion of pancreatic stone protein in diabetic nephropathy. causal interaction,diagnostic usage,unassigned 3,4,0 3.1.3.3 Diabetic Retinopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33554697&form=6&db=m Polygonatum sibiricum polysaccharide inhibits high glucose-induced oxidative stress, inflammatory response, and apoptosis in RPE cells. ongoing research,unassigned 1,0 3.1.3.3 Disorders of Excessive Somnolence http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20185356&form=6&db=m Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study. causal interaction,unassigned 1,0 3.1.3.3 Drug-Related Side Effects and Adverse Reactions http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17477341&form=6&db=m Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off-Target Effects from Chemical Structure. diagnostic usage,ongoing research,unassigned 4,1,0 3.1.3.3 Dry Eye Syndromes http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28270126&form=6&db=m Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes. unassigned - 3.1.3.3 Dry Eye Syndromes http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31517725&form=6&db=m Prevalence of Novel Candidate Sjögren Syndrome Autoantibodies in the Penn Sjögren's International Collaborative Clinical Alliance Cohort. diagnostic usage,unassigned 3,0 3.1.3.3 Dry Socket http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29633581&form=6&db=m Persistent socket pain postenucleation and post evisceration: a systematic review. unassigned - 3.1.3.3 Duodenogastric Reflux http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3080289&form=6&db=m Comparative inhibition of coffee-induced gastric acid secretion employing misoprostol and cimetidine. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1566133&form=6&db=m Low body weight in Parkinson's disease. diagnostic usage,unassigned 2,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2721044&form=6&db=m Early progressive supranuclear palsy: pathology and clinical presentation. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8451002&form=6&db=m Perceptual analysis of speech disorders in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11176964&form=6&db=m Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. causal interaction,diagnostic usage,therapeutic application,unassigned 2,2,3,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14673883&form=6&db=m Health-related quality of life in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18688134&form=6&db=m Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18691446&form=6&db=m Differentiation of PA from early PSP with different patterns of symptoms and CBF reduction. unassigned - 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20046384&form=6&db=m Major depressive disorder preceding the onset of progressive supranuclear palsy. causal interaction,ongoing research,unassigned 2,2,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20457507&form=6&db=m Acoustical Analysis of Speech in Progressive Supranuclear Palsy. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25371679&form=6&db=m Trial of Zolpidem, Eszopiclone, and Other GABA Agonists in a Patient with Progressive Supranuclear Palsy. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25683763&form=6&db=m Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25732053&form=6&db=m Progressive Supranuclear Palsy: What do we know About it? causal interaction,unassigned 3,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27111692&form=6&db=m Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration. causal interaction,diagnostic usage,unassigned 3,1,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27894006&form=6&db=m Distinct patterns of imprecise consonant articulation among Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. unassigned - 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28702192&form=6&db=m Freezing of gait is an early clinical feature of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28918891&form=6&db=m Case diagnosis and characterization of suspected paralytic shellfish poisoning in Alaska. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,1,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29191439&form=6&db=m Effects of cerebellar neuromodulation in movement disorders: A systematic review. therapeutic application,unassigned 1,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29457122&form=6&db=m A case of spinal anesthesia in a patient with progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Dysarthria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33719524&form=6&db=m Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Dyskinesias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16353177&form=6&db=m Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease. causal interaction,unassigned 2,0 3.1.3.3 Dyskinesias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17534959&form=6&db=m Levodopa responsiveness in disorders with parkinsonism: a review of the literature. therapeutic application,unassigned 1,0 3.1.3.3 Dyskinesias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29191439&form=6&db=m Effects of cerebellar neuromodulation in movement disorders: A systematic review. therapeutic application,unassigned 1,0 3.1.3.3 Dyskinesias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31087195&form=6&db=m Dyskinesia in multiple system atrophy and progressive supranuclear palsy. diagnostic usage,unassigned 1,0 3.1.3.3 Dyskinesias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33744691&form=6&db=m Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Dyspareunia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22422793&form=6&db=m The clinical features and management of perineal endometriosis with anal sphincter involvement: a clinical analysis of 31 cases. therapeutic application,unassigned 3,0 3.1.3.3 Dyspnea http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25814797&form=6&db=m Assessment of spontaneous pneumothorax in adults in a tertiary care hospital. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Dyspnea http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34304085&form=6&db=m Bilateral primary spontaneous pneumothorax with multiple bleb performed by VATS and wedge resection: A rare case in Indonesian adult and review article. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2215950&form=6&db=m Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. causal interaction,unassigned 2,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3627456&form=6&db=m Limb dystonia in progressive supranuclear palsy. therapeutic application,unassigned 2,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8060688&form=6&db=m [Widespread argentophilic structures in progressive supranuclear palsy--an autopsy case report] diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9120447&form=6&db=m Dystonia in progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 3,3,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9577667&form=6&db=m [Progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10388790&form=6&db=m Clinical genetics of familial progressive supranuclear palsy. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10525996&form=6&db=m Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. therapeutic application,unassigned 1,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11332186&form=6&db=m [An assessment of dysphagia using videofluorography in Parkinson's disease and progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11993530&form=6&db=m Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia. therapeutic application,unassigned 4,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12111365&form=6&db=m Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia. causal interaction,unassigned 4,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12691807&form=6&db=m Levodopa-induced oromandibular dystonia in progressive supranuclear palsy. causal interaction,ongoing research,unassigned 1,1,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16597502&form=6&db=m Laryngeal dystonia causing upper airway obstruction in progressive supranuclear palsy. therapeutic application,unassigned 1,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19099114&form=6&db=m Clinical features of dystonia in atypical parkinsonism. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21387699&form=6&db=m [A case of a syndrome resembling PSP after aortic arch replacement under deep hypothermic circulatory arrest]. therapeutic application,unassigned 1,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21690028&form=6&db=m [Progressive supranuclear palsy: what's new?]. diagnostic usage,therapeutic application,unassigned 3,3,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23603547&form=6&db=m [Dopaminergic drug-induced jaw-opening dystonia in a patient with progressive supranuclear palsy]. causal interaction,therapeutic application,unassigned 2,4,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24668247&form=6&db=m Nocturnal manifestations of atypical and vascular parkinsonism: How do they differ from Parkinson's disease? unassigned - 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24868411&form=6&db=m Levodopa-induced facial dystonia in a case of progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 3,2,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29191439&form=6&db=m Effects of cerebellar neuromodulation in movement disorders: A systematic review. therapeutic application,unassigned 1,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29196058&form=6&db=m Comparison of dystonia between Parkinson's disease and atypical parkinsonism: The clinical usefulness of dystonia distribution and characteristics in the differential diagnosis of parkinsonism. causal interaction,unassigned 1,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31579148&form=6&db=m Alternating flexed-extended posturing in progressive supranuclear palsy. therapeutic application,unassigned 1,0 3.1.3.3 Dystonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32075473&form=6&db=m Progressive supranuclear palsy presenting with hyperkinetic movement disorder and hemiplegic dystonia: a case report. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Dystonic Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3799710&form=6&db=m Progressive supranuclear palsy: report of a case with torticollis, blepharospasm, and dysfluency. causal interaction,unassigned 3,0 3.1.3.3 Echolalia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34017242&form=6&db=m Case Report: Barely Able to Speak, Can't Stop Echoing: Echolalic Dynamic Aphasia in Progressive Supranuclear Palsy. ongoing research,therapeutic application,unassigned 2,1,0 3.1.3.3 Empyema http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16364854&form=6&db=m Pleural space problems after living lobar transplantation. diagnostic usage,unassigned 4,0 3.1.3.3 Encephalitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9125748&form=6&db=m [A 85-year-old woman with the onset of progressive gait disturbance at 80 years of the age] diagnostic usage,therapeutic application,unassigned 3,2,0 3.1.3.3 Encephalitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29368307&form=6&db=m Hashimoto's encephalopathy presenting as pseudobulbar palsy. causal interaction,unassigned 4,0 3.1.3.3 Encephalitis, Arbovirus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15022178&form=6&db=m Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism? causal interaction,ongoing research,therapeutic application,unassigned 1,1,1,0 3.1.3.3 Endometrial Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14710095&form=6&db=m Membrane-associated serine/threonine protein phosphatase in endometrial cancer. diagnostic usage,ongoing research,unassigned 2,3,0 3.1.3.3 Epiretinal Membrane http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3174019&form=6&db=m Perisilicone proliferation after vitrectomy for proliferative vitreoretinopathy. therapeutic application,unassigned 1,0 3.1.3.3 Erythema Infectiosum http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12921761&form=6&db=m Detection of IgE anti-parvovirus B19 and increased CD23+ B cells in parvovirus B19 infection: relation to Th2 cytokines. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Esophageal Achalasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28745833&form=6&db=m Full-layer mucosal histology in achalasia: Histological epithelial wave is characteristic in "pinstripe pattern"-positive achalasia. diagnostic usage,unassigned 3,0 3.1.3.3 Esophageal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9457474&form=6&db=m A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,3,0 3.1.3.3 Esophageal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10696116&form=6&db=m The use of mushroom glucans and proteoglycans in cancer treatment. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Essential Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7723949&form=6&db=m Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Essential Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12225316&form=6&db=m Enlargements of somatosensory-evoked potentials in progressive supranuclear palsy. causal interaction,ongoing research,unassigned 4,4,0 3.1.3.3 Essential Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12411832&form=6&db=m The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-beta-carbomethoxy-3-beta-(4-fluorophenyl)-tropane in patients with movement disorders. causal interaction,diagnostic usage,ongoing research,unassigned 1,1,1,0 3.1.3.3 Essential Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27364040&form=6&db=m Obsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential Tremor. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Exotropia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19795006&form=6&db=m Exodeviated ophthalmoplegia in a patient with progressive supranuclear palsy. therapeutic application,unassigned 1,0 3.1.3.3 Facial Nerve Injuries http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20728030&form=6&db=m Superficial parotidectomy versus retrograde partial superficial parotidectomy in treating benign salivary gland tumor (pleomorphic adenoma). causal interaction,unassigned 2,0 3.1.3.3 Febrile Neutropenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30240355&form=6&db=m Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Fecal Incontinence http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22422793&form=6&db=m The clinical features and management of perineal endometriosis with anal sphincter involvement: a clinical analysis of 31 cases. therapeutic application,unassigned 3,0 3.1.3.3 Fetal Death http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24996551&form=6&db=m Perinatal and infant outcomes of prenatal diagnosis of heterotaxy syndrome (asplenia and polysplenia). diagnostic usage,unassigned 3,0 3.1.3.3 Foodborne Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=386250&form=6&db=m Measurements of paralytic shellfish poisons. A review of biological and chemical procedures. unassigned - 3.1.3.3 Foodborne Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17035133&form=6&db=m Saxitoxin puffer fish poisoning in the United States, with the first report of Pyrodinium bahamense as the putative toxin source. causal interaction,unassigned 2,0 3.1.3.3 Foodborne Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18728730&form=6&db=m Non-traditional vectors for paralytic shellfish poisoning. causal interaction,unassigned 2,0 3.1.3.3 Foodborne Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31786272&form=6&db=m Simultaneous determination of twelve paralytic shellfish poisoning toxins in bivalve molluscs by UPLC-MS/MS and its applications to a food poisoning incident. diagnostic usage,unassigned 1,0 3.1.3.3 Foot Deformities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16941460&form=6&db=m Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,1,1 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10495033&form=6&db=m Neurofibrillary tangle parkinsonian disorders--tau pathology and tau genetics. causal interaction,unassigned 3,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10530520&form=6&db=m The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases. causal interaction,unassigned 3,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11578815&form=6&db=m Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11861703&form=6&db=m Sequence analysis of tau in familial and sporadic progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12112206&form=6&db=m Further extension of the H1 haplotype associated with progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,3,1 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12220379&form=6&db=m Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders. causal interaction,ongoing research,unassigned 3,4,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12781592&form=6&db=m Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation. causal interaction,unassigned 4,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12847166&form=6&db=m Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP. causal interaction,diagnostic usage,unassigned 3,1,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14570999&form=6&db=m Parkinsonism plus syndrome--a review. causal interaction,unassigned 3,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14572447&form=6&db=m Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. causal interaction,ongoing research,unassigned 2,3,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15178937&form=6&db=m Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,1,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15390131&form=6&db=m Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration. causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16361371&form=6&db=m Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies. unassigned - 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16432153&form=6&db=m Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies. unassigned - 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16987883&form=6&db=m Untangling the tau gene association with neurodegenerative disorders. causal interaction,unassigned 4,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17709155&form=6&db=m Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,2,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17721707&form=6&db=m Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,1,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17878804&form=6&db=m [Neurophysiology of corticobasal degeneration] causal interaction,unassigned 3,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18362099&form=6&db=m Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,2,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18971445&form=6&db=m Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20610990&form=6&db=m Neuropathology of variants of progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20847421&form=6&db=m A combination of CSF tau ratio and midsaggital midbraintopons atrophy for the early diagnosis of progressive supranuclear palsy. ongoing research,unassigned 1,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21245475&form=6&db=m Applause sign: is it really specific for Parkinsonian disorders? Evidence from cortical dementias. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,3,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21447110&form=6&db=m Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,2,4 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21959586&form=6&db=m Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases. unassigned - 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21987561&form=6&db=m [Progressive nonfluent aphasia]. unassigned - 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22009441&form=6&db=m Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies. unassigned - 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22277388&form=6&db=m Frontotemporal lobar degeneration (FTLD) concept and classification update. causal interaction,unassigned 1,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23196569&form=6&db=m [Frontotemporal lobar degeneration (FTLD) - changes of its concept and classification based on aggregated proteins]. unassigned - 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23300100&form=6&db=m [The genetics of corticobasal syndrome]. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24086739&form=6&db=m A Novel MAPT Mutation, G55R, in a Frontotemporal Dementia Patient Leads to Altered Tau Function. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24759627&form=6&db=m Family history of frontotemporal lobar degeneration in Asia - an international multi-center research. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24992742&form=6&db=m [A clinical case of progressive supranuclear palsy with long-term frontal presentation preceding the onset of gaze palsy]. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,1,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25663411&form=6&db=m Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,1,3,1 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26324212&form=6&db=m The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,1,1 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26900156&form=6&db=m The Differential Diagnosis and Treatment of Atypical Parkinsonism. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27915581&form=6&db=m FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28881351&form=6&db=m Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,2,1 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30195029&form=6&db=m Energization and spoken language production: Evidence from progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31155302&form=6&db=m Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,2,2 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31433871&form=6&db=m Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,4,1 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31999351&form=6&db=m Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 3.1.3.3 Frontotemporal Dementia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32075473&form=6&db=m Progressive supranuclear palsy presenting with hyperkinetic movement disorder and hemiplegic dystonia: a case report. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15101498&form=6&db=m Non-Alzheimer's disease dementias: anatomic, clinical, and molecular correlates. ongoing research,therapeutic application,unassigned 3,3,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15986225&form=6&db=m Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16401843&form=6&db=m Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. diagnostic usage,ongoing research,therapeutic application,unassigned 4,1,1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17117169&form=6&db=m Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases? causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,4 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17721707&form=6&db=m Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18362099&form=6&db=m Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,2,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20156164&form=6&db=m New insights into biological markers of frontotemporal lobar degeneration spectrum. therapeutic application,unassigned 1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21554923&form=6&db=m Biomarkers in frontotemporal lobar degenerations-Progress and challenges. unassigned - 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22277388&form=6&db=m Frontotemporal lobar degeneration (FTLD) concept and classification update. causal interaction,unassigned 1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22818528&form=6&db=m Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS. causal interaction,diagnostic usage,ongoing research,unassigned 2,1,3,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23196569&form=6&db=m [Frontotemporal lobar degeneration (FTLD) - changes of its concept and classification based on aggregated proteins]. unassigned - 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24386122&form=6&db=m Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders. diagnostic usage,therapeutic application,unassigned 4,2,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26227957&form=6&db=m An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome. causal interaction,unassigned 3,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26413239&form=6&db=m Genetics of Progressive Supranuclear Palsy. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27260836&form=6&db=m Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease. causal interaction,unassigned 3,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29050232&form=6&db=m Progressive modulation of the human olfactory bulb transcriptome during Alzheimer´s disease evolution: novel insights into the olfactory signaling across proteinopathies. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29415231&form=6&db=m Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies. unassigned - 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30546007&form=6&db=m Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP. ongoing research,unassigned 1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30832741&form=6&db=m Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau). diagnostic usage,unassigned 2,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30999060&form=6&db=m The olfactory bulb proteotype differs across frontotemporal dementia spectrum. causal interaction,unassigned 1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32869362&form=6&db=m Sensitivity-Specificity of Tau and Amyloid ? Positron Emission Tomography in Frontotemporal Lobar Degeneration. unassigned - 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33125873&form=6&db=m High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies. ongoing research,unassigned 1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33662165&form=6&db=m First symptom guides diagnosis and prognosis in neurodegenerative diseases-a retrospective study of autopsy proven cases. causal interaction,unassigned 1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33754963&form=6&db=m Genetic pleiotropy and the shared pathological features of corticobasal degeneration and progressive supranuclear palsy: a case report and a review of the literature. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Frontotemporal Lobar Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34472165&form=6&db=m Seizure prevalence in neurodegenerative diseases-a study of autopsy proven cases. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,2,1,3 3.1.3.3 Gallstones http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8501356&form=6&db=m Serum pancreatic stone protein in pancreatic diseases. causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Ganglioglioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7745428&form=6&db=m Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Gaucher Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25145891&form=6&db=m Central ocular motor disorders, including gaze palsy and nystagmus. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Glioblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22158480&form=6&db=m Serine/threonine protein phosphatase 6 modulates the radiation sensitivity of glioblastoma. ongoing research,unassigned 2,0 3.1.3.3 Glioblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24309981&form=6&db=m Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Glioblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25411133&form=6&db=m Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[(18)F]fluoroethyl)-L-tyrosine PET. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Glioblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27399498&form=6&db=m 219?Liquid Biopsy Can Distinguish Recurrent Glioblastomas From Pseudoprogression and Radiation Necrosis After Concurrent Radiochemotherapy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,1,1,0 3.1.3.3 Glioblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29105360&form=6&db=m Pseudoprogression as an adverse event of glioblastoma therapy. unassigned - 3.1.3.3 Glioblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30070662&form=6&db=m Systemic siRNA delivery to tumors by cell-penetrating ?-helical polypeptide-based metastable nanoparticles. causal interaction,ongoing research,unassigned 3,1,0 3.1.3.3 Glioblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31208813&form=6&db=m Combined analysis of MGMT methylation and dynamic-susceptibility-contrast MRI for the distinction between early and pseudo-progression in glioblastoma patients. causal interaction,ongoing research,unassigned 1,1,0 3.1.3.3 Glioblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32129893&form=6&db=m Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma. therapeutic application,unassigned 4,0 3.1.3.3 Glioblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33105661&form=6&db=m A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma. ongoing research,unassigned 2,0 3.1.3.3 Glioblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33381018&form=6&db=m Can Tumor Location on Pre-treatment MRI Predict Likelihood of Pseudo-Progression vs. Tumor Recurrence in Glioblastoma?-A Feasibility Study. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Glioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11574781&form=6&db=m Evaluation of polysaccharopeptide effects against C6 glioma in combination with radiation. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,2,2 3.1.3.3 Glioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25145891&form=6&db=m Central ocular motor disorders, including gaze palsy and nystagmus. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Glioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26647493&form=6&db=m Pseudoprogression: Patient experience and nursing in uncertainty. causal interaction,ongoing research,therapeutic application,unassigned 2,2,1,0 3.1.3.3 Glioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27180091&form=6&db=m Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Glioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29594248&form=6&db=m Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma. diagnostic usage,ongoing research,therapeutic application,unassigned 1,3,3,0 3.1.3.3 Glioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30488294&form=6&db=m Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide. causal interaction,unassigned 3,0 3.1.3.3 Glioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31852075&form=6&db=m The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma: A meta-analysis. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Glioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32501974&form=6&db=m Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression. causal interaction,diagnostic usage,therapeutic application,unassigned 1,1,4,0 3.1.3.3 Glioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33341429&form=6&db=m Differentiating high-grade glioma recurrence from pseudoprogression: Comparing diffusion kurtosis imaging and diffusion tensor imaging. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,2,1 3.1.3.3 Hallucinations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17303592&form=6&db=m Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Hallucinations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18328771&form=6&db=m Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: A prospective study. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,2,3,1 3.1.3.3 Hallucinations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18941145&form=6&db=m Predominant cortical dysfunction in Guadeloupean parkinsonism. causal interaction,unassigned 4,0 3.1.3.3 Hallucinations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26788328&form=6&db=m Hydrocephalic Parkinsonism: lessons from normal pressure hydrocephalus mimics. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Hallucinations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31727210&form=6&db=m Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration. causal interaction,unassigned 2,0 3.1.3.3 Heart Failure http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29926425&form=6&db=m Four and a half LIM domain protein signaling and cardiomyopathy. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 HELLP Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12872421&form=6&db=m [Hepatic Rupture as a Complication of Hypertensive Disease of Pregnancy Maternal and the HELLP Syndrome] unassigned - 3.1.3.3 Hemangiosarcoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22988473&form=6&db=m Single agent polysaccharopeptide delays metastases and improves survival in naturally occurring hemangiosarcoma. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,4,0 3.1.3.3 Hematuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2615013&form=6&db=m In vitro immunoglobulin production by peripheral blood mononuclear cells as a prognostic factor in IgA nephropathy. causal interaction,unassigned 3,0 3.1.3.3 Hematuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7051750&form=6&db=m Renal glomerular changes associated with liver cirrhosis. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Hemorrhagic Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25997420&form=6&db=m Vascular Parkinsonism: deconstructing a syndrome. causal interaction,unassigned 3,0 3.1.3.3 Hemothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26042737&form=6&db=m The effect of pleural abrasion on the treatment of primary spontaneous pneumothorax: a systematic review of randomized controlled trials. causal interaction,diagnostic usage,therapeutic application,unassigned 2,2,2,0 3.1.3.3 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17299464&form=6&db=m Intake of purple sweet potato beverage affects on serum hepatic biomarker levels of healthy adult men with borderline hepatitis. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 3.1.3.3 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28595034&form=6&db=m Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. causal interaction,diagnostic usage,unassigned 3,2,0 3.1.3.3 Herpes Simplex http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3018018&form=6&db=m Detection of herpes simplex virus and adenovirus DNA by dot blot hybridization using in vitro synthesized RNA transcripts. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Herpes Zoster http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10824983&form=6&db=m Sperm surface proteins in mammalian fertilization. ongoing research,therapeutic application,unassigned 1,1,0 3.1.3.3 Herpes Zoster http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10954159&form=6&db=m Aggregated and monomeric forms of proteins in boar seminal plasma: characterization and binding properties. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,1,0 3.1.3.3 Hidradenitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31081461&form=6&db=m Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. therapeutic application,unassigned 1,0 3.1.3.3 HIV Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22160793&form=6&db=m Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Huntington Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7799001&form=6&db=m The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Huntington Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12220379&form=6&db=m Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders. causal interaction,ongoing research,unassigned 3,4,0 3.1.3.3 Huntington Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18972544&form=6&db=m Applause sign in Parkinsonian disorders and Huntington's disease. diagnostic usage,ongoing research,therapeutic application,unassigned 4,4,3,0 3.1.3.3 Huntington Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28256434&form=6&db=m Pathologic correlates of supranuclear gaze palsy with parkinsonism. causal interaction,unassigned 3,0 3.1.3.3 Hydrocephalus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4027083&form=6&db=m [Cerebrospinal fluid absorption mechanism--based on measurement of CSF flow rate in shunt tube] unassigned - 3.1.3.3 Hydrocephalus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4863106&form=6&db=m The in vitro evaluation of the PSP and indigo carmine tests for obstruction in hydrocephalus. diagnostic usage,unassigned 3,0 3.1.3.3 Hydrocephalus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7990846&form=6&db=m Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. diagnostic usage,therapeutic application,unassigned 2,3,0 3.1.3.3 Hydrocephalus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25997420&form=6&db=m Vascular Parkinsonism: deconstructing a syndrome. causal interaction,unassigned 3,0 3.1.3.3 Hydrocephalus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26788328&form=6&db=m Hydrocephalic Parkinsonism: lessons from normal pressure hydrocephalus mimics. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Hydrocephalus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32396693&form=6&db=m Magnetic Resonance Imaging Biomarkers Distinguish Normal Pressure Hydrocephalus From Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,3,0 3.1.3.3 Hydrocephalus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32416639&form=6&db=m Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Hydrocephalus, Normal Pressure http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26788328&form=6&db=m Hydrocephalic Parkinsonism: lessons from normal pressure hydrocephalus mimics. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Hydrocephalus, Normal Pressure http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32396693&form=6&db=m Magnetic Resonance Imaging Biomarkers Distinguish Normal Pressure Hydrocephalus From Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,3,0 3.1.3.3 Hyperalgesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33670311&form=6&db=m Subcutaneous ?-Conotoxins Alleviate Mechanical Pain in Rodent Models of Acute Peripheral Neuropathy. unassigned - 3.1.3.3 Hyperemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27288784&form=6&db=m Peripheral arterial endothelial dysfunction of neurodegenerative diseases. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Hyperglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33274214&form=6&db=m Seed Proteomic Profiles of Three Paeonia Varieties and Evaluation of Peony Seed Protein as a Food Product. causal interaction,therapeutic application,unassigned 4,3,0 3.1.3.3 Hyperhidrosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15219004&form=6&db=m Characterisation of pleural inflammation occurring after primary spontaneous pneumothorax. diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Hyperkinesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11748741&form=6&db=m Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Hyperkinesis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32075473&form=6&db=m Progressive supranuclear palsy presenting with hyperkinetic movement disorder and hemiplegic dystonia: a case report. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Hyperlipidemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28595034&form=6&db=m Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. causal interaction,diagnostic usage,unassigned 3,2,0 3.1.3.3 Hyperlipidemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30384541&form=6&db=m [Effect of polysaccharides from Polygonatum sibiricum on lipid-metabolism related mRNA and protein expression in hyperlipidemic mice]. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,1,1,1 3.1.3.3 Hyperlipidemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31030754&form=6&db=m Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,1,1 3.1.3.3 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1718146&form=6&db=m Immune enhancement of a polysaccharides peptides isolated from Coriolus versicolor. ongoing research,therapeutic application,unassigned 2,1,0 3.1.3.3 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2373292&form=6&db=m Use of the biventer cervicis nerve-muscle preparation to detect early changes following exposure to organophosphates inducing delayed neuropathy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,4,0 3.1.3.3 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9446842&form=6&db=m Dietary supplementation with mushroom-derived protein-bound glucan does not enhance immune function in young and old mice. unassigned - 3.1.3.3 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27478445&form=6&db=m Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherence. diagnostic usage,unassigned 1,0 3.1.3.3 Hypersensitivity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28926718&form=6&db=m Corrigendum. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2615013&form=6&db=m In vitro immunoglobulin production by peripheral blood mononuclear cells as a prognostic factor in IgA nephropathy. causal interaction,unassigned 3,0 3.1.3.3 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3419596&form=6&db=m Risk factors for progressive supranuclear palsy. diagnostic usage,unassigned 2,0 3.1.3.3 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6506359&form=6&db=m Relationship between postoperative blood pressure change and renal pathophysiology in primary aldosteronism. diagnostic usage,unassigned 2,0 3.1.3.3 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9138338&form=6&db=m [Incidence, etiology and prognostic value of persistent significant proteinuria in kidney transplants] causal interaction,diagnostic usage,unassigned 2,4,0 3.1.3.3 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=13274394&form=6&db=m Renal function studies in hypertension: with particular reference to the intravenous PSP test. ongoing research,therapeutic application,unassigned 2,1,0 3.1.3.3 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16154793&form=6&db=m Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP). causal interaction,diagnostic usage,ongoing research,unassigned 1,3,2,0 3.1.3.3 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31420308&form=6&db=m Hypertension and progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 3.1.3.3 Hypertension http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34062646&form=6&db=m Environmental Risk Factors for Progressive Supranuclear Palsy. causal interaction,diagnostic usage,unassigned 3,1,0 3.1.3.3 Hypesthesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21384428&form=6&db=m Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1308417&form=6&db=m [Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of a case and review of the literature] causal interaction,unassigned 4,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3315157&form=6&db=m Progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9055798&form=6&db=m Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10752576&form=6&db=m Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale. diagnostic usage,unassigned 2,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10967656&form=6&db=m [An autopsy case of corticobasal degeneration without prominent cortical pathology--an imitator of progressive supranuclear palsy] diagnostic usage,ongoing research,unassigned 1,2,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11731878&form=6&db=m Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,unassigned 2,4,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14502653&form=6&db=m Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14598074&form=6&db=m Natural history and clinical features of progressive supranuclear palsy: a clinical study. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15834857&form=6&db=m Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. unassigned - 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16772027&form=6&db=m Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20131396&form=6&db=m Clinical and dual-tasking aspects in frequent and infrequent fallers with progressive supranuclear palsy. unassigned - 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23236012&form=6&db=m Facial bradykinesia. unassigned - 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23760683&form=6&db=m Assessing bradykinesia in parkinsonian disorders. diagnostic usage,unassigned 3,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24963674&form=6&db=m Progressive supranuclear palsy. unassigned - 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27526039&form=6&db=m Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28982612&form=6&db=m Brain regional iron contents in progressive supranuclear palsy. therapeutic application,unassigned 1,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31216016&form=6&db=m Coexistence of Progressive Supranuclear Palsy With Pontocerebellar Atrophy and Myotonic Dystrophy Type 1. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,2,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33045651&form=6&db=m The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34461552&form=6&db=m Laboratory based assessment of gait and balance impairment in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Hypotension, Orthostatic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10869054&form=6&db=m Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy. ongoing research,unassigned 1,0 3.1.3.3 Hypotension, Orthostatic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27861346&form=6&db=m Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia: Case report. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Hypotension, Orthostatic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31484717&form=6&db=m Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension. causal interaction,diagnostic usage,unassigned 2,3,0 3.1.3.3 Hypothyroidism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16725120&form=6&db=m Adult-onset hypothyroidism impairs paired-pulse facilitation and long-term potentiation of the rat dorsal hippocampo-medial prefrontal cortex pathway in vivo. unassigned - 3.1.3.3 Hypoventilation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28367478&form=6&db=m Central hypoventilation in progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 1,3,0 3.1.3.3 Ichthyosis, Lamellar http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10511478&form=6&db=m The pathogenesis of severe congenital ichthyosis of the neonate. causal interaction,unassigned 3,0 3.1.3.3 Immune System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27478445&form=6&db=m Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherence. diagnostic usage,unassigned 1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1717346&form=6&db=m Stress-induced expression of the Escherichia coli phage shock protein operon is dependent on sigma 54 and modulated by positive and negative feedback mechanisms. therapeutic application,unassigned 3,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7596833&form=6&db=m Analysis of the proteins and cis-acting elements regulating the stress-induced phage shock protein operon. causal interaction,unassigned 1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7747731&form=6&db=m Pseudomonas peritonitis in peritoneal dialysis patients: the Network #9 Peritonitis Study. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9790132&form=6&db=m Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: a case-control study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10072755&form=6&db=m A phagemid vector using the E. coli phage shock promoter facilitates phage display of toxic proteins. unassigned - 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12921761&form=6&db=m Detection of IgE anti-parvovirus B19 and increased CD23+ B cells in parvovirus B19 infection: relation to Th2 cytokines. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16045608&form=6&db=m The phage-shock-protein response. causal interaction,unassigned 1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17198474&form=6&db=m Prognostic value of flow cytometry in surgically treated primary gastric lymphoma. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17966413&form=6&db=m Regulation of the phage-shock-protein stress response in Yersinia enterocolitica. unassigned - 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22326397&form=6&db=m Identification of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4-one derivatives as inhibitors of the phosphatase SerB653 in Porphyromonas gingivalis, implicated in periodontitis. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23098130&form=6&db=m The value of pancreatic stone protein in predicting acute appendicitis in patients presenting at the emergency department with abdominal pain. ongoing research,unassigned 1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23296629&form=6&db=m Pancreatic stone protein as a novel marker for neonatal sepsis. diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24007786&form=6&db=m PSP and NT-proCNP assessed for predisposition to infection. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25705419&form=6&db=m A validation of presepsin levels in kidney dysfunction patients: four case reports. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,4,1 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25793700&form=6&db=m Pancreatic stone protein predicts postoperative infection in cardiac surgery patients irrespective of cardiopulmonary bypass or surgical technique. diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25823228&form=6&db=m Leishmania donovani secretory serine protease alters macrophage inflammatory response via COX-2 mediated PGE-2 production. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25912382&form=6&db=m vRNA structured population model for Hepatitis C Virus dynamics. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26044874&form=6&db=m Polysaccharide peptide from Coriolus versicolor induces interleukin 6-related extension of endotoxin fever in rats. causal interaction,ongoing research,therapeutic application,unassigned 4,2,4,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26286986&form=6&db=m Propagation of prions causing synucleinopathies in cultured cells. ongoing research,therapeutic application,unassigned 4,1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26336475&form=6&db=m Prognostic value of sCD14-ST (presepsin) in cardiac surgery. causal interaction,diagnostic usage,ongoing research,unassigned 2,1,1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26374246&form=6&db=m Evaluating the Role of Phage-Shock Protein A in Burkholderia pseudomallei. causal interaction,unassigned 2,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27446132&form=6&db=m Understanding the Impact of Drought on Foliar and Xylem Invading Bacterial Pathogen Stress in Chickpea. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28003058&form=6&db=m Effect of the endoparasite Amoebophrya sp. on toxin content and composition in the paralytic shellfish poisoning dinoflagellate Alexandrium fundyense (Dinophyceae). unassigned - 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28155994&form=6&db=m Pancreatic stone protein and soluble CD25 for infection and sepsis in an emergency department. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,3,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29497398&form=6&db=m Cerebrospinal Fluid Presepsin As a Marker of Nosocomial Infections of the Central Nervous System: A Prospective Observational Study. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30240355&form=6&db=m Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31208426&form=6&db=m Respiratory virus associated with surgery in children patients. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31408597&form=6&db=m [Inflammation markers and bloodstream infection (review of literature).] unassigned - 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31421036&form=6&db=m Clinical application of presepsin as diagnostic biomarker of infection: overview and updates. causal interaction,ongoing research,therapeutic application,unassigned 3,1,4,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31972652&form=6&db=m Pancreatic Stone Protein Predicts Sepsis in Severely Burned Patients Irrespective of Trauma Severity: A Monocentric Observational Study. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32333860&form=6&db=m Presepsin in risk stratification of SARS-CoV-2 patients. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33761707&form=6&db=m Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34049579&form=6&db=m Accuracy of pancreatic stone protein for the diagnosis of infection in hospitalized adults: a systematic review and individual patient level meta-analysis. diagnostic usage,ongoing research,therapeutic application,unassigned 4,3,1,0 3.1.3.3 Influenza, Human http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18841406&form=6&db=m Heterogeneous selective pressure acting on influenza B victoria- and yamagata-like hemagglutinins. diagnostic usage,ongoing research,unassigned 1,4,0 3.1.3.3 Insulin Resistance http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15975979&form=6&db=m Effects of calcineurin activation on insulin-, AICAR- and contraction-induced glucose transport in skeletal muscle. ongoing research,therapeutic application,unassigned 2,2,0 3.1.3.3 Intellectual Disability http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23665607&form=6&db=m Profile of children with poor school performance in Mumbai. causal interaction,unassigned 1,0 3.1.3.3 Intellectual Disability http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25080166&form=6&db=m Phosphoserine phosphatase (PSPH) gene mutation in an intellectual disability family from Pakistan. ongoing research,unassigned 1,0 3.1.3.3 Intellectual Disability http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26960553&form=6&db=m On the phenotypic spectrum of serine biosynthesis defects. causal interaction,unassigned 4,0 3.1.3.3 Ischemic Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16258676&form=6&db=m [Vascular Wallerian degeneration on magnetic resonance in a patient with probable progressive supranuclear palsy: aetiology or casual link?] ongoing research,therapeutic application,unassigned 2,3,0 3.1.3.3 Ischemic Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21841326&form=6&db=m Reduction of Neuromelanin-Positive Nigral Volume in Patients with MSA, PSP and CBD. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,1,0 3.1.3.3 Ischemic Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27430328&form=6&db=m Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,1 3.1.3.3 Ischemic Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31735079&form=6&db=m Risk stratification model for post-stroke pneumonia in patients with acute ischemic stroke. diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Ischemic Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33761707&form=6&db=m Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Kernicterus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6067403&form=6&db=m Serum albumin reserve PSP dye binding capacity in infants with kernicterus. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Kidney Failure, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8501356&form=6&db=m Serum pancreatic stone protein in pancreatic diseases. causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Kidney Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15657874&form=6&db=m A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Kidney Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22446046&form=6&db=m Novel in-frame deletion mutation in FLCN gene in a Korean family with recurrent primary spontaneous pneumothorax. unassigned - 3.1.3.3 Language Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19733862&form=6&db=m Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. therapeutic application,unassigned 1,0 3.1.3.3 Language Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34381350&form=6&db=m Language Disorder in Progressive Supranuclear Palsy and Corticobasal Syndrome: Neural Correlates and Detection by the MLSE Screening Tool. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,2,0 3.1.3.3 Learning Disabilities http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23665607&form=6&db=m Profile of children with poor school performance in Mumbai. causal interaction,unassigned 1,0 3.1.3.3 Leishmaniasis, Visceral http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25823228&form=6&db=m Leishmania donovani secretory serine protease alters macrophage inflammatory response via COX-2 mediated PGE-2 production. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1334850&form=6&db=m Augmentation of retinoic acid-induced granulocytic differentiation in HL-60 leukemia cells by serine/threonine protein phosphatase inhibitors. causal interaction,ongoing research,therapeutic application,unassigned 4,1,1,0 3.1.3.3 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1471606&form=6&db=m The anti-tumor effect of a small polypeptide from Coriolus versicolor (SPCV). causal interaction,unassigned 3,0 3.1.3.3 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15870943&form=6&db=m The cell death process of the anticancer agent polysaccharide-peptide (PSP) in human promyelocytic leukemic HL-60 cells. causal interaction,ongoing research,therapeutic application,unassigned 3,4,4,0 3.1.3.3 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15944782&form=6&db=m Induction of S phase cell arrest and caspase activation by polysaccharide peptide isolated from Coriolus versicolor enhanced the cell cycle dependent activity and apoptotic cell death of doxorubicin and etoposide, but not cytarabine in HL-60 cells. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,1,4 3.1.3.3 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18292947&form=6&db=m Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,4 3.1.3.3 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20423495&form=6&db=m Polysaccharopeptides derived from Coriolus versicolor potentiate the S-phase specific cytotoxicity of Camptothecin (CPT) on human leukemia HL-60 cells. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,1 3.1.3.3 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20557672&form=6&db=m Gossypol exerts its cytotoxic effect on HL-60 leukemic cell line via decreasing activity of protein phosphatase 2A and interacting with human telomerase reverse transcriptase activity. ongoing research,unassigned 4,0 3.1.3.3 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22035740&form=6&db=m A comparison of races and leukemia subtypes among patients in different cancer survivorship phases. unassigned - 3.1.3.3 Leukemia, Lymphocytic, Chronic, B-Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1859890&form=6&db=m Trisomy 12 in chronic lymphocytic leukemia: an interphase cytogenetic study. diagnostic usage,unassigned 3,0 3.1.3.3 Leukemia, Myeloid http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10374865&form=6&db=m Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors. causal interaction,unassigned 3,0 3.1.3.3 Leukemia, T-Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1295619&form=6&db=m Progressive spastic paraparesis associated with human T-cell leukemia virus type I (HTLV-I). diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Leukocytosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1295619&form=6&db=m Progressive spastic paraparesis associated with human T-cell leukemia virus type I (HTLV-I). diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8780065&form=6&db=m Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,3,0 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9006651&form=6&db=m Neurofibrillary tangles in the dentate granule cells of patients with Alzheimer's disease, Lewy body disease and progressive supranuclear palsy. unassigned - 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9055798&form=6&db=m Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10852537&form=6&db=m Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,1,3 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12172913&form=6&db=m Lewy bodies in progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14507342&form=6&db=m Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. diagnostic usage,unassigned 1,0 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24575030&form=6&db=m Brain dopamine transporter binding and glucose metabolism in progressive supranuclear palsy-like creutzfeldt-jakob disease. causal interaction,unassigned 2,0 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26227957&form=6&db=m An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome. causal interaction,unassigned 3,0 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27260836&form=6&db=m Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease. causal interaction,unassigned 3,0 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27553513&form=6&db=m Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseases. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29756231&form=6&db=m Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes. therapeutic application,unassigned 1,0 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29779682&form=6&db=m Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis. diagnostic usage,unassigned 1,0 3.1.3.3 Lewy Body Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31484717&form=6&db=m Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension. causal interaction,diagnostic usage,unassigned 2,3,0 3.1.3.3 Liver Cirrhosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8501356&form=6&db=m Serum pancreatic stone protein in pancreatic diseases. causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Liver Cirrhosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9261615&form=6&db=m Assessing the permeability of the gastrointestinal mucosa after oral administration of phenolsulfonphthalein. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 3.1.3.3 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9638432&form=6&db=m Significance of the peroral phenolsulfonphthalein test in hepatic resection: a possible predictor of bacterial translocation. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12843624&form=6&db=m Influence of liver disease on phenolsulfonphthalein absorption from liver surface to examine possibility of direct liver surface application for drug targeting. unassigned - 3.1.3.3 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31805321&form=6&db=m Proteoglycan isolated from Corbicula fluminea exerts hepato-protective effects against alcohol-induced liver injury in mice. diagnostic usage,therapeutic application,unassigned 2,4,0 3.1.3.3 Liver Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33095752&form=6&db=m Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection. causal interaction,unassigned 3,0 3.1.3.3 Liver Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23324392&form=6&db=m Enhancing the utility of Proteomics Signature Profiling (PSP) with Pathway Derived Subnets (PDSs), performance analysis and specialised ontologies. ongoing research,therapeutic application,unassigned 3,1,0 3.1.3.3 Lordosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15019793&form=6&db=m Induction of pseudopregnancy using artificial VCS: importance of lordosis intensity and prestimulus estrous cycle length. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,3,0 3.1.3.3 Lung Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15657874&form=6&db=m A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Lung Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17583135&form=6&db=m [Management of pneumothorax] causal interaction,unassigned 3,0 3.1.3.3 Lung Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27241265&form=6&db=m A biomechanical hypothesis for the pathophysiology of apical lung disease. causal interaction,unassigned 4,0 3.1.3.3 Lung Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30971282&form=6&db=m Unilateral single-port thoracoscopic surgery for bilateral pneumothorax or pulmonary bullae. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,1,2,4 3.1.3.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9457474&form=6&db=m A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,3,0 3.1.3.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12122559&form=6&db=m Toxicokinetics and effects of fibrous and nonfibrous particles. causal interaction,therapeutic application,unassigned 1,2,0 3.1.3.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27385997&form=6&db=m Pulmonary sclerosing pneumocytoma mimicking lung cancer: Case report and review of the literature. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27676292&form=6&db=m RHOB expression controls the activity of serine/threonine protein phosphatase PP2A to modulate mesenchymal phenotype and invasion in non-small cell lung cancers. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,2,0 3.1.3.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27876671&form=6&db=m Relevance of the rat lung tumor response to particle overload for human risk assessment-Update and interpretation of new data since ILSI 2000. unassigned - 3.1.3.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28818721&form=6&db=m Immunomodulatory effects of herbal formula of astragalus polysaccharide (APS) and polysaccharopeptide (PSP) in mice with lung cancer. unassigned - 3.1.3.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29221270&form=6&db=m Analysis of the clinical differentiation of pulmonary sclerosing pneumocytoma and lung cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,3 3.1.3.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29343453&form=6&db=m Polygonatum sibiricum polysaccharides play anti-cancer effect through TLR4-MAPK/NF-?B signaling pathways. unassigned - 3.1.3.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30977310&form=6&db=m Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 3.1.3.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31428771&form=6&db=m Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion: a case report. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31446747&form=6&db=m Phosphoserine Phosphatase Promotes Lung Cancer Progression through the Dephosphorylation of IRS-1 and a Noncanonical L-Serine-Independent Pathway. unassigned - 3.1.3.3 Lymphatic Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16201166&form=6&db=m [Resection of gastric carcinoma with preserving of the spleen and pancreas and functional clearance lymph nodes of the spleen hillus and splenic artery] causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Lymphatic Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31428771&form=6&db=m Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion: a case report. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Lymphatic Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32441345&form=6&db=m Clinical and histopathologic features of pulmonary sclerosing pneumocytoma with dense spindle stromal cells and lymph node metastasis. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Lymphatic Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32666331&form=6&db=m Pulmonary sclerosing pneumocytoma with mediastinal lymph node metastasis: a case report. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Lymphoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30365125&form=6&db=m Protective effect of polysaccharide peptide on cerebral ischemia?reperfusion injury in rats. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,4,0 3.1.3.3 Lymphoma, B-Cell http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15823484&form=6&db=m Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma. diagnostic usage,unassigned 3,0 3.1.3.3 Machado-Joseph Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9520070&form=6&db=m Hypertrophy of the inferior olivary nucleus in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Macular Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9294327&form=6&db=m [Progressive supranuclear palsy with macular degeneration--report of three cases] causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Macular Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33688173&form=6&db=m Impact of a Patient Support Program on Patient Beliefs About Neovascular Age-Related Macular Degeneration and Persistence to Anti-Vascular Endothelial Growth Factor Therapy. ongoing research,unassigned 1,0 3.1.3.3 Malaria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11377737&form=6&db=m Characterization of a novel serine/threonine protein phosphatase (PfPPJ) from the malaria parasite, Plasmodium falciparum. ongoing research,therapeutic application,unassigned 2,3,0 3.1.3.3 Malaria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11737864&form=6&db=m A novel tetratricopeptide repeat (TPR) containing PP5 serine/threonine protein phosphatase in the malaria parasite, Plasmodium falciparum. therapeutic application,unassigned 2,0 3.1.3.3 Malaria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12057017&form=6&db=m Characterisation and expression of a PP1 serine/threonine protein phosphatase (PfPP1) from the malaria parasite, Plasmodium falciparum: demonstration of its essential role using RNA interference. ongoing research,unassigned 2,0 3.1.3.3 Mania http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28343053&form=6&db=m Self-Reported Graphic Personal and Social Performance Scale (SRG-PSP) for measuring functionality in patients with bipolar disorder. diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Melanoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33674745&form=6&db=m PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1. therapeutic application,unassigned 1,0 3.1.3.3 Memory Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3748383&form=6&db=m Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. diagnostic usage,unassigned 2,0 3.1.3.3 Mesothelioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2882044&form=6&db=m Enzyme pathology of human mesotheliomas. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,1,0 3.1.3.3 Migraine Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3332539&form=6&db=m Menstrual migraine: a possible pathogenic implication of platelet function. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Miller Fisher Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8319395&form=6&db=m [Clinical analysis of paralytic shellfish poisoning following ingestion of oysters] causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Motor Neuron Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10440304&form=6&db=m Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,2,0 3.1.3.3 Motor Neuron Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15178937&form=6&db=m Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,1,0 3.1.3.3 Motor Neuron Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23026537&form=6&db=m Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia. causal interaction,unassigned 3,0 3.1.3.3 Motor Neuron Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24759627&form=6&db=m Family history of frontotemporal lobar degeneration in Asia - an international multi-center research. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Motor Neuron Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25308964&form=6&db=m The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,4,0 3.1.3.3 Motor Neuron Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27070344&form=6&db=m Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants. unassigned - 3.1.3.3 Motor Neuron Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29368307&form=6&db=m Hashimoto's encephalopathy presenting as pseudobulbar palsy. causal interaction,unassigned 4,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8867115&form=6&db=m Thalamic stimulation-evoked sensations in chronic pain patients and in nonpain (movement disorder) patients. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11748741&form=6&db=m Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12225316&form=6&db=m Enlargements of somatosensory-evoked potentials in progressive supranuclear palsy. causal interaction,ongoing research,unassigned 4,4,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12411832&form=6&db=m The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-beta-carbomethoxy-3-beta-(4-fluorophenyl)-tropane in patients with movement disorders. causal interaction,diagnostic usage,ongoing research,unassigned 1,1,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12654953&form=6&db=m Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16941460&form=6&db=m Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,1,1 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17079809&form=6&db=m PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17724746&form=6&db=m Long lasting pure freezing of gait preceding progressive supranuclear palsy: A clinicopathological study. therapeutic application,unassigned 3,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19412943&form=6&db=m Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21207078&form=6&db=m In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,2,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21384428&form=6&db=m Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21420891&form=6&db=m Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP? causal interaction,diagnostic usage,ongoing research,unassigned 1,3,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21447110&form=6&db=m Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,2,4 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24488721&form=6&db=m Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24573655&form=6&db=m Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease. unassigned - 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26854325&form=6&db=m Environmental and Occupational Risk Factors for Progressive Supranuclear Palsy: Case-Control Study. therapeutic application,unassigned 1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27709685&form=6&db=m Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,2,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28150443&form=6&db=m Manual MRI morphometry in Parkinsonian syndromes. causal interaction,unassigned 1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28436538&form=6&db=m Longitudinal magnetic resonance imaging in progressive supranuclear palsy: A new combined score for clinical trials. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,2,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28467028&form=6&db=m Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,1,3 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28653647&form=6&db=m Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28714593&form=6&db=m Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,3,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29278274&form=6&db=m The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29455271&form=6&db=m Progressive Supranuclear Palsy: an Update. diagnostic usage,unassigned 2,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29460073&form=6&db=m Progressive supranuclear palsy and idiopathic Parkinson's disease are associated with local reduction of in vivo brain viscoelasticity. unassigned - 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29602288&form=6&db=m Preclinical, Phase I, and phase II investigational clinical trials for treatment of progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29756366&form=6&db=m Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29902389&form=6&db=m The diagnosis of progressive supranuclear palsy: current opinions and challenges. causal interaction,diagnostic usage,unassigned 4,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30363575&form=6&db=m Clinimetric Analysis of the Motor Section of the Progressive Supranuclear Palsy Rating Scale: Reliability and Factor Analysis. diagnostic usage,ongoing research,unassigned 1,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30468693&form=6&db=m MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy. causal interaction,unassigned 1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30547248&form=6&db=m Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes. diagnostic usage,ongoing research,unassigned 2,3,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30637280&form=6&db=m Is the Latency from Progressive Supranuclear Palsy Onset to Diagnosis Improving? ongoing research,unassigned 2,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30726566&form=6&db=m Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30884283&form=6&db=m The language profile of progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,2,1 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30894142&form=6&db=m Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation. diagnostic usage,unassigned 3,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31059154&form=6&db=m Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31190253&form=6&db=m Validation of the Italian version of carers' quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy. ongoing research,unassigned 1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31283855&form=6&db=m One decade ago, one decade ahead in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,3,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31350659&form=6&db=m Validation of the Italian version of the PSP Quality of Life questionnaire. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,2,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31390854&form=6&db=m Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study. ongoing research,therapeutic application,unassigned 1,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31392246&form=6&db=m An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31527182&form=6&db=m Midbrain MRI assessments in progressive supranuclear palsy subtypes. diagnostic usage,unassigned 2,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31665686&form=6&db=m Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,3,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31710146&form=6&db=m Multimodal Magnetic Resonance Imaging Quantification of Brain Changes in Progressive Supranuclear Palsy. unassigned - 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31860007&form=6&db=m Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32075473&form=6&db=m Progressive supranuclear palsy presenting with hyperkinetic movement disorder and hemiplegic dystonia: a case report. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32142177&form=6&db=m Association of Tripartite Motif Containing 11 rs564309 with Tau Pathology in Progressive Supranuclear Palsy. causal interaction,unassigned 4,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32228519&form=6&db=m Midbrain/pons area ratio and clinical features predict the prognosis of progressive Supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32259098&form=6&db=m Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study. unassigned - 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32502214&form=6&db=m Patient and care partner views on exercise and structured physical activity for people with Progressive Supranuclear Palsy. therapeutic application,unassigned 1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33165511&form=6&db=m Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33341150&form=6&db=m Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,4 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33385754&form=6&db=m Disease course and treatment patterns in progressive supranuclear palsy: A real-world study. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33755262&form=6&db=m Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,3,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33911380&form=6&db=m Subtypes of PSP and Prognosis: A Retrospective Analysis. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34417776&form=6&db=m Clinical Correlation Between Vertical Gaze Palsy and Midbrain Volume in Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 4,1,0 3.1.3.3 Movement Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34492729&form=6&db=m Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy. diagnostic usage,unassigned 2,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1870289&form=6&db=m [An autopsy case of progressive supranuclear palsy with central pontine myelinolysis] causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8780065&form=6&db=m Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9280681&form=6&db=m [PET and SPECT in Parkinson's disease] therapeutic application,unassigned 2,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9366183&form=6&db=m [A case of progressive supranuclear palsy associated with bilateral vocal cord abductor paralysis] causal interaction,unassigned 2,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9520011&form=6&db=m Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9781517&form=6&db=m Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium. diagnostic usage,ongoing research,therapeutic application,unassigned 4,3,1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11458995&form=6&db=m Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy. ongoing research,unassigned 1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11595348&form=6&db=m Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy. causal interaction,ongoing research,unassigned 1,1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11912113&form=6&db=m Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,1,1 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11921116&form=6&db=m Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11940310&form=6&db=m [The application of Gallyas-Braak stainings in pathologic diagnosis of neurodegenerative diseases] diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11993530&form=6&db=m Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia. therapeutic application,unassigned 4,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15728291&form=6&db=m Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16093228&form=6&db=m Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16093629&form=6&db=m Morning glory sign: a particular MR finding in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16456665&form=6&db=m Coexistence of PSP and MSA: a case report and review of the literature. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16691119&form=6&db=m Lewy bodies in progressive supranuclear palsy represent an independent disease process. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16897134&form=6&db=m Neuroimaging of PD, PSP, CBD and MSA-PET and SPECT studies. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17401522&form=6&db=m MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects. diagnostic usage,unassigned 4,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18972544&form=6&db=m Applause sign in Parkinsonian disorders and Huntington's disease. diagnostic usage,ongoing research,therapeutic application,unassigned 4,4,3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20396463&form=6&db=m Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21210294&form=6&db=m Progressive supranuclear palsy presenting with urinary retention and sleep apnea. unassigned - 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21236720&form=6&db=m Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21396886&form=6&db=m The contribution of trigemino-cervical reflexes in distinguishing progressive supranuclear palsy from multiple system atrophy. unassigned - 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22421702&form=6&db=m Amantadine-induced myoclonus in a patient with progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22488922&form=6&db=m Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24252572&form=6&db=m The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease. causal interaction,unassigned 4,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24749759&form=6&db=m Enteric GFAP expression and phosphorylation in Parkinson's disease. causal interaction,diagnostic usage,unassigned 2,1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25683763&form=6&db=m Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26756744&form=6&db=m Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders. diagnostic usage,unassigned 1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26980757&form=6&db=m Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations. ongoing research,unassigned 1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27070344&form=6&db=m Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants. unassigned - 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27364040&form=6&db=m Obsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential Tremor. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28179466&form=6&db=m Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28256434&form=6&db=m Pathologic correlates of supranuclear gaze palsy with parkinsonism. causal interaction,unassigned 3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28500752&form=6&db=m Which ante mortem clinical features predict progressive supranuclear palsy pathology? causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29339765&form=6&db=m Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29356135&form=6&db=m Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30352750&form=6&db=m Eye movement deficits in X-linked dystonia-parkinsonism are related to striatal degeneration. causal interaction,unassigned 3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30391822&form=6&db=m MIBG myocardial scintigraphy in progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31484717&form=6&db=m Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension. causal interaction,diagnostic usage,unassigned 2,3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31552724&form=6&db=m Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes. diagnostic usage,therapeutic application,unassigned 3,2,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31621617&form=6&db=m Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study. unassigned - 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31847511&form=6&db=m Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,4,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33271461&form=6&db=m Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33517029&form=6&db=m Central nystagmus in progressive supranuclear palsy: A neglected clinical feature? causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33581485&form=6&db=m Association of PSP phenotypes with survival: A brain-bank study. diagnostic usage,unassigned 3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33714084&form=6&db=m A novel diagnostic marker for progressive supranuclear palsy targeting atrophy of the subthalamic nucleus. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33785066&form=6&db=m Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: five cases of spinocerebellar ataxia type 31 with nigrostriatal dopaminergic dysfunction. causal interaction,unassigned 1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34000497&form=6&db=m Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia. diagnostic usage,therapeutic application,unassigned 4,2,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34105000&form=6&db=m Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis. causal interaction,unassigned 1,0 3.1.3.3 Multiple System Atrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34209067&form=6&db=m Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Muscle Cramp http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24668247&form=6&db=m Nocturnal manifestations of atypical and vascular parkinsonism: How do they differ from Parkinson's disease? unassigned - 3.1.3.3 Muscle Rigidity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3315157&form=6&db=m Progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Muscle Rigidity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7955710&form=6&db=m [Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 2,2,0 3.1.3.3 Muscle Rigidity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24963674&form=6&db=m Progressive supranuclear palsy. unassigned - 3.1.3.3 Muscle Spasticity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8451002&form=6&db=m Perceptual analysis of speech disorders in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Muscle Spasticity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18688134&form=6&db=m Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Muscle Spasticity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20457507&form=6&db=m Acoustical Analysis of Speech in Progressive Supranuclear Palsy. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Muscle Spasticity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25683763&form=6&db=m Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Myasthenia Gravis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8319395&form=6&db=m [Clinical analysis of paralytic shellfish poisoning following ingestion of oysters] causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Mycoses http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23220607&form=6&db=m Toll recognition signal activates oenocytoid cell lysis via a crosstalk between plasmatocyte-spreading peptide and eicosanoids in response to a fungal infection. causal interaction,unassigned 4,0 3.1.3.3 Mycoses http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31421036&form=6&db=m Clinical application of presepsin as diagnostic biomarker of infection: overview and updates. causal interaction,ongoing research,therapeutic application,unassigned 3,1,4,0 3.1.3.3 Myeloproliferative Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1964582&form=6&db=m Gene dosage effect in acquired monosomy 7: distinct behaviour of beta-glucuronidase and phosphoserine phosphatase. unassigned - 3.1.3.3 Myocardial Infarction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28905041&form=6&db=m Presepsin (sCD14-ST): could it be a novel marker for the diagnosis of ST elevation myocardial infarction? causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.1.3.3 Myoclonus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1742094&form=6&db=m [An autopsy case of progressive supranuclear palsy with olivary hypertrophy] causal interaction,unassigned 3,0 3.1.3.3 Myoclonus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9292700&form=6&db=m Progressive supranuclear palsy with palatal myoclonus. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Myoclonus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22421702&form=6&db=m Amantadine-induced myoclonus in a patient with progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Myotonic Dystrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16215455&form=6&db=m Tau-positive fine granules in the cerebral white matter: a novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Myotonic Dystrophy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31216016&form=6&db=m Coexistence of Progressive Supranuclear Palsy With Pontocerebellar Atrophy and Myotonic Dystrophy Type 1. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,2,0 3.1.3.3 Nasal Obstruction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28926718&form=6&db=m Corrigendum. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Nasopharyngeal Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28888001&form=6&db=m A targeted nanocarrier based on polyspermine for the effective delivery of methotrexate in nasopharyngeal carcinoma. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Neonatal Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27689072&form=6&db=m The Role of Pancreatic Stone Protein in Diagnosis of Early Onset Neonatal Sepsis. diagnostic usage,therapeutic application,unassigned 4,3,0 3.1.3.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16201166&form=6&db=m [Resection of gastric carcinoma with preserving of the spleen and pancreas and functional clearance lymph nodes of the spleen hillus and splenic artery] causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22911124&form=6&db=m Parenchyma-Sparing Resections for Pancreatic Neuroendocrine Tumors. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22988473&form=6&db=m Single agent polysaccharopeptide delays metastases and improves survival in naturally occurring hemangiosarcoma. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,4,0 3.1.3.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25882777&form=6&db=m Radiation necrosis presenting as pseudoprogression (PsP) during alectinib treatment of previously radiated brain metastases in ALK-positive NSCLC: Implications for disease assessment and management. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31132819&form=6&db=m Percutaneous Sacroplasty for Painful Sacral Metastases Involving Multiple Sacral Vertebral Bodies: Initial Experience with an Interpedicular Approach. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,4,0 3.1.3.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31428771&form=6&db=m Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion: a case report. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31659445&form=6&db=m Understanding symptomatic experience, impact, and emotional response in recently diagnosed metastatic castration-resistant prostate cancer: a qualitative study. unassigned - 3.1.3.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31966733&form=6&db=m Benign tumor behaves malignantly: a case report of bilateral multiple pulmonary sclerosing pneumocytoma. diagnostic usage,unassigned 3,0 3.1.3.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32021404&form=6&db=m Fluoroscopy-Guided Percutaneous Sacroplasty for Painful Metastases at the Sacral Ala. diagnostic usage,ongoing research,therapeutic application,unassigned 2,3,4,0 3.1.3.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32441345&form=6&db=m Clinical and histopathologic features of pulmonary sclerosing pneumocytoma with dense spindle stromal cells and lymph node metastasis. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32666331&form=6&db=m Pulmonary sclerosing pneumocytoma with mediastinal lymph node metastasis: a case report. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Neoplasm Metastasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34485321&form=6&db=m Case Report: Rare Pulmonary Sclerosing Pneumocytoma: Large, Multiple, Metastatic, and Fatal. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1455310&form=6&db=m Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures. diagnostic usage,ongoing research,unassigned 3,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1769009&form=6&db=m Enzymic composition and growth rate of human pleural mesothelioma transplants in nude mice. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6277448&form=6&db=m Enzyme pathology and the histologic categorization of human lung tumors: the continuum of quantitative biochemical indices of neoplasticity. diagnostic usage,unassigned 3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7694265&form=6&db=m Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma. causal interaction,diagnostic usage,unassigned 3,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8282538&form=6&db=m Activation of peritoneal macrophages by polysaccharopeptide from the mushroom, Coriolus versicolor. ongoing research,unassigned 4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8959327&form=6&db=m Cell cycle-independent regulation of p21Waf1/Cip1 and retinoblastoma protein during okadaic acid-induced apoptosis is coupled with induction of Bax protein in human breast carcinoma cells. ongoing research,therapeutic application,unassigned 3,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9125847&form=6&db=m [Minisatellite instability induced by okadaic acid] therapeutic application,unassigned 1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9166995&form=6&db=m Polysaccharide peptide (PSP) restores immunosuppression induced by cyclophosphamide in rats. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10546517&form=6&db=m Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results. causal interaction,unassigned 4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10696116&form=6&db=m The use of mushroom glucans and proteoglycans in cancer treatment. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10851500&form=6&db=m Immunotherapy with low-dose interleukin-2 and a polysaccharopeptide derived from Coriolus versicolor. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10896920&form=6&db=m Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers. ongoing research,therapeutic application,unassigned 2,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11467773&form=6&db=m Differences in association of the serine/threonine protein phosphatase PP-2A with microtubules of metastatic and nonmetastatic tumor cells. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11574781&form=6&db=m Evaluation of polysaccharopeptide effects against C6 glioma in combination with radiation. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,2,2 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11749812&form=6&db=m Chemo- and radio-protective effects of polysaccharide of Spirulina platensis on hemopoietic system of mice and dogs. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12122559&form=6&db=m Toxicokinetics and effects of fibrous and nonfibrous particles. causal interaction,therapeutic application,unassigned 1,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12167967&form=6&db=m Thrombotic thrombocytopenic purpura associated with clopidogrel: further evaluation. diagnostic usage,unassigned 1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12461331&form=6&db=m The significance of the margin in parotid surgery for pleomorphic adenoma. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12567775&form=6&db=m [Effect of polysaccharide from Spirulina platensis on hematopoietic cells proliferation, apoptosis and Bcl-2 expression in mice bearing tumor treated with chemotherapy] causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12814145&form=6&db=m Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. diagnostic usage,therapeutic application,unassigned 2,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12939504&form=6&db=m Down regulation of a novel protein, PSP, in rat hepatoma cdRLh 84-beared tumor. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14645703&form=6&db=m Cancerous stem cells can arise from pediatric brain tumors. unassigned - 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15054863&form=6&db=m Inhaled particles and lung cancer, part B: paradigms and risk assessment. therapeutic application,unassigned 1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15234192&form=6&db=m Fungal polysaccharopeptide inhibits tumor angiogenesis and tumor growth in mice. ongoing research,therapeutic application,unassigned 2,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15657874&form=6&db=m A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15870943&form=6&db=m The cell death process of the anticancer agent polysaccharide-peptide (PSP) in human promyelocytic leukemic HL-60 cells. causal interaction,ongoing research,therapeutic application,unassigned 3,4,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16010435&form=6&db=m Molecular characterization of Coriolus versicolor PSP-induced apoptosis in human promyelotic leukemic HL-60 cells using cDNA microarray. causal interaction,ongoing research,unassigned 3,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16297519&form=6&db=m Effects of polysaccharide peptide (PSP) from Coriolus versicolor on the pharmacokinetics of cyclophosphamide in the rat and cytotoxicity in HepG2 cells. ongoing research,unassigned 4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16310221&form=6&db=m Polysaccharide peptides from COV-1 strain of Coriolus versicolor induce hyperalgesia via inflammatory mediator release in the mouse. ongoing research,unassigned 1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16698162&form=6&db=m Modulation of antipyrine clearance by polysaccharide peptide (PSP) isolated from Coriolus versicolor in the rat. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17198474&form=6&db=m Prognostic value of flow cytometry in surgically treated primary gastric lymphoma. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17995702&form=6&db=m Potential of a novel polysaccharide preparation (GLPP) from Anhui-grown Ganoderma lucidum in tumor treatment and immunostimulation. causal interaction,unassigned 1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18292947&form=6&db=m Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,4 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18588945&form=6&db=m Protein phosphatase 2A regulatory subunits and cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,3,1 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18619354&form=6&db=m [Immunoregulatory activity of polysaccharopeptide and astragalus polysaccharides on EAC tumor-bearing mice] causal interaction,unassigned 2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18686097&form=6&db=m Immunoregulatory and Anti-Tumor Effects of Polysaccharopeptide and Astragalus polysaccharides on Tumor-Bearing Mice. causal interaction,unassigned 3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19012039&form=6&db=m Downregulation of CPI-17 contributes to dysfunctional motility in chronic intestinal inflammation model mice and ulcerative colitis patients. therapeutic application,unassigned 2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19193202&form=6&db=m PI3K/Akt mediates expression of TNF-alpha mRNA and activation of NF-kappaB in calyculin A-treated primary osteoblasts. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19507761&form=6&db=m Pleomorphic adenoma: extracapsular dissection versus partial superficial parotidectomy with facial nerve dissection. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19784394&form=6&db=m Inhibitory effects of polysaccharide extract from Spirulina platensis on corneal neovascularization. unassigned - 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20423495&form=6&db=m Polysaccharopeptides derived from Coriolus versicolor potentiate the S-phase specific cytotoxicity of Camptothecin (CPT) on human leukemia HL-60 cells. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,1 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20523052&form=6&db=m Pleural granuloma mimicking malignancy 42 years after slurry talc injection for primary spontaneous pneumothorax. causal interaction,diagnostic usage,therapeutic application,unassigned 2,4,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21603625&form=6&db=m Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population. causal interaction,ongoing research,therapeutic application,unassigned 3,1,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22397319&form=6&db=m Dose-response and threshold analysis of tumor prevalence after intratracheal instillation of six types of low- and high-surface-area particles in a chronic rat experiment. causal interaction,ongoing research,therapeutic application,unassigned 3,3,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22911124&form=6&db=m Parenchyma-Sparing Resections for Pancreatic Neuroendocrine Tumors. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22988473&form=6&db=m Single agent polysaccharopeptide delays metastases and improves survival in naturally occurring hemangiosarcoma. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23469127&form=6&db=m Antioxidant, Antityrosinase and Antitumor Activity Comparison: The Potential Utilization of Fibrous Root Part of Bletilla striata (Thunb.) Reichb.f. unassigned - 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23497877&form=6&db=m PSP activates monocytes in resting human peripheral blood mononuclear cells: Immunomodulatory implications for cancer treatment. causal interaction,ongoing research,therapeutic application,unassigned 3,3,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24025258&form=6&db=m Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24069258&form=6&db=m Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes. diagnostic usage,ongoing research,unassigned 4,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24335185&form=6&db=m Clinical features in association with neurodegenerative diseases and malignancies. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25129068&form=6&db=m Polysaccharopeptide enhanced the anti-cancer effect of gamma-tocotrienol through activation of AMPK. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,4 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25411133&form=6&db=m Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[(18)F]fluoroethyl)-L-tyrosine PET. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25614677&form=6&db=m [Immunomodulatory and antitumor properties of polysaccharide peptide (PSP)]. therapeutic application,unassigned 1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25693640&form=6&db=m A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system. diagnostic usage,ongoing research,unassigned 1,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25776463&form=6&db=m Estrogen regulation of phosphoserine phosphatase during regression and recrudescence of female reproductive organs. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25793315&form=6&db=m cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. causal interaction,unassigned 3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25880614&form=6&db=m Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands. therapeutic application,unassigned 3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25935704&form=6&db=m The proximal serrated polyp detection rate is an easy-to-measure proxy for the detection rate of clinically relevant serrated polyps. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26032186&form=6&db=m A study on immunomodulatory mechanism of Polysaccharopeptide mediated by TLR4 signaling pathway. ongoing research,unassigned 4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26044874&form=6&db=m Polysaccharide peptide from Coriolus versicolor induces interleukin 6-related extension of endotoxin fever in rats. causal interaction,ongoing research,therapeutic application,unassigned 4,2,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26546866&form=6&db=m Polysaccharopeptide exerts immunoregulatory effects via MyD88-dependent signaling pathway. causal interaction,ongoing research,unassigned 1,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26673798&form=6&db=m Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27349874&form=6&db=m Inhibition of phosphoserine phosphatase enhances the anticancer efficacy of 5-fluorouracil in colorectal cancer. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27421136&form=6&db=m Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27704386&form=6&db=m Molecular and histologic characteristics of pseudoprogression in diffuse gliomas. causal interaction,unassigned 4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27876671&form=6&db=m Relevance of the rat lung tumor response to particle overload for human risk assessment-Update and interpretation of new data since ILSI 2000. unassigned - 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27910783&form=6&db=m Recent Advances and Challenges in Studies of Control of Cancer Stem Cells and the Gut Microbiome by the Trametes-Derived Polysaccharopeptide PSP (Review). ongoing research,unassigned 4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28439535&form=6&db=m A murine preclinical syngeneic transplantation model for breast cancer precision medicine. causal interaction,therapeutic application,unassigned 1,3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28476802&form=6&db=m Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,2,1 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28595034&form=6&db=m Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. causal interaction,diagnostic usage,unassigned 3,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28601783&form=6&db=m Potential impact of the Affordable Care Act's preventive services provision on breast cancer stage: A preliminary assessment. causal interaction,unassigned 3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28805452&form=6&db=m Birt-Hogg-Dube Syndrome with a Novel Mutation in the FLCN Gene. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28932226&form=6&db=m Immunomodulatory Properties of Coriolus versicolor: The Role of Polysaccharopeptide. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29236566&form=6&db=m Genome profile in a extremely rare case of pulmonary sclerosing pneumocytoma presenting with diffusely-scattered nodules in the right lung. causal interaction,unassigned 2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29307989&form=6&db=m Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29343453&form=6&db=m Polygonatum sibiricum polysaccharides play anti-cancer effect through TLR4-MAPK/NF-?B signaling pathways. unassigned - 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29594248&form=6&db=m Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma. diagnostic usage,ongoing research,therapeutic application,unassigned 1,3,3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29633581&form=6&db=m Persistent socket pain postenucleation and post evisceration: a systematic review. unassigned - 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29798408&form=6&db=m [Retrospective study of partial superficial parotidectomy and superficial parotidectomy on superficial parotid benign tumor]. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30070662&form=6&db=m Systemic siRNA delivery to tumors by cell-penetrating ?-helical polypeptide-based metastable nanoparticles. causal interaction,ongoing research,unassigned 3,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30094640&form=6&db=m Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns? diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30240355&form=6&db=m Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30389701&form=6&db=m Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma. causal interaction,ongoing research,therapeutic application,unassigned 3,1,3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30662358&form=6&db=m PSPH Mediates the Metastasis and Proliferation of Non-small Cell Lung Cancer through MAPK Signaling Pathways. causal interaction,unassigned 4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30977310&form=6&db=m Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31030754&form=6&db=m Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,1,1 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31194169&form=6&db=m Pulmonary sclerosing pneumocytoma demonstrating intratumoral hematoma. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31274552&form=6&db=m Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31446709&form=6&db=m [Partial superficial parotidectomy versus superficial parotidectomy for treatment of parotid benign tumors: evidence-based medicine analysis]. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31527340&form=6&db=m Efficacy of an anti-cancer strategy targeting SET in canine osteosarcoma. unassigned - 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31708570&form=6&db=m A Retrospective Case-Control Study on the Chest Wall and Lung Characteristics in Patients with Primary Spontaneous Pneumothorax. therapeutic application,unassigned 2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31784034&form=6&db=m Positive Resection Margins Detected by Standardized Study of a Pancreaticoduodenectomy Sample: Is There Any Real Impact on Long-term Survival? causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31852075&form=6&db=m The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma: A meta-analysis. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31885094&form=6&db=m DC-AL GAN: Pseudoprogression and true tumor progression of glioblastoma multiform image classification based on DCGAN and AlexNet. causal interaction,unassigned 1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31923719&form=6&db=m Peptide-enhanced tumor accumulation of upconversion nanoparticles for sensitive upconversion luminescence/magnetic resonance dual-mode bioimaging of colorectal tumors. therapeutic application,unassigned 1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31993738&form=6&db=m Primary spontaneous pneumothorax in children: factors predicting recurrence and contralateral occurrence. ongoing research,therapeutic application,unassigned 1,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32362539&form=6&db=m A meta-analysis of the pros and cons of partial superficial parotidectomy versus superficial parotidectomy for the treatment of benign parotid neoplasms. causal interaction,therapeutic application,unassigned 1,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32466253&form=6&db=m Trametes versicolor (Synn. Coriolus versicolor) Polysaccharides in Cancer Therapy: Targets and Efficacy. diagnostic usage,therapeutic application,unassigned 3,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32475918&form=6&db=m Characterization and Immunological Activities of Polysaccharides from Polygonatum sibiricum. causal interaction,unassigned 3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32590790&form=6&db=m Pulmonary sclerosing pneumocytoma in an 18-year-old male patient: A case report and literature review. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32749609&form=6&db=m Review of surgical techniques and guide for decision making in the treatment of benign parotid tumors. unassigned - 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32814655&form=6&db=m Comparison of postoperative complications and facial nerve recovery rates after conventional and partial superficial parotidectomy of benign parotid tumours: a prospective study. ongoing research,therapeutic application,unassigned 3,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32969571&form=6&db=m Autophagy regulates levels of tumor suppressor enzyme protein phosphatase 6. causal interaction,diagnostic usage,unassigned 3,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32982042&form=6&db=m Peptide-Induced Self-Assembly of Therapeutics into a Well-Defined Nanoshell with Tumor-Triggered Shape and Charge Switch. causal interaction,unassigned 2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33079432&form=6&db=m PSPH induces cell autophagy and promotes cell proliferation and invasion in the hepatocellular carcinoma cell line Huh7 via the AMPK/mTOR/ULK1 signaling pathway. causal interaction,unassigned 3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33105661&form=6&db=m A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma. ongoing research,unassigned 2,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33126624&form=6&db=m Immunostimulatory Effects of Polysaccharides from Spirulina platensis In Vivo and Vitro and Their Activation Mechanism on RAW246.7 Macrophages. causal interaction,unassigned 3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33309518&form=6&db=m Phosphatase magnesium-dependent 1 ? (PPM1D), serine/threonine protein phosphatase and novel pharmacological target in cancer. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33357311&form=6&db=m [Analysis of Clinical Characteristics of 35 Cases ?of Pulmonary Sclerosing Pneumocytoma]. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33381018&form=6&db=m Can Tumor Location on Pre-treatment MRI Predict Likelihood of Pseudo-Progression vs. Tumor Recurrence in Glioblastoma?-A Feasibility Study. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33660695&form=6&db=m Analysis of the F-18 FDG PET/CT features of pulmonary sclerosing pneumocytoma. diagnostic usage,ongoing research,unassigned 1,3,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33726710&form=6&db=m The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma. diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33819271&form=6&db=m Machine learning-based investigation of the cancer protein secretory pathway. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,1,1 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33959496&form=6&db=m Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features. diagnostic usage,unassigned 1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34039780&form=6&db=m Huge Pulmonary Sclerosing Pneumocytoma with Endobronchial Invasion: A Case Report with a Literature Review. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34074439&form=6&db=m Monitoring hydrogen polysulfide during ferroptosis with a two-photon fluorescent probe. unassigned - 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34288212&form=6&db=m Surgical interventions for management of benign parotid tumors: A systematic review and network meta-analysis. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34430194&form=6&db=m A case of pulmonary sclerosing pneumocytoma diagnosed preoperatively using transbronchial cryobiopsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34485321&form=6&db=m Case Report: Rare Pulmonary Sclerosing Pneumocytoma: Large, Multiple, Metastatic, and Fatal. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Nephritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6225713&form=6&db=m [Clinico-biochemical study of experimental renal injuries in rats. 3. Relations between serum half-life of phenolsulfonphthalein and renal injuries] unassigned - 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7969952&form=6&db=m Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,2,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8710059&form=6&db=m Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9191782&form=6&db=m Characterizing swallowing abnormalities in progressive supranuclear palsy. ongoing research,unassigned 2,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10025574&form=6&db=m A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy. diagnostic usage,unassigned 1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10584668&form=6&db=m Progression of falls in postmortem-confirmed parkinsonian disorders. diagnostic usage,therapeutic application,unassigned 4,2,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11176964&form=6&db=m Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. causal interaction,diagnostic usage,therapeutic application,unassigned 2,2,3,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11408338&form=6&db=m The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. diagnostic usage,unassigned 2,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12563380&form=6&db=m Progressive supranuclear palsy in a sample of Brazilian population: clinical features of 16 patients. unassigned - 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12654952&form=6&db=m Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12654953&form=6&db=m Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12784275&form=6&db=m Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study. diagnostic usage,unassigned 2,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14978673&form=6&db=m Accuracy of clinical diagnosis of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16289932&form=6&db=m Neurodegenerative disorders mimicking progressive supranuclear palsy: a report of three cases. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18195676&form=6&db=m Progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,3,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18541806&form=6&db=m Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18992014&form=6&db=m Progressive supranuclear palsy combined with Alzheimer's disease: A clinicopathological study of two autopsy cases. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19458322&form=6&db=m Familial aggregation of parkinsonism in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,4,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19508347&form=6&db=m Clinical heterogeneity in progressive supranuclear palsy: Problems of clinical diagnostic criteria of NINDS-SPSP in a retrospective study of seven Japanese autopsy cases. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20819168&form=6&db=m Smad ubiquitination regulatory factor-2 in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23436751&form=6&db=m Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24615741&form=6&db=m Rate of decline in progressive supranuclear palsy. diagnostic usage,unassigned 1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26954800&form=6&db=m Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27381106&form=6&db=m Correlation between qualitative balance indices, dynamic posturography and structural brain imaging in patients with progressive supranuclear palsy and its subtypes. unassigned - 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28432758&form=6&db=m Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28467028&form=6&db=m Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,1,3 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28702192&form=6&db=m Freezing of gait is an early clinical feature of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29710120&form=6&db=m A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30831462&form=6&db=m Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,2,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31420309&form=6&db=m Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson's disease. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31665686&form=6&db=m Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,3,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32110153&form=6&db=m Phenotypic Variants of Patients with Progressive Supranuclear Palsy. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Nervous System Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32731191&form=6&db=m Understanding the relationship between freezing of gait and other progressive supranuclear palsy features. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Neurobehavioral Manifestations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3265862&form=6&db=m Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. diagnostic usage,unassigned 1,0 3.1.3.3 Neurobehavioral Manifestations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7824102&form=6&db=m Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,4,3 3.1.3.3 Neurobehavioral Manifestations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23762677&form=6&db=m Zolpidem in progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Neurobehavioral Manifestations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25663411&form=6&db=m Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,1,3,1 3.1.3.3 Neurobehavioral Manifestations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28250027&form=6&db=m Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Neurobehavioral Manifestations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34382461&form=6&db=m Burden on caregivers of schizophrenia outpatients in Brazil: Relationship to symptomatology and functioning. unassigned - 3.1.3.3 Neuroblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8564065&form=6&db=m Characterization of human and rat immortalized clones parotid acinar cells with respect to specific proteins and their mRNAs, and receptor-linked adenylate cyclase. ongoing research,unassigned 4,0 3.1.3.3 Neuroblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9863767&form=6&db=m Differential effects of physostigmine and organophosphates on nicotinic receptors in neuronal cells of different species. ongoing research,unassigned 3,0 3.1.3.3 Neuroblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15897155&form=6&db=m Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells. ongoing research,unassigned 2,0 3.1.3.3 Neuroblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17665694&form=6&db=m Application of the neuroblastoma assay for paralytic shellfish poisons to neurotoxic freshwater cyanobacteria: interlaboratory calibration and comparison with other methods of analysis. diagnostic usage,unassigned 3,0 3.1.3.3 Neuroblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25223551&form=6&db=m An improved sensitive assay for the detection of PSP toxins with neuroblastoma cell-based impedance biosensor. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Neuroblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30365125&form=6&db=m Protective effect of polysaccharide peptide on cerebral ischemia?reperfusion injury in rats. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,4,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2569956&form=6&db=m [Treatment of progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7496773&form=6&db=m Familial progressive supranuclear palsy. Description of a pedigree and review of the literature. unassigned - 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8208392&form=6&db=m Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8841954&form=6&db=m Structural basis of dementia in neurodegenerative disorders. causal interaction,unassigned 1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9018027&form=6&db=m Cerebral oxygen metabolism in patients with progressive supranuclear palsy: a positron emission tomography study. diagnostic usage,unassigned 4,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9366183&form=6&db=m [A case of progressive supranuclear palsy associated with bilateral vocal cord abductor paralysis] causal interaction,unassigned 2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10483782&form=6&db=m Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease. unassigned - 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10522876&form=6&db=m The tau gene A0 allele and progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10525997&form=6&db=m Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. causal interaction,unassigned 3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11087782&form=6&db=m An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11089576&form=6&db=m Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy. causal interaction,unassigned 1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11940310&form=6&db=m [The application of Gallyas-Braak stainings in pathologic diagnosis of neurodegenerative diseases] diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12105325&form=6&db=m Brain aconitase activity is not decreased in progressive supranuclear palsy. causal interaction,ongoing research,unassigned 4,1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12220379&form=6&db=m Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders. causal interaction,ongoing research,unassigned 3,4,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12784275&form=6&db=m Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study. diagnostic usage,unassigned 2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12796528&form=6&db=m Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15282366&form=6&db=m Progressive supranuclear palsy. causal interaction,unassigned 2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15651324&form=6&db=m [Advance of SPECT: differential diagnosis and evaluation of pathophysiology of neurodegenerative disorders] causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16195395&form=6&db=m High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. unassigned - 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16447770&form=6&db=m [MRI diagnosis of neurodegenerative disorders] causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16569380&form=6&db=m Current and future treatments in progressive supranuclear palsy. causal interaction,unassigned 2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16897135&form=6&db=m Myocardial (123)I-MIBG scintigraphy in patients with PSP, CBD and MSA. causal interaction,therapeutic application,unassigned 3,3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17709155&form=6&db=m Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17724746&form=6&db=m Long lasting pure freezing of gait preceding progressive supranuclear palsy: A clinicopathological study. therapeutic application,unassigned 3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18332837&form=6&db=m Progressive Supranuclear Palsy: A Current Review. diagnostic usage,unassigned 3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18989114&form=6&db=m Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19235444&form=6&db=m Progressive supranuclear palsy: a review of co-existing neurodegeneration. diagnostic usage,unassigned 3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19714246&form=6&db=m Comprehensive mRNA expression profiling distinguishes tauopathies and identifies shared molecular pathways. ongoing research,unassigned 4,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20569300&form=6&db=m Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies. ongoing research,therapeutic application,unassigned 2,1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21181185&form=6&db=m Magnetic resonance imaging in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,1 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23225274&form=6&db=m A?1-15/16 as a potential diagnostic marker in neurodegenerative diseases. diagnostic usage,unassigned 3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23415606&form=6&db=m STX6 rs1411478 is not associated with increased risk of Parkinson's disease. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23432126&form=6&db=m Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. causal interaction,unassigned 1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24335185&form=6&db=m Clinical features in association with neurodegenerative diseases and malignancies. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26810527&form=6&db=m Clusterin CSF levels in differential diagnosis of neurodegenerative disorders. diagnostic usage,unassigned 4,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27797445&form=6&db=m Tau imaging with [(18) F]THK-5351 in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,3,1 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28653647&form=6&db=m Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28702192&form=6&db=m Freezing of gait is an early clinical feature of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29339765&form=6&db=m Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29373002&form=6&db=m Progressive Supranuclear Palsy - A Case Study from the Perspective of a Primary Care Physician Son. unassigned - 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29703774&form=6&db=m [11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 4,3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29756231&form=6&db=m Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes. therapeutic application,unassigned 1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30089514&form=6&db=m Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases. unassigned - 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30514650&form=6&db=m Medical decision-making in progressive supranuclear palsy: A comparison to other neurodegenerative disorders. causal interaction,diagnostic usage,ongoing research,unassigned 2,3,2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30874837&form=6&db=m To be or not to be: PP2A as a dual player in CNS functions, its role in neurodegeneration, and its interaction with brain insulin signaling. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30882841&form=6&db=m Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30892739&form=6&db=m In vivo binding of a tau imaging probe, [11 C]PBB3, in patients with progressive supranuclear palsy. unassigned - 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31155302&form=6&db=m Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,2,2 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31543804&form=6&db=m Progressive Supranuclear Palsy with Wall-Eyed Bilateral Internuclear Ophthalmoplegia Syndrome: Authors' Second Case. causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31695675&form=6&db=m Frontrunner in Translation: Progressive Supranuclear Palsy. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31752626&form=6&db=m The Progressive Supranuclear Palsy: Past and Present Aspects. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32293067&form=6&db=m Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32341240&form=6&db=m Alpha-synuclein Levels in the Differential Diagnosis of Lewy Bodies Dementia and Other Neurodegenerative Disorders: A Meta-analysis. diagnostic usage,unassigned 2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32416639&form=6&db=m Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32536421&form=6&db=m Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33207193&form=6&db=m Tau Pathology Drives Dementia Risk-Associated Gene Networks toward Chronic Inflammatory States and Immunosuppression. ongoing research,unassigned 4,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33459640&form=6&db=m Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration. therapeutic application,unassigned 1,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33755262&form=6&db=m Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,3,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34000497&form=6&db=m Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia. diagnostic usage,therapeutic application,unassigned 4,2,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34184486&form=6&db=m [Progressive supranuclear palsy]. causal interaction,diagnostic usage,unassigned 3,4,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34306851&form=6&db=m Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Neurodegenerative Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34492729&form=6&db=m Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy. diagnostic usage,unassigned 2,0 3.1.3.3 Neuroendocrine Tumors http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22911124&form=6&db=m Parenchyma-Sparing Resections for Pancreatic Neuroendocrine Tumors. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Neuroinflammatory Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21741294&form=6&db=m Cytokine expression and microglial activation in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,4,0 3.1.3.3 Neuroinflammatory Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26916334&form=6&db=m Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD. ongoing research,unassigned 2,0 3.1.3.3 Neuroinflammatory Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29703774&form=6&db=m [11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 4,3,0 3.1.3.3 Neuroinflammatory Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32951237&form=6&db=m Neuroinflammation and tau co-localize in vivo in progressive supranuclear palsy. causal interaction,unassigned 1,0 3.1.3.3 Neuroinflammatory Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32982676&form=6&db=m Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP). causal interaction,diagnostic usage,ongoing research,unassigned 1,3,1,0 3.1.3.3 Neuroinflammatory Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33315235&form=6&db=m Neutrophil-to-lymphocyte ratio (NLR) at boundaries of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS). unassigned - 3.1.3.3 Neuroinflammatory Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33731439&form=6&db=m Neuroinflammation predicts disease progression in progressive supranuclear palsy. diagnostic usage,therapeutic application,unassigned 4,2,0 3.1.3.3 Neurologic Manifestations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26960553&form=6&db=m On the phenotypic spectrum of serine biosynthesis defects. causal interaction,unassigned 4,0 3.1.3.3 Neuroma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29633581&form=6&db=m Persistent socket pain postenucleation and post evisceration: a systematic review. unassigned - 3.1.3.3 Nutrition Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1736346&form=6&db=m Radiolucent and calcified pancreatic lithiasis: two different diseases. Role of alcohol and heredity. unassigned - 3.1.3.3 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28135399&form=6&db=m Purple Sweet Potato Attenuate Weight Gain in High Fat Diet Induced Obese Mice. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Obesity http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33132226&form=6&db=m Psycho-Physiological Responses to a 4-Month High-Intensity Interval Training-Centered Multidisciplinary Weight-Loss Intervention in Adolescents with Obesity. unassigned - 3.1.3.3 Olfaction Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28943542&form=6&db=m A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders. unassigned - 3.1.3.3 Oligodendroglioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24285548&form=6&db=m Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas. causal interaction,therapeutic application,unassigned 1,3,0 3.1.3.3 Oligodendroglioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29594248&form=6&db=m Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma. diagnostic usage,ongoing research,therapeutic application,unassigned 1,3,3,0 3.1.3.3 Olivopontocerebellar Atrophies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9277099&form=6&db=m [Vertical oculomotor disorders in progressive supranuclear palsy and spino-cerebellar degeneration] causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Olivopontocerebellar Atrophies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11458995&form=6&db=m Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy. ongoing research,unassigned 1,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1308417&form=6&db=m [Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of a case and review of the literature] causal interaction,unassigned 4,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1629370&form=6&db=m Neuro-ophthalmic findings in progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,4,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3315157&form=6&db=m Progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6398402&form=6&db=m Progressive supranuclear palsy. Clinical and pharmacologic update. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7955710&form=6&db=m [Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 2,2,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964695&form=6&db=m Eyelid motor abnormalities in progressive supranuclear palsy. therapeutic application,unassigned 2,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964699&form=6&db=m Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques. diagnostic usage,unassigned 2,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8060688&form=6&db=m [Widespread argentophilic structures in progressive supranuclear palsy--an autopsy case report] diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8952364&form=6&db=m [Improvement of ophthalmoplegia by 5-hydroxytryptophan in two cases of progressive supranuclear palsy] therapeutic application,unassigned 2,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9014435&form=6&db=m [Progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9577667&form=6&db=m [Progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12465065&form=6&db=m Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15834857&form=6&db=m Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. unassigned - 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16569380&form=6&db=m Current and future treatments in progressive supranuclear palsy. causal interaction,unassigned 2,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18195676&form=6&db=m Progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,3,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19795006&form=6&db=m Exodeviated ophthalmoplegia in a patient with progressive supranuclear palsy. therapeutic application,unassigned 1,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22347799&form=6&db=m Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25289173&form=6&db=m Long-term follow-up of deep brain stimulation of peduncolopontine nucleus in progressive supranuclear palsy: Report of three cases. causal interaction,unassigned 2,0 3.1.3.3 Ophthalmoplegia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32651138&form=6&db=m Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Osteoarthritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5390461&form=6&db=m [Articular PSP clearance in osteoarthritis of the knee] unassigned - 3.1.3.3 Osteoarthritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5390958&form=6&db=m [Effect of non-steroid anti-inflammatory drugs for osteoarthritis of the knee; PSP clearance test] therapeutic application,unassigned 4,0 3.1.3.3 Osteoarthritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5488868&form=6&db=m Effect of non-steroidal anti-inflammatory drugs on osteoarthritis of the knee. With special reference to PSP clearance as an indicator. ongoing research,therapeutic application,unassigned 2,4,0 3.1.3.3 Osteoarthritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20144114&form=6&db=m Effect of Non-Steroidal Anti-Inflammatory Drugs on Osteoarthritis of the Knee: With Special Reference to PSP Clearance as an Indicator. ongoing research,therapeutic application,unassigned 2,4,0 3.1.3.3 Osteoarthritis, Knee http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5390461&form=6&db=m [Articular PSP clearance in osteoarthritis of the knee] unassigned - 3.1.3.3 Osteoarthritis, Knee http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5390958&form=6&db=m [Effect of non-steroid anti-inflammatory drugs for osteoarthritis of the knee; PSP clearance test] therapeutic application,unassigned 4,0 3.1.3.3 Osteoarthritis, Knee http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5488868&form=6&db=m Effect of non-steroidal anti-inflammatory drugs on osteoarthritis of the knee. With special reference to PSP clearance as an indicator. ongoing research,therapeutic application,unassigned 2,4,0 3.1.3.3 Osteoarthritis, Knee http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20144114&form=6&db=m Effect of Non-Steroidal Anti-Inflammatory Drugs on Osteoarthritis of the Knee: With Special Reference to PSP Clearance as an Indicator. ongoing research,therapeutic application,unassigned 2,4,0 3.1.3.3 Osteolysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27554324&form=6&db=m Polygonatum sibiricum polysaccharide inhibits osteoporosis by promoting osteoblast formation and blocking osteoclastogenesis through Wnt/?-catenin signalling pathway. causal interaction,therapeutic application,unassigned 1,3,0 3.1.3.3 Osteomyelitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29091592&form=6&db=m Procalcitonin and Pancreatic Stone Protein Function as Biomarkers in Early Diagnosis of Pediatric Acute Osteomyelitis. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,3,1 3.1.3.3 Osteoporosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26261494&form=6&db=m Effects of Polygonatum sibiricum polysaccharide on the osteogenic differentiation of bone mesenchymal stem cells in mice. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Osteoporosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27293836&form=6&db=m Abnormal bone mineral density and bone turnover marker expression profiles in patients with primary spontaneous pneumothorax. diagnostic usage,ongoing research,unassigned 4,1,0 3.1.3.3 Osteoporosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27554324&form=6&db=m Polygonatum sibiricum polysaccharide inhibits osteoporosis by promoting osteoblast formation and blocking osteoclastogenesis through Wnt/?-catenin signalling pathway. causal interaction,therapeutic application,unassigned 1,3,0 3.1.3.3 Osteoporosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28629266&form=6&db=m Polygonatum Sibiricum Polysaccharide Promotes Osteoblastic Differentiation Through the ERK/GSK-3?/?-Catenin Signaling Pathway In Vitro. therapeutic application,unassigned 4,0 3.1.3.3 Osteoporosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30632458&form=6&db=m The Role and Mechanism of miRNA-1224 in the Polygonatum Sibiricum Polysaccharide Regulation of Bone Marrow-Derived Macrophages to Osteoclast Differentiation. therapeutic application,unassigned 4,0 3.1.3.3 Ovarian Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14534713&form=6&db=m Independent action of serine/threonine protein phosphatase in ovarian cancer plasma membrane and cytosol during gonadotropin-releasing hormone stimulation. diagnostic usage,ongoing research,unassigned 3,4,0 3.1.3.3 Pancreatic Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7898566&form=6&db=m Current status of pancreatic stone protein. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,3,0 3.1.3.3 Pancreatic Fistula http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22911124&form=6&db=m Parenchyma-Sparing Resections for Pancreatic Neuroendocrine Tumors. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Pancreatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8501356&form=6&db=m Serum pancreatic stone protein in pancreatic diseases. causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Pancreaticobiliary Maljunction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15628732&form=6&db=m Activated pancreatic enzyme and pancreatic stone protein (PSP/reg) in bile of patients with pancreaticobiliary maljunction/ choledochal cysts. diagnostic usage,unassigned 1,0 3.1.3.3 Pancreatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1578808&form=6&db=m [Analysis of pancreatic stone protein gene of hereditary pancreatitis] causal interaction,ongoing research,therapeutic application,unassigned 4,4,1,0 3.1.3.3 Pancreatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2510147&form=6&db=m Pancreatic stone protein: quantification in pancreatic juice by enzyme-linked immunosorbent assay and comparison with other methods. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Pancreatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2699918&form=6&db=m Chronic calcifying pancreatitis: epidemiology and current concept of the lithogenesis. causal interaction,unassigned 4,0 3.1.3.3 Pancreatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8501356&form=6&db=m Serum pancreatic stone protein in pancreatic diseases. causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Pancreatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9361087&form=6&db=m Change of pancreatic enzymes, pancreatic stone protein (PSP), and plasma alpha(2)-macroglobulin-trypsin complex-like substance (MTLS) in the activation of pancreatic juice. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Pancreatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16360171&form=6&db=m Exocrine meets endocrine: pancreatic stone protein and regenerating protein--two sides of the same coin. therapeutic application,unassigned 1,0 3.1.3.3 Pancreatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26962808&form=6&db=m Pancreatic Stent or Rectal Indomethacin-Which Better Prevents Post-ERCP Pancreatitis?: A Propensity Score Matching Analysis. therapeutic application,unassigned 4,0 3.1.3.3 Pancreatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30134826&form=6&db=m Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Pancreatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33302662&form=6&db=m Prophylactic effect of rectal indomethacin plus nitroglycerin administration for preventing pancreatitis after endoscopic retrograde cholangiopancreatography in female patients. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,4,0 3.1.3.3 Pancreatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34268662&form=6&db=m Role of Pancreatic Stone Protein as an Early Biomarker for Risk Stratification of Acute Pancreatitis. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Pancreatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3387420&form=6&db=m Organic matrix of pancreatic stones associated with nutritional pancreatitis. causal interaction,unassigned 4,0 3.1.3.3 Pancreatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3550781&form=6&db=m Immunocytochemical localization of pancreatic stone protein in the human digestive tract. diagnostic usage,ongoing research,unassigned 3,4,0 3.1.3.3 Pancreatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7716137&form=6&db=m Pancreatic stone protein and lactoferrin in human pancreatic juice in chronic pancreatitis. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,2 3.1.3.3 Pancreatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7898566&form=6&db=m Current status of pancreatic stone protein. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,3,0 3.1.3.3 Pancreatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8482198&form=6&db=m Idiopathic chronic calcifying pancreatitis with diabetes mellitus. Analysis of pancreatic stone protein gene. ongoing research,unassigned 4,0 3.1.3.3 Pancreatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8501356&form=6&db=m Serum pancreatic stone protein in pancreatic diseases. causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Pancreatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19648675&form=6&db=m [Clinical trial on pancreatic duct stones caused by chronic pancreatitis.] causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Panniculitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17997742&form=6&db=m Poststeroid panniculitis. therapeutic application,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1552311&form=6&db=m Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1629370&form=6&db=m Neuro-ophthalmic findings in progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2463046&form=6&db=m Selective decrease of large neurons in the neostriatum in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2721044&form=6&db=m Early progressive supranuclear palsy: pathology and clinical presentation. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2816286&form=6&db=m Tremor in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3895032&form=6&db=m Treatment of progressive supranuclear palsy with tricyclic antidepressants. ongoing research,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7799001&form=6&db=m The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7955710&form=6&db=m [Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 2,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7955713&form=6&db=m [Adult-onset dementia with abundant neurofibrillary tangles resembling progressive supranuclear palsy] diagnostic usage,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964695&form=6&db=m Eyelid motor abnormalities in progressive supranuclear palsy. therapeutic application,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964698&form=6&db=m Cognitive disturbances in progressive supranuclear palsy. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7984527&form=6&db=m [Progressive supranuclear paralysis. Quantification of dopamine D2 receptors using radionuclide tomography] causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7990846&form=6&db=m Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. diagnostic usage,therapeutic application,unassigned 2,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8154868&form=6&db=m Eye movements in parkinsonian syndromes. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8208392&form=6&db=m Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8208393&form=6&db=m The syndrome of 'pure akinesia' and its relationship to progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8319395&form=6&db=m [Clinical analysis of paralytic shellfish poisoning following ingestion of oysters] causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8363349&form=6&db=m Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8627344&form=6&db=m Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. diagnostic usage,ongoing research,unassigned 1,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8648326&form=6&db=m Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8673495&form=6&db=m What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features? causal interaction,ongoing research,unassigned 1,4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8679336&form=6&db=m [A 65-year-old man with Parkinsonism, gaze palsy, and dementia] therapeutic application,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8710059&form=6&db=m Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8780065&form=6&db=m Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8928621&form=6&db=m Progressive supranuclear palsy: a clinicopathological study of 21 cases. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9018027&form=6&db=m Cerebral oxygen metabolism in patients with progressive supranuclear palsy: a positron emission tomography study. diagnostic usage,unassigned 4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9055798&form=6&db=m Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9277099&form=6&db=m [Vertical oculomotor disorders in progressive supranuclear palsy and spino-cerebellar degeneration] causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9294327&form=6&db=m [Progressive supranuclear palsy with macular degeneration--report of three cases] causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9451717&form=6&db=m Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9577667&form=6&db=m [Progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9633705&form=6&db=m Progressive supranuclear palsy: a survey of the disease course. diagnostic usage,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9818850&form=6&db=m Caregiving in progressive supranuclear palsy. diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9841787&form=6&db=m Structural and functional meta-analytic evidence for fronto-subcortical system deficit in progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10072441&form=6&db=m Association of an extended haplotype in the tau gene with progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10218631&form=6&db=m Progressive supranuclear palsy with dementia: cortical pathology. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10388790&form=6&db=m Clinical genetics of familial progressive supranuclear palsy. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10440304&form=6&db=m Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10525996&form=6&db=m Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. therapeutic application,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10718204&form=6&db=m Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 1,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10830408&form=6&db=m Research goals in progressive supranuclear palsy. First International Brainstorming Conference on PSP. therapeutic application,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10967656&form=6&db=m [An autopsy case of corticobasal degeneration without prominent cortical pathology--an imitator of progressive supranuclear palsy] diagnostic usage,ongoing research,unassigned 1,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11087782&form=6&db=m An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11295776&form=6&db=m Impairment of eyeblink classical conditioning in progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11346024&form=6&db=m Diagnosis and management of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11458995&form=6&db=m Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy. ongoing research,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11708994&form=6&db=m Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography. causal interaction,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11731878&form=6&db=m Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,unassigned 2,4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11912113&form=6&db=m Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,1,1 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11921116&form=6&db=m Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12112206&form=6&db=m Further extension of the H1 haplotype associated with progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,3,1 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12410387&form=6&db=m Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains. ongoing research,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12552038&form=6&db=m APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 4,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12584413&form=6&db=m Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. causal interaction,unassigned 4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12654952&form=6&db=m Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12654953&form=6&db=m Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12773891&form=6&db=m [Contribution of oculomotor examination for the etiological diagnosis of parkinsonian syndromes] causal interaction,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12815662&form=6&db=m Influence of target size on vertical gaze palsy in a pathologically proven case of progressive supranuclear palsy. causal interaction,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14673883&form=6&db=m Health-related quality of life in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14978673&form=6&db=m Accuracy of clinical diagnosis of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15022178&form=6&db=m Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism? causal interaction,ongoing research,therapeutic application,unassigned 1,1,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15205125&form=6&db=m MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. causal interaction,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15235807&form=6&db=m Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15351634&form=6&db=m Deficits in long-term retention of learned motor skills in patients with cortical or subcortical degeneration. ongoing research,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15365723&form=6&db=m Distribution of tuft-shaped astrocytes in the cerebral cortex in progressive supranuclear palsy. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15651349&form=6&db=m [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis] diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15728291&form=6&db=m Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15754175&form=6&db=m Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study. diagnostic usage,ongoing research,unassigned 4,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15774434&form=6&db=m Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,1,1 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15788542&form=6&db=m Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,1,1 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15965048&form=6&db=m A new noninvasive test to detect mitochondrial dysfunction of skeletal muscles in progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15985570&form=6&db=m New and reliable MRI diagnosis for progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16000317&form=6&db=m The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. causal interaction,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16006341&form=6&db=m Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology. causal interaction,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16092076&form=6&db=m Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16093228&form=6&db=m Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16353177&form=6&db=m Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease. causal interaction,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16447770&form=6&db=m [MRI diagnosis of neurodegenerative disorders] causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16832075&form=6&db=m Measuring quality of life in PSP: the PSP-QoL. causal interaction,therapeutic application,unassigned 2,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16839689&form=6&db=m Effect of MAPT and APOE on prognosis of progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16897134&form=6&db=m Neuroimaging of PD, PSP, CBD and MSA-PET and SPECT studies. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17154033&form=6&db=m [Successful outcome of VP shunt operation in 3 cases of idiopathic normal pressure hydrocephalus with long duration of illness] causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17204917&form=6&db=m The ratio of square wave jerk rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease. causal interaction,unassigned 4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17587253&form=6&db=m Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. diagnostic usage,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17675576&form=6&db=m Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of parkinsonism-dementia complex of Guam but not alzheimer's disease or progressive supranuclear palsy. causal interaction,ongoing research,therapeutic application,unassigned 3,2,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17709703&form=6&db=m Frontal presentation in progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18195676&form=6&db=m Progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18260059&form=6&db=m [Steele-Richardson-Olszewski syndrome] diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18283396&form=6&db=m The auditory startle response in parkinsonism may reveal the extent but not type of pathology. diagnostic usage,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18332837&form=6&db=m Progressive Supranuclear Palsy: A Current Review. diagnostic usage,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18541806&form=6&db=m Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18561341&form=6&db=m Lack of trigemino-cervical reflexes in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18948373&form=6&db=m Balance and eye movement training to improve gait in people with progressive supranuclear palsy: quasi-randomized clinical trial. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19099114&form=6&db=m Clinical features of dystonia in atypical parkinsonism. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19158937&form=6&db=m Cortical Alzheimer Type Pathology Does Not Influence tau Pathology in Progressive Supranuclear Palsy. causal interaction,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19236979&form=6&db=m Improvement of gaze control after balance and eye movement training in patients with progressive supranuclear palsy: a quasi-randomized controlled trial. causal interaction,unassigned 4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20077483&form=6&db=m Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis. diagnostic usage,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20944816&form=6&db=m Behavioral changes as the earliest clinical manifestation of progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21154980&form=6&db=m Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21236720&form=6&db=m Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21387699&form=6&db=m [A case of a syndrome resembling PSP after aortic arch replacement under deep hypothermic circulatory arrest]. therapeutic application,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21412832&form=6&db=m Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21722681&form=6&db=m Alterations of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic produced in rat brain tissues after systemic administration of saxitoxin. therapeutic application,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21972942&form=6&db=m Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C. causal interaction,diagnostic usage,unassigned 3,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22160793&form=6&db=m Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22277395&form=6&db=m The diagnosis of neurodegenerative disorders based on clinical and pathological findings using an MRI approach. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22329857&form=6&db=m Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C. causal interaction,diagnostic usage,unassigned 3,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22488922&form=6&db=m Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22556362&form=6&db=m Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. causal interaction,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23127882&form=6&db=m Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23146616&form=6&db=m Electrophysiological features of lower motor neuron involvement in progressive supranuclear palsy. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23173978&form=6&db=m Transcranial brain sonography findings in two main variants of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23180183&form=6&db=m MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy. therapeutic application,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23300100&form=6&db=m [The genetics of corticobasal syndrome]. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23436751&form=6&db=m Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23746093&form=6&db=m Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. causal interaction,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24041972&form=6&db=m Microtubule-associated protein tau genetic variations are uncommon cause of frontotemporal dementia in south India. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24615741&form=6&db=m Rate of decline in progressive supranuclear palsy. diagnostic usage,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24868411&form=6&db=m Levodopa-induced facial dystonia in a case of progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 3,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24873720&form=6&db=m Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24935235&form=6&db=m Functional correlates of vertical gaze palsy and other ocular motor deficits in PSP: an FDG-PET study. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24963674&form=6&db=m Progressive supranuclear palsy. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24992742&form=6&db=m [A clinical case of progressive supranuclear palsy with long-term frontal presentation preceding the onset of gaze palsy]. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25683763&form=6&db=m Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25732053&form=6&db=m Progressive Supranuclear Palsy: What do we know About it? causal interaction,unassigned 3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26556659&form=6&db=m Spinocerebellar degeneration: Discrepancies between clinical and pathological diagnoses. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26885623&form=6&db=m The Cure PSP Care Guide: A Telephonic Nursing Intervention for Individuals and Families Living With Progressive Supranuclear Palsy. therapeutic application,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26900156&form=6&db=m The Differential Diagnosis and Treatment of Atypical Parkinsonism. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26980757&form=6&db=m Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations. ongoing research,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27042679&form=6&db=m Parkinson disease and progressive supranuclear palsy: protein expression in skin. diagnostic usage,ongoing research,unassigned 1,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27070344&form=6&db=m Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27132501&form=6&db=m Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy. diagnostic usage,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27245243&form=6&db=m Blood-Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy. diagnostic usage,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27364040&form=6&db=m Obsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential Tremor. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27411806&form=6&db=m MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome. diagnostic usage,ongoing research,unassigned 4,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27747983&form=6&db=m Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 4,2,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27842578&form=6&db=m An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability. therapeutic application,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27915581&form=6&db=m FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28131191&form=6&db=m Potential multisystem degeneration in Asidan patients. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28179466&form=6&db=m Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28207803&form=6&db=m Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms. diagnostic usage,therapeutic application,unassigned 2,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28415165&form=6&db=m Progressive Supranuclear Gaze Palsy with Predominant Cerebellar Ataxia: A Case Series with Videos. causal interaction,diagnostic usage,unassigned 2,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28706282&form=6&db=m Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetry. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28725681&form=6&db=m Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,2,2 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29336906&form=6&db=m Progression of white matter damage in progressive supranuclear palsy with predominant parkinsonism. diagnostic usage,therapeutic application,unassigned 1,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29460982&form=6&db=m Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,3,2 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29467306&form=6&db=m Gait analysis in PSP and NPH: Dual-task conditions make the difference. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29779682&form=6&db=m Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis. diagnostic usage,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29902389&form=6&db=m The diagnosis of progressive supranuclear palsy: current opinions and challenges. causal interaction,diagnostic usage,unassigned 4,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29926172&form=6&db=m Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype. diagnostic usage,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30025721&form=6&db=m Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromes. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30131406&form=6&db=m Progressive supranuclear palsy responding to intravenous thiamine: superimposed Wernicke's encephalopathy? causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30363831&form=6&db=m Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology. causal interaction,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30726566&form=6&db=m Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30796010&form=6&db=m Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy. diagnostic usage,unassigned 4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30803901&form=6&db=m Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study. diagnostic usage,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31392246&form=6&db=m An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31414383&form=6&db=m CSF sAPP? and sAPP? levels in Alzheimer's Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis. causal interaction,unassigned 4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31433871&form=6&db=m Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,4,1 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31446709&form=6&db=m [Partial superficial parotidectomy versus superficial parotidectomy for treatment of parotid benign tumors: evidence-based medicine analysis]. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31527182&form=6&db=m Midbrain MRI assessments in progressive supranuclear palsy subtypes. diagnostic usage,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31552724&form=6&db=m Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes. diagnostic usage,therapeutic application,unassigned 3,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31559910&form=6&db=m Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy. diagnostic usage,unassigned 2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31621617&form=6&db=m Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31665686&form=6&db=m Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31752626&form=6&db=m The Progressive Supranuclear Palsy: Past and Present Aspects. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31796642&form=6&db=m Natural clinical course of progressive supranuclear palsy in Chinese patients in Hong Kong. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32142177&form=6&db=m Association of Tripartite Motif Containing 11 rs564309 with Tau Pathology in Progressive Supranuclear Palsy. causal interaction,unassigned 4,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32259098&form=6&db=m Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study. unassigned - 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32293067&form=6&db=m Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32415030&form=6&db=m Parkinsonism with newly diagnosed flare-up rheumatoid arthritis mimicking progressive supranuclear palsy. therapeutic application,unassigned 1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32536421&form=6&db=m Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32959131&form=6&db=m Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33043429&form=6&db=m Superficial or partial superficial parotidectomy for the treatment of primary benign parotid tumors. causal interaction,diagnostic usage,unassigned 3,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33588132&form=6&db=m Spatial attention and spatial short term memory in PSP and Parkinson's disease. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33613435&form=6&db=m The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome-A Pilot Study. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33744691&form=6&db=m Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34177779&form=6&db=m Gait Analysis in Progressive Supranuclear Palsy Phenotypes. diagnostic usage,ongoing research,unassigned 4,1,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34209067&form=6&db=m Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34425331&form=6&db=m Sleep disturbances in the speech-language variant of progressive supranuclear palsy. unassigned - 3.1.3.3 Paresis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20205175&form=6&db=m Long-term results of morbidity after parotid gland surgery in benign disease. unassigned - 3.1.3.3 Paresis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23762677&form=6&db=m Zolpidem in progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Paresis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31446709&form=6&db=m [Partial superficial parotidectomy versus superficial parotidectomy for treatment of parotid benign tumors: evidence-based medicine analysis]. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Paresthesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8867115&form=6&db=m Thalamic stimulation-evoked sensations in chronic pain patients and in nonpain (movement disorder) patients. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Paresthesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15145009&form=6&db=m Incidence of chest wall paresthesia after video-assisted thoracic surgery for primary spontaneous pneumothorax. therapeutic application,unassigned 1,0 3.1.3.3 Paresthesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25207248&form=6&db=m Early outcomes of single-port video-assisted thoracic surgery for primary spontaneous pneumothorax. therapeutic application,unassigned 2,0 3.1.3.3 Paresthesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28918891&form=6&db=m Case diagnosis and characterization of suspected paralytic shellfish poisoning in Alaska. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,1,0 3.1.3.3 Paresthesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30505556&form=6&db=m Uniportal vs. triportal video-assisted thoracic surgery in the treatment of primary pneumothorax-a propensity matched bicentric study. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Paresthesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32852262&form=6&db=m Comparison of single-port vs. two-port VATS technique for primary spontaneous pneumothorax. therapeutic application,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1497499&form=6&db=m Local cerebral blood flow and its response to intravenous levodopa in progressive supranuclear palsy. Comparison with Parkinson's disease. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1578232&form=6&db=m Positron emission tomography (PET) in "pure akinesia". causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1629370&form=6&db=m Neuro-ophthalmic findings in progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2054646&form=6&db=m Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology. therapeutic application,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2440513&form=6&db=m Brain neuropeptides in progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2811889&form=6&db=m Eyelid movement abnormalities in progressive supranuclear palsy. causal interaction,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2816286&form=6&db=m Tremor in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2836033&form=6&db=m Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2891795&form=6&db=m Brain somatostatin concentrations do not decrease in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,2,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2975699&form=6&db=m D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3368077&form=6&db=m Brain amino acids and glutathione in progressive supranuclear palsy. causal interaction,ongoing research,unassigned 1,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3379428&form=6&db=m The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3577208&form=6&db=m Progressive supranuclear palsy: a brief personalized history. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6398402&form=6&db=m Progressive supranuclear palsy. Clinical and pharmacologic update. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6637400&form=6&db=m Neuronal loss in the basal nucleus of Meynert in progressive supranuclear palsy. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7525868&form=6&db=m Alterations of neurotransmitter receptors and neurotransmitter transporters in progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7834957&form=6&db=m [Autonomic nervous function in progressive supranuclear palsy--comparison with Parkinson's disease and healthy controls] causal interaction,diagnostic usage,ongoing research,unassigned 1,4,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7876847&form=6&db=m Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7903988&form=6&db=m [Steele-Richardson-Olszewski syndrome] causal interaction,diagnostic usage,unassigned 4,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964684&form=6&db=m Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964691&form=6&db=m The epidemiology of PSP. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7984527&form=6&db=m [Progressive supranuclear paralysis. Quantification of dopamine D2 receptors using radionuclide tomography] causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7990846&form=6&db=m Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. diagnostic usage,therapeutic application,unassigned 2,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8208392&form=6&db=m Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8282945&form=6&db=m Micturitional disturbance in progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8628467&form=6&db=m Limited usefulness of electroconvulsive therapy in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,2 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8648326&form=6&db=m Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8811682&form=6&db=m Progressive supranuclear palsy: MRI and pathological findings. ongoing research,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9055798&form=6&db=m Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9443491&form=6&db=m Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene. causal interaction,ongoing research,unassigned 1,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9520011&form=6&db=m Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9797005&form=6&db=m Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10378376&form=6&db=m Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10440304&form=6&db=m Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10824045&form=6&db=m Progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10852537&form=6&db=m Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,1,3 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10904943&form=6&db=m [Semiquantitative evaluation of cranial computerized tomography as diagnostic support in progressive supranuclear palsy] diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11442435&form=6&db=m Abnormal signals on proton density-weighted MRI of the superior cerebellar peduncle in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 2,3,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11912112&form=6&db=m Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 2,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11912113&form=6&db=m Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,1,1 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11921116&form=6&db=m Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11960887&form=6&db=m Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12225316&form=6&db=m Enlargements of somatosensory-evoked potentials in progressive supranuclear palsy. causal interaction,ongoing research,unassigned 4,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12401443&form=6&db=m Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease. causal interaction,ongoing research,therapeutic application,unassigned 4,4,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12589575&form=6&db=m Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. diagnostic usage,unassigned 4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12736089&form=6&db=m Study of the rostral midbrain atrophy in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12773885&form=6&db=m [Progressive supranuclear palsy] causal interaction,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14598079&form=6&db=m Progressive supranuclear palsy: analysis of six cases. diagnostic usage,unassigned 4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15205125&form=6&db=m MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. causal interaction,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15242422&form=6&db=m Midbrain hypometabolism as early diagnostic sign for progressive supranuclear palsy. ongoing research,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15261857&form=6&db=m Patterns of abnormal motor cortex excitability in atypical parkinsonian syndromes. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15282366&form=6&db=m Progressive supranuclear palsy. causal interaction,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15351634&form=6&db=m Deficits in long-term retention of learned motor skills in patients with cortical or subcortical degeneration. ongoing research,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15377682&form=6&db=m Abnormalities of optokinetic nystagmus in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 2,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15728291&form=6&db=m Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15754175&form=6&db=m Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study. diagnostic usage,ongoing research,unassigned 4,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15774434&form=6&db=m Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,1,1 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15843423&form=6&db=m Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,2,2 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15930045&form=6&db=m Apraxia in movement disorders. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15985570&form=6&db=m New and reliable MRI diagnosis for progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16014651&form=6&db=m A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16093228&form=6&db=m Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16093629&form=6&db=m Morning glory sign: a particular MR finding in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16154793&form=6&db=m Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP). causal interaction,diagnostic usage,ongoing research,unassigned 1,3,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16455792&form=6&db=m Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16531926&form=6&db=m 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,4,3 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16602104&form=6&db=m Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. diagnostic usage,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16691119&form=6&db=m Lewy bodies in progressive supranuclear palsy represent an independent disease process. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16815875&form=6&db=m Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 2,3,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16897134&form=6&db=m Neuroimaging of PD, PSP, CBD and MSA-PET and SPECT studies. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16908744&form=6&db=m Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16987883&form=6&db=m Untangling the tau gene association with neurodegenerative disorders. causal interaction,unassigned 4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17085483&form=6&db=m Haplotype-specific expression of exon 10 at the human MAPT locus. causal interaction,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17124191&form=6&db=m Mixing pro- and antisaccades in patients with parkinsonian syndromes. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17204917&form=6&db=m The ratio of square wave jerk rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease. causal interaction,unassigned 4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17275393&form=6&db=m Differentiation of Parkinson's disease and progressive supranuclear palsy with magnetic resonance imaging: The first Brazilian experience. ongoing research,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17483697&form=6&db=m Muscarinic receptors in the thalamus in progressive supranuclear palsy and other neurodegenerative disorders. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,2,1 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17534953&form=6&db=m Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17670978&form=6&db=m An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease. causal interaction,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17709155&form=6&db=m Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17712855&form=6&db=m Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. diagnostic usage,unassigned 4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17998447&form=6&db=m Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18265929&form=6&db=m Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18283396&form=6&db=m The auditory startle response in parkinsonism may reveal the extent but not type of pathology. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18779957&form=6&db=m Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 2,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18785245&form=6&db=m Parkinsonism and dystonia caused by the illicit use of ephedrone--a longitudinal study. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18792126&form=6&db=m Autonomic dysfunction in patients with progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 3,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18819991&form=6&db=m Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,2,2 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18971445&form=6&db=m Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18972544&form=6&db=m Applause sign in Parkinsonian disorders and Huntington's disease. diagnostic usage,ongoing research,therapeutic application,unassigned 4,4,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19224319&form=6&db=m Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20209627&form=6&db=m Hyposmia in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,1,2 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20396463&form=6&db=m Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20457507&form=6&db=m Acoustical Analysis of Speech in Progressive Supranuclear Palsy. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20477368&form=6&db=m Diagnostic potential of saccadometry in progressive supranuclear palsy. diagnostic usage,therapeutic application,unassigned 3,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20629130&form=6&db=m Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,1,4 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20669002&form=6&db=m [Progressive supranuclear palsy : Living environment of the patients in Germany.] causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20692498&form=6&db=m Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes. causal interaction,therapeutic application,unassigned 1,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20818672&form=6&db=m Cerebellar dysfunction in progressive supranuclear palsy: a transcranial magnetic stimulation study. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21236720&form=6&db=m Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22065210&form=6&db=m Instability of syllable repetition in progressive supranuclear palsy. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22115673&form=6&db=m Comparison of REM sleep behaviour disorder variables between patients with progressive supranuclear palsy and those with Parkinson's disease. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,1 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22421702&form=6&db=m Amantadine-induced myoclonus in a patient with progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22488922&form=6&db=m Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22556362&form=6&db=m Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. causal interaction,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22595619&form=6&db=m Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease. ongoing research,therapeutic application,unassigned 4,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22832867&form=6&db=m Corneal Sensitivity, Blink Rate, and Corneal Nerve Density in Progressive Supranuclear Palsy and Parkinson Disease. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22862741&form=6&db=m Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies. causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22883477&form=6&db=m Deterioration of horizontal saccades in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,2,3,1 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23242279&form=6&db=m Essential tremor followed by progressive supranuclear palsy: postmortem reports of 11 patients. causal interaction,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23248593&form=6&db=m Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease. diagnostic usage,ongoing research,unassigned 2,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23264798&form=6&db=m Hummingbird sign in progressive supranuclear palsy disease. causal interaction,unassigned 4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23415606&form=6&db=m STX6 rs1411478 is not associated with increased risk of Parkinson's disease. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24252572&form=6&db=m The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease. causal interaction,unassigned 4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24349849&form=6&db=m Progressive supranuclear palsy misdiagnosed as Parkinson's disease: a case report and review of literature. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24486693&form=6&db=m Word-retrieval in two cases of progressive supranuclear palsy. causal interaction,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24749759&form=6&db=m Enteric GFAP expression and phosphorylation in Parkinson's disease. causal interaction,diagnostic usage,unassigned 2,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24757116&form=6&db=m Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. therapeutic application,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25683763&form=6&db=m Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25997420&form=6&db=m Vascular Parkinsonism: deconstructing a syndrome. causal interaction,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26980757&form=6&db=m Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations. ongoing research,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27042679&form=6&db=m Parkinson disease and progressive supranuclear palsy: protein expression in skin. diagnostic usage,ongoing research,unassigned 1,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27190673&form=6&db=m Whole-Brain Atrophy Rate in Idiopathic Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy. ongoing research,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27381106&form=6&db=m Correlation between qualitative balance indices, dynamic posturography and structural brain imaging in patients with progressive supranuclear palsy and its subtypes. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27470326&form=6&db=m A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism. causal interaction,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27532657&form=6&db=m Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review. ongoing research,therapeutic application,unassigned 2,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27679572&form=6&db=m Whole-Brain Atrophy Differences between Progressive Supranuclear Palsy and Idiopathic Parkinson's Disease. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27723878&form=6&db=m Subregional Pattern of Striatal Dopamine Transporter Loss on 18F FP-CIT Positron Emission Tomography in Patients With Pure Akinesia With Gait Freezing. diagnostic usage,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27747983&form=6&db=m Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 4,2,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28131191&form=6&db=m Potential multisystem degeneration in Asidan patients. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28158197&form=6&db=m Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments. diagnostic usage,therapeutic application,unassigned 1,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28256434&form=6&db=m Pathologic correlates of supranuclear gaze palsy with parkinsonism. causal interaction,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28267762&form=6&db=m Impaired perception of surface tilt in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28500752&form=6&db=m Which ante mortem clinical features predict progressive supranuclear palsy pathology? causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28632098&form=6&db=m Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of Parkinson's disease, PSP and MSA-P. diagnostic usage,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28803444&form=6&db=m Atypical Parkinsonian syndromes: a general neurologist's perspective. causal interaction,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28870563&form=6&db=m Executive dysfunction, behavioral changes and quality of life in Chinese patients with progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28987055&form=6&db=m The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease. ongoing research,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29238748&form=6&db=m Non motor symptoms in progressive supranuclear palsy: prevalence and severity. diagnostic usage,ongoing research,unassigned 4,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29356135&form=6&db=m Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29460982&form=6&db=m Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,3,2 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29948175&form=6&db=m Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30062400&form=6&db=m Long-term treatment with rotigotine in drug-naïve PSP patients. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30089514&form=6&db=m Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30339310&form=6&db=m Pedunculopontine tegmentum cholinergic loss leads to a progressive decline in motor abilities and neuropathological changes resembling progressive supranuclear palsy. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30352750&form=6&db=m Eye movement deficits in X-linked dystonia-parkinsonism are related to striatal degeneration. causal interaction,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30363434&form=6&db=m Role of Corpus Callosum Volumetry in Differentiating the Subtypes of Progressive Supranuclear Palsy and Early Parkinson's Disease. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30363831&form=6&db=m Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology. causal interaction,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30831462&form=6&db=m Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30884283&form=6&db=m The language profile of progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,2,1 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31155302&form=6&db=m Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,2,2 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31299107&form=6&db=m The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy. ongoing research,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31414383&form=6&db=m CSF sAPP? and sAPP? levels in Alzheimer's Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis. causal interaction,unassigned 4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31527182&form=6&db=m Midbrain MRI assessments in progressive supranuclear palsy subtypes. diagnostic usage,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31665686&form=6&db=m Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31743601&form=6&db=m Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31878122&form=6&db=m Prediction of the Clinical Severity of Progressive Supranuclear Palsy by Diffusion Tensor Imaging. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31897945&form=6&db=m Serum adiponectin levels between patients with Parkinson's disease and those with PSP. diagnostic usage,unassigned 4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31942756&form=6&db=m A Cortical Substrate for Square-Wave Jerks in Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 1,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32218768&form=6&db=m Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P)-A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD). causal interaction,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32220093&form=6&db=m Progressive Supranuclear Palsy and Statin Use. diagnostic usage,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32241079&form=6&db=m The Non-Motor Symptom Profile of Progressive Supranuclear Palsy. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32259098&form=6&db=m Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32357260&form=6&db=m Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. diagnostic usage,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32416639&form=6&db=m Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32536421&form=6&db=m Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32612521&form=6&db=m Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism. diagnostic usage,unassigned 2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32651138&form=6&db=m Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32731191&form=6&db=m Understanding the relationship between freezing of gait and other progressive supranuclear palsy features. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32751888&form=6&db=m Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32959131&form=6&db=m Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33271461&form=6&db=m Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33341150&form=6&db=m Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,4 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33385754&form=6&db=m Disease course and treatment patterns in progressive supranuclear palsy: A real-world study. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33421177&form=6&db=m Cutaneous sensory and autonomic denervation in progressive supranuclear palsy. unassigned - 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33515312&form=6&db=m Immediate Effects of Sensorimotor Training in Airway Protection (smTAP) on Cough Outcomes in Progressive Supranuclear Palsy: A Feasibility Study. causal interaction,ongoing research,therapeutic application,unassigned 3,3,4,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33536537&form=6&db=m Iron accumulation in the oculomotor nerve of the progressive supranuclear palsy brain. diagnostic usage,ongoing research,unassigned 2,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33549583&form=6&db=m Phonemic fluency quantity and quality: Comparing patients with PSP, Parkinson's disease and focal frontal and subcortical lesions. therapeutic application,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33588132&form=6&db=m Spatial attention and spatial short term memory in PSP and Parkinson's disease. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33644483&form=6&db=m Effects of Lee Silverman Voice Treatment (LSVT LOUD) on Swallowing in Patients with Progressive Supranuclear Palsy: A Pilot Study. causal interaction,unassigned 3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33714084&form=6&db=m A novel diagnostic marker for progressive supranuclear palsy targeting atrophy of the subthalamic nucleus. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33744691&form=6&db=m Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34046156&form=6&db=m Validation of the Parkinson's Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy. therapeutic application,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34105000&form=6&db=m Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis. causal interaction,unassigned 1,0 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34173683&form=6&db=m Sensorimotor Cough Dysfunction Is Prevalent and Pervasive in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,3,1 3.1.3.3 Parkinson Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34177779&form=6&db=m Gait Analysis in Progressive Supranuclear Palsy Phenotypes. diagnostic usage,ongoing research,unassigned 4,1,0 3.1.3.3 Parkinson Disease, Postencephalitic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6107328&form=6&db=m Progressive supranuclear palsy: clinico-pathological and biochemical studies. causal interaction,unassigned 1,0 3.1.3.3 Parkinson Disease, Postencephalitic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8558176&form=6&db=m Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,2,0 3.1.3.3 Parkinson Disease, Postencephalitic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8673495&form=6&db=m What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features? causal interaction,ongoing research,unassigned 1,4,0 3.1.3.3 Parkinson Disease, Postencephalitic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8780065&form=6&db=m Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,3,0 3.1.3.3 Parkinson Disease, Postencephalitic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14502653&form=6&db=m Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Parkinson Disease, Postencephalitic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15022178&form=6&db=m Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism? causal interaction,ongoing research,therapeutic application,unassigned 1,1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1934773&form=6&db=m [Cerebral blood flow pattern in progressive supranuclear palsy] causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7625148&form=6&db=m Olfactory function in atypical parkinsonian syndromes. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7990846&form=6&db=m Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. diagnostic usage,therapeutic application,unassigned 2,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8334795&form=6&db=m [A case of progressive supranuclear palsy showing marked improvements of frontal hypoperfusion, as well as parkinsonism with amitriptyline] causal interaction,therapeutic application,unassigned 4,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8602756&form=6&db=m Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8710069&form=6&db=m Follow-up study of risk factors in progressive supranuclear palsy. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8928621&form=6&db=m Progressive supranuclear palsy: a clinicopathological study of 21 cases. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9014454&form=6&db=m [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease] causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9055798&form=6&db=m Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9125748&form=6&db=m [A 85-year-old woman with the onset of progressive gait disturbance at 80 years of the age] diagnostic usage,therapeutic application,unassigned 3,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9577667&form=6&db=m [Progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9877531&form=6&db=m Clinical and genetic aspects of progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10378376&form=6&db=m Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10388790&form=6&db=m Clinical genetics of familial progressive supranuclear palsy. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10435501&form=6&db=m Motor programming is more affected in progressive supranuclear palsy than in Parkinson's disease: a spatiotemporal study of event-related desynchronization. causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10440304&form=6&db=m Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10519868&form=6&db=m Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10525996&form=6&db=m Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. therapeutic application,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10584668&form=6&db=m Progression of falls in postmortem-confirmed parkinsonian disorders. diagnostic usage,therapeutic application,unassigned 4,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10945805&form=6&db=m Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11487180&form=6&db=m Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. causal interaction,therapeutic application,unassigned 2,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11578815&form=6&db=m Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11595348&form=6&db=m Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy. causal interaction,ongoing research,unassigned 1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11699567&form=6&db=m Progressive supranuclear palsy on Guam. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11739828&form=6&db=m Pathophysiology of slow vertical saccades in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11912113&form=6&db=m Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,1,1 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11921116&form=6&db=m Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11960887&form=6&db=m Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12217621&form=6&db=m Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12584413&form=6&db=m Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. causal interaction,unassigned 4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14502653&form=6&db=m Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14741660&form=6&db=m Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15205125&form=6&db=m MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. causal interaction,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15294329&form=6&db=m Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15651349&form=6&db=m [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis] diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15965048&form=6&db=m A new noninvasive test to detect mitochondrial dysfunction of skeletal muscles in progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16006341&form=6&db=m Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology. causal interaction,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16092076&form=6&db=m Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16093629&form=6&db=m Morning glory sign: a particular MR finding in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16569380&form=6&db=m Current and future treatments in progressive supranuclear palsy. causal interaction,unassigned 2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16936386&form=6&db=m Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16987883&form=6&db=m Untangling the tau gene association with neurodegenerative disorders. causal interaction,unassigned 4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17481936&form=6&db=m Signal changes of superior cerebellar peduncle on fluid-attenuated inversion recovery in progressive supranuclear palsy. causal interaction,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17493041&form=6&db=m Progressive supranuclear palsy: pathology and genetics. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17941460&form=6&db=m [Dopamine agonists--clinical applications beyond Parkinson's disease] causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17991785&form=6&db=m MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17998447&form=6&db=m Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18267272&form=6&db=m MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice. diagnostic usage,therapeutic application,unassigned 2,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18315566&form=6&db=m Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats. diagnostic usage,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18422568&form=6&db=m How do patients with parkinsonism present? A clinicopathological study. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18785640&form=6&db=m The PSP-associated MAPT H1 subhaplotype in Guadeloupean atypical parkinsonism. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18972544&form=6&db=m Applause sign in Parkinsonian disorders and Huntington's disease. diagnostic usage,ongoing research,therapeutic application,unassigned 4,4,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19099114&form=6&db=m Clinical features of dystonia in atypical parkinsonism. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19233037&form=6&db=m Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. diagnostic usage,therapeutic application,unassigned 4,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19458322&form=6&db=m Familial aggregation of parkinsonism in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19765889&form=6&db=m The effect of repeated administrations of granulocyte colony stimulating factor for blood stem cells mobilization in patients with progressive supranuclear palsy, corticobasal degeneration and multiple system atrophy. causal interaction,therapeutic application,unassigned 1,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19785640&form=6&db=m Anal sphincter EMG in the diagnosis of parkinsonian syndromes. causal interaction,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20108376&form=6&db=m Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study. causal interaction,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20396463&form=6&db=m Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20482608&form=6&db=m Familial aggregation in Progressive Supranuclear Palsy and Corticobasal Syndrome. diagnostic usage,unassigned 2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20610990&form=6&db=m Neuropathology of variants of progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20625759&form=6&db=m Familial aggregation in atypical Parkinson's disease: a case control study in multiple system atrophy and progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 4,2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20692498&form=6&db=m Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes. causal interaction,therapeutic application,unassigned 1,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20810128&form=6&db=m Vertical wrinkling of the forehead or Procerus sign in Progressive Supranuclear Palsy. diagnostic usage,unassigned 2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20836136&form=6&db=m Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20878992&form=6&db=m Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy. diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21154980&form=6&db=m Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21181185&form=6&db=m Magnetic resonance imaging in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,1 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21396886&form=6&db=m The contribution of trigemino-cervical reflexes in distinguishing progressive supranuclear palsy from multiple system atrophy. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21412832&form=6&db=m Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21420891&form=6&db=m Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP? causal interaction,diagnostic usage,ongoing research,unassigned 1,3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21748523&form=6&db=m Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy. diagnostic usage,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21783505&form=6&db=m Atypical parkinsonism on Guadeloupe, comparison with the parkinsonism-dementia complex of Guam, and environmental toxic hypotheses. therapeutic application,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21817180&form=6&db=m [A 62-year-old Woman Presenting with Progressive Nonfluent Aphasia, Apraxia of Eyelid Opening, Supranuclear Gaze Palsy, and Asymmetric Rigidity]. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21832222&form=6&db=m MRI measurements predict PSP in unclassifiable parkinsonisms: A cohort study. diagnostic usage,ongoing research,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22115673&form=6&db=m Comparison of REM sleep behaviour disorder variables between patients with progressive supranuclear palsy and those with Parkinson's disease. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,1 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22181323&form=6&db=m Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22925882&form=6&db=m Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23314836&form=6&db=m Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography. causal interaction,diagnostic usage,therapeutic application,unassigned 2,4,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23436751&form=6&db=m Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23907408&form=6&db=m Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24059611&form=6&db=m Ultrasonography and MR Imaging in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24749759&form=6&db=m Enteric GFAP expression and phosphorylation in Parkinson's disease. causal interaction,diagnostic usage,unassigned 2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24814162&form=6&db=m Undetectable specific striatal [¹²³I]-ioflupane binding in patients with parkinsonism. causal interaction,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24868411&form=6&db=m Levodopa-induced facial dystonia in a case of progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 3,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25289173&form=6&db=m Long-term follow-up of deep brain stimulation of peduncolopontine nucleus in progressive supranuclear palsy: Report of three cases. causal interaction,unassigned 2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25683763&form=6&db=m Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25773707&form=6&db=m Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,2,1 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25868897&form=6&db=m Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis. causal interaction,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25997420&form=6&db=m Vascular Parkinsonism: deconstructing a syndrome. causal interaction,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26413239&form=6&db=m Genetics of Progressive Supranuclear Palsy. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26449840&form=6&db=m Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26900156&form=6&db=m The Differential Diagnosis and Treatment of Atypical Parkinsonism. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26935895&form=6&db=m Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26951846&form=6&db=m Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. diagnostic usage,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26954800&form=6&db=m Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26980757&form=6&db=m Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations. ongoing research,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27318371&form=6&db=m Paraneoplastic syndrome mimicking progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27334897&form=6&db=m Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27421545&form=6&db=m Functional MRI of disease progression in Parkinson disease and atypical parkinsonian syndromes. causal interaction,therapeutic application,unassigned 3,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27495201&form=6&db=m Diagnostic Approach to Atypical Parkinsonian Syndromes. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27526039&form=6&db=m Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27553513&form=6&db=m Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseases. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27558375&form=6&db=m MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27915581&form=6&db=m FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28256434&form=6&db=m Pathologic correlates of supranuclear gaze palsy with parkinsonism. causal interaction,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28386688&form=6&db=m Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28432758&form=6&db=m Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28500752&form=6&db=m Which ante mortem clinical features predict progressive supranuclear palsy pathology? causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28510312&form=6&db=m The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28702192&form=6&db=m Freezing of gait is an early clinical feature of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28725681&form=6&db=m Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,2,2 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28782342&form=6&db=m 'Hummingbird' Sign in a Patient with Guam Parkinsonism-Dementia Complex. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29126761&form=6&db=m MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29196955&form=6&db=m Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29254097&form=6&db=m Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29279191&form=6&db=m MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29336906&form=6&db=m Progression of white matter damage in progressive supranuclear palsy with predominant parkinsonism. diagnostic usage,therapeutic application,unassigned 1,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29339765&form=6&db=m Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29356135&form=6&db=m Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy. diagnostic usage,ongoing research,unassigned 2,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29574085&form=6&db=m Combined measurement of plasma cystatin C and low-density lipoprotein cholesterol: A valuable tool for evaluating progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 3,4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29728749&form=6&db=m The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29801913&form=6&db=m Progressive spasticity, supranuclear gaze palsy and postural instability, without parkinsonism: what's in a phenotype? causal interaction,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29902389&form=6&db=m The diagnosis of progressive supranuclear palsy: current opinions and challenges. causal interaction,diagnostic usage,unassigned 4,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30068492&form=6&db=m A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30238268&form=6&db=m Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis. ongoing research,therapeutic application,unassigned 3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30363434&form=6&db=m Role of Corpus Callosum Volumetry in Differentiating the Subtypes of Progressive Supranuclear Palsy and Early Parkinson's Disease. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30373485&form=6&db=m MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy. diagnostic usage,unassigned 2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30391822&form=6&db=m MIBG myocardial scintigraphy in progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30482314&form=6&db=m Falls in frontotemporal dementia and related syndromes. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30637277&form=6&db=m C9orf72 and its Relevance in Parkinsonism and Movement Disorders: A Comprehensive Review of the Literature. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30726566&form=6&db=m Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30831462&form=6&db=m Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30836131&form=6&db=m Improved language production with transcranial direct current stimulation in progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 1,4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30884283&form=6&db=m The language profile of progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,2,1 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30894142&form=6&db=m Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30979821&form=6&db=m Presynaptic striatal dopaminergic function in atypical parkinsonisms: A meta-analysis of imaging studies. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30988382&form=6&db=m Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30989369&form=6&db=m Motor, cognitive and behavioral differences in MDS PSP phenotypes. causal interaction,diagnostic usage,ongoing research,unassigned 2,3,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31190253&form=6&db=m Validation of the Italian version of carers' quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy. ongoing research,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31264017&form=6&db=m Deep learning to differentiate parkinsonian disorders separately using single midsagittal MR imaging: a proof of concept study. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31319800&form=6&db=m Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report. diagnostic usage,unassigned 2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31333840&form=6&db=m How to spot ocular abnormalities in progressive supranuclear palsy? A practical review. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31356287&form=6&db=m Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31390857&form=6&db=m Increased Signal in the Superior Cerebellar Peduncle of Patients with Progressive Supranuclear Palsy. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31392246&form=6&db=m An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31433871&form=6&db=m Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,4,1 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31450511&form=6&db=m Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31506735&form=6&db=m Late-onset Niemann-Pick disease type C overlapping with frontotemporal dementia syndromes: a case report. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31527182&form=6&db=m Midbrain MRI assessments in progressive supranuclear palsy subtypes. diagnostic usage,unassigned 2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31552724&form=6&db=m Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes. diagnostic usage,therapeutic application,unassigned 3,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31603934&form=6&db=m Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31743601&form=6&db=m Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31752626&form=6&db=m The Progressive Supranuclear Palsy: Past and Present Aspects. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31999351&form=6&db=m Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32092195&form=6&db=m Automated MRI Classification in Progressive Supranuclear Palsy: a Large International Cohort Study. diagnostic usage,ongoing research,unassigned 1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32145223&form=6&db=m Central auditory processing in parkinsonian disorders: A systematic review. causal interaction,therapeutic application,unassigned 1,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32259098&form=6&db=m Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32319242&form=6&db=m Early Impairment of Chopsticks Skills in Parkinsonism Suggests Progressive Supranuclear Palsy. causal interaction,unassigned 2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32357260&form=6&db=m Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. diagnostic usage,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32380911&form=6&db=m Swallow tail sign on susceptibility map-weighted imaging (SMWI) for disease diagnosing and severity evaluating in parkinsonism. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32710162&form=6&db=m Magnetic resonance parkinsonism indices and interpeduncular angle in idiopathic normal pressure hydrocephalus and progressive supranuclear palsy. ongoing research,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32751888&form=6&db=m Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32768878&form=6&db=m Suicidal and death ideation in patients with progressive supranuclear palsy and corticobasal syndrome. diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33179436&form=6&db=m Atypical parkinsonian syndromes in a North African tertiary referral center. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33271461&form=6&db=m Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33341150&form=6&db=m Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,4 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33581485&form=6&db=m Association of PSP phenotypes with survival: A brain-bank study. diagnostic usage,unassigned 3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33613435&form=6&db=m The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome-A Pilot Study. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33704556&form=6&db=m Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes. unassigned - 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33714084&form=6&db=m A novel diagnostic marker for progressive supranuclear palsy targeting atrophy of the subthalamic nucleus. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33744691&form=6&db=m Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33755262&form=6&db=m Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,3,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34000497&form=6&db=m Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia. diagnostic usage,therapeutic application,unassigned 4,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34062646&form=6&db=m Environmental Risk Factors for Progressive Supranuclear Palsy. causal interaction,diagnostic usage,unassigned 3,1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34089275&form=6&db=m Clinical Utility of 18 F-APN-1607 Tau PET Imaging in Patients with Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34105000&form=6&db=m Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis. causal interaction,unassigned 1,0 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34173683&form=6&db=m Sensorimotor Cough Dysfunction Is Prevalent and Pervasive in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,3,1 3.1.3.3 Parkinsonian Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34325703&form=6&db=m Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism. causal interaction,unassigned 3,0 3.1.3.3 Peptic Ulcer http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8501356&form=6&db=m Serum pancreatic stone protein in pancreatic diseases. causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Periodontal Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28497053&form=6&db=m Numerical Evaluation of Image Contrast for Thicker and Thinner Objects among Current Intraoral Digital Imaging Systems. therapeutic application,unassigned 2,0 3.1.3.3 Periodontitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22326397&form=6&db=m Identification of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4-one derivatives as inhibitors of the phosphatase SerB653 in Porphyromonas gingivalis, implicated in periodontitis. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Peritonitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7747731&form=6&db=m Pseudomonas peritonitis in peritoneal dialysis patients: the Network #9 Peritonitis Study. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Peritonitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24604486&form=6&db=m Pancreatic stone protein (PSP) and pancreatitis-associated protein (PAP): a protocol of a cohort study on the diagnostic efficacy and prognostic value of PSP and PAP as postoperative markers of septic complications in patients undergoing abdominal surgery (PSP study). causal interaction,diagnostic usage,unassigned 3,2,0 3.1.3.3 Phantom Limb http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29633581&form=6&db=m Persistent socket pain postenucleation and post evisceration: a systematic review. unassigned - 3.1.3.3 Pheochromocytoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1744178&form=6&db=m Germ cell mitogenic activity is associated with nerve growth factor-like protein(s). ongoing research,unassigned 3,0 3.1.3.3 Pheochromocytoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8080455&form=6&db=m Okadaic acid induces activator protein 1 activity and immediate early gene transcription in rat pheochromocytoma cells. Mechanism of action. diagnostic usage,unassigned 3,0 3.1.3.3 phosphoglycerate dehydrogenase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8739971&form=6&db=m 3-Phosphoglycerate dehydrogenase deficiency and 3-phosphoserine phosphatase deficiency: inborn errors of serine biosynthesis. causal interaction,unassigned 4,0 3.1.3.3 phosphoglycerate dehydrogenase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10222452&form=6&db=m Continuing education in neurometabolic disorders--serine deficiency disorders. causal interaction,unassigned 4,0 3.1.3.3 phosphoglycerate dehydrogenase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16763900&form=6&db=m Treatment with amino acids in serine deficiency disorders. causal interaction,unassigned 4,0 3.1.3.3 phosphoserine phosphatase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8739971&form=6&db=m 3-Phosphoglycerate dehydrogenase deficiency and 3-phosphoserine phosphatase deficiency: inborn errors of serine biosynthesis. causal interaction,unassigned 4,0 3.1.3.3 phosphoserine phosphatase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9222972&form=6&db=m Phosphoserine phosphatase deficiency in a patient with Williams syndrome. causal interaction,unassigned 4,0 3.1.3.3 phosphoserine phosphatase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10222452&form=6&db=m Continuing education in neurometabolic disorders--serine deficiency disorders. causal interaction,unassigned 4,0 3.1.3.3 phosphoserine phosphatase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14673469&form=6&db=m Mutations responsible for 3-phosphoserine phosphatase deficiency. causal interaction,unassigned 4,0 3.1.3.3 phosphoserine phosphatase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16763900&form=6&db=m Treatment with amino acids in serine deficiency disorders. causal interaction,unassigned 4,0 3.1.3.3 phosphoserine phosphatase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26589312&form=6&db=m Novel Report of Phosphoserine Phosphatase Deficiency in an Adult with Myeloneuropathy and Limb Contractures. causal interaction,unassigned 4,0 3.1.3.3 phosphoserine phosphatase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26888760&form=6&db=m Erratum to: Novel Report of Phosphoserine Phosphatase Deficiency in an Adult with Myeloneuropathy and Limb Contractures. causal interaction,unassigned 4,0 3.1.3.3 Photophobia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18328771&form=6&db=m Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: A prospective study. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,2,3,1 3.1.3.3 Photophobia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34316674&form=6&db=m Clinical implications of photophobia in progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Phyllodes Tumor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25030440&form=6&db=m Expression of serine and glycine-related enzymes in phyllodes tumor. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,2,1 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2019279&form=6&db=m A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia. causal interaction,unassigned 2,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2555999&form=6&db=m New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. unassigned - 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8558176&form=6&db=m Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,2,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8673495&form=6&db=m What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features? causal interaction,ongoing research,unassigned 1,4,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8780065&form=6&db=m Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,3,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9055798&form=6&db=m Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9386773&form=6&db=m Distribution of cerebral cortical lesions in corticobasal degeneration: a clinicopathological study of five autopsy cases in Japan. unassigned - 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10483782&form=6&db=m Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease. unassigned - 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12392790&form=6&db=m The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau. causal interaction,ongoing research,therapeutic application,unassigned 3,1,1,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12410387&form=6&db=m Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains. ongoing research,unassigned 2,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14572447&form=6&db=m Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. causal interaction,ongoing research,unassigned 2,3,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14629785&form=6&db=m Pick Complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15641585&form=6&db=m Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies. unassigned - 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16033782&form=6&db=m The evolution and pathology of frontotemporal dementia. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16215455&form=6&db=m Tau-positive fine granules in the cerebral white matter: a novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16637593&form=6&db=m [Abeta, tau and alpha-synuclein and glial cells] causal interaction,unassigned 1,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17080728&form=6&db=m Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies. ongoing research,unassigned 2,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18267261&form=6&db=m The many faces of corticobasal degeneration. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18315566&form=6&db=m Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats. diagnostic usage,unassigned 1,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21987561&form=6&db=m [Progressive nonfluent aphasia]. unassigned - 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22277388&form=6&db=m Frontotemporal lobar degeneration (FTLD) concept and classification update. causal interaction,unassigned 1,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23196569&form=6&db=m [Frontotemporal lobar degeneration (FTLD) - changes of its concept and classification based on aggregated proteins]. unassigned - 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24086739&form=6&db=m A Novel MAPT Mutation, G55R, in a Frontotemporal Dementia Patient Leads to Altered Tau Function. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26227957&form=6&db=m An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome. causal interaction,unassigned 3,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27260836&form=6&db=m Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease. causal interaction,unassigned 3,0 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29891013&form=6&db=m Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain. unassigned - 3.1.3.3 Pick Disease of the Brain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33125873&form=6&db=m High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies. ongoing research,unassigned 1,0 3.1.3.3 Pleural Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31253375&form=6&db=m Clinical Impact of a Pleural Unit in a Tertiary Level Hospital. unassigned - 3.1.3.3 Pleural Effusion http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1554754&form=6&db=m Digital chest radiography with storage phosphor systems: potential masking of bilateral pleural effusions. unassigned - 3.1.3.3 Pleural Effusion http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16364854&form=6&db=m Pleural space problems after living lobar transplantation. diagnostic usage,unassigned 4,0 3.1.3.3 Pneumonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9790132&form=6&db=m Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: a case-control study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,1 3.1.3.3 Pneumonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24680314&form=6&db=m Repeated inhalation exposure of rats to an anionic high molecular weight polymer aerosol: Application of prediction models to better understand pulmonary effects and modes of action. causal interaction,unassigned 3,0 3.1.3.3 Pneumonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26270456&form=6&db=m Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,2 3.1.3.3 Pneumonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27430328&form=6&db=m Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,1 3.1.3.3 Pneumonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31796642&form=6&db=m Natural clinical course of progressive supranuclear palsy in Chinese patients in Hong Kong. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Pneumonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33761707&form=6&db=m Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Pneumonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34173683&form=6&db=m Sensorimotor Cough Dysfunction Is Prevalent and Pervasive in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,3,1 3.1.3.3 Pneumonia, Aspiration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26270456&form=6&db=m Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,4,2 3.1.3.3 Pneumonia, Aspiration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29457122&form=6&db=m A case of spinal anesthesia in a patient with progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8484388&form=6&db=m Primary spontaneous pneumothorax in men. diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9315819&form=6&db=m The clinician's perspective on pneumothorax management. unassigned - 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9371212&form=6&db=m Recurrence of primary spontaneous pneumothorax. diagnostic usage,ongoing research,therapeutic application,unassigned 4,3,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10638146&form=6&db=m [Video-assisted thoracic surgery in the treatment of spontaneous pneumothorax] diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10936128&form=6&db=m Can CT scanning be used to select patients with unilateral primary spontaneous pneumothorax for bilateral surgery? causal interaction,therapeutic application,unassigned 3,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12901831&form=6&db=m [Video-assisted thoracoscopic surgery for spontaneous pneumothorax] diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14752657&form=6&db=m Staple line coverage with absorbable mesh after thoracoscopic bullectomy for spontaneous pneumothorax. diagnostic usage,ongoing research,unassigned 1,3,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15219004&form=6&db=m Characterisation of pleural inflammation occurring after primary spontaneous pneumothorax. diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15359923&form=6&db=m Alveolar epithelial permeability in patients with primary spontaneous pneumothorax as determined by Tc-99m DTPA aerosol scintigraphy. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,4,3,1 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16088709&form=6&db=m Pneumothorax. causal interaction,therapeutic application,unassigned 3,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16364854&form=6&db=m Pleural space problems after living lobar transplantation. diagnostic usage,unassigned 4,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16844363&form=6&db=m Prediction of recurrent spontaneous pneumothorax: CT scan findings versus management features. ongoing research,therapeutic application,unassigned 2,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18197926&form=6&db=m Simultaneous bilateral primary spontaneous pneumothorax. unassigned - 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18505456&form=6&db=m Mutation analysis of the FLCN gene in Chinese patients with sporadic and familial isolated primary spontaneous pneumothorax. causal interaction,unassigned 4,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18802734&form=6&db=m Additional mechanical pleurodesis after thoracoscopic wedge resection and covering procedure for primary spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 1,4,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19651381&form=6&db=m Evidence-based management of paediatric primary spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 3,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19934128&form=6&db=m What is the difference in size of spontaneous pneumothorax between inspiratory and expiratory x-rays? diagnostic usage,unassigned 1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20825809&form=6&db=m Primary spontaneous pneumothorax-the role of the emergency observation unit. causal interaction,therapeutic application,unassigned 1,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21115258&form=6&db=m Video-assisted thoracoscopic surgery management of spontaneous pneumothorax - long-term results. diagnostic usage,unassigned 1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21703557&form=6&db=m Clinical manifestations of primary spontaneous pneumothorax in pediatric patients: an analysis of 78 patients. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22217820&form=6&db=m Small-bore catheter versus chest tube drainage for pneumothorax. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22293309&form=6&db=m Fibulin-5 Protein Is Reduced in the Lung of Patients with Spontaneous Pneumothorax Who Are Under 25 Years Old. diagnostic usage,unassigned 3,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22785214&form=6&db=m Role of Blebs and Bullae Detected by High-Resolution Computed Tomography and Recurrent Spontaneous Pneumothorax. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22790990&form=6&db=m Fibulin-5 protein is reduced in the lung of patients with spontaneous pneumothorax who are under 25 years old. diagnostic usage,unassigned 3,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23603638&form=6&db=m Size of Pneumothorax can be a New Indication for Surgical Treatment in Primary Spontaneous Pneumothorax: A Prospective Study. causal interaction,diagnostic usage,ongoing research,unassigned 4,2,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23775414&form=6&db=m Natural Course of Spontaneous Pneumothorax without Bullae or Blebs under High-Resolution Computed Tomography. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24734096&form=6&db=m Pneumothorax. causal interaction,therapeutic application,unassigned 2,4,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24893950&form=6&db=m Factors associated with proceeding to surgical intervention and recurrence of primary spontaneous pneumothorax in adolescent patients. causal interaction,therapeutic application,unassigned 1,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26034222&form=6&db=m Do atmospheric conditions influence the first episode of primary spontaneous pneumothorax? ongoing research,unassigned 2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26042737&form=6&db=m The effect of pleural abrasion on the treatment of primary spontaneous pneumothorax: a systematic review of randomized controlled trials. causal interaction,diagnostic usage,therapeutic application,unassigned 2,2,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26366808&form=6&db=m The etiology and therapy of primary spontaneous pneumothoraces. therapeutic application,unassigned 1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27122783&form=6&db=m Abnormal Changes of a 12-Lead Electrocardiogram in Male Patients with Left Primary Spontaneous Pneumothorax. diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27164729&form=6&db=m Clinical Profile of Spontaneous Pneumothorax in Adults: A Retrospective Study. causal interaction,unassigned 4,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27203581&form=6&db=m Multicentric Genome-Wide Association Study for Primary Spontaneous Pneumothorax. causal interaction,unassigned 3,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27345097&form=6&db=m Primary Spontaneous Pneumothorax in Menstruating Women Has High Recurrence. ongoing research,unassigned 3,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27445518&form=6&db=m Identifying Primary Spontaneous Pneumothorax from Administrative Databases: A Validation Study. causal interaction,unassigned 1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27909771&form=6&db=m Association Between BMI and Recurrence of Primary Spontaneous Pneumothorax. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,4,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28168984&form=6&db=m Pleurectomy versus pleural abrasion for primary spontaneous pneumothorax in children. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28298628&form=6&db=m The Size of Spontaneous Pneumothorax is a Predictor of Unsuccessful Catheter Drainage. diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28386166&form=6&db=m Primary and Secondary Spontaneous Pneumothorax: Prevalence, Clinical Features, and In-Hospital Mortality. diagnostic usage,ongoing research,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28465661&form=6&db=m Primary Spontaneous Pneumothorax Admitted in Emergency Unit: Does First Episode Differ from Recurrence? A Cross-Sectional Study. diagnostic usage,unassigned 3,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28805452&form=6&db=m Birt-Hogg-Dube Syndrome with a Novel Mutation in the FLCN Gene. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29078667&form=6&db=m Uniportal video-assisted thoracic surgery for pneumothorax and blebs/bullae. therapeutic application,unassigned 4,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29351696&form=6&db=m Risk of Primary Spontaneous Pneumothorax According to Chest Configuration. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29411175&form=6&db=m Will the presence of radiological signs of tension pneumothorax affect the clinical presentation of primary spontaneous pneumothorax? diagnostic usage,ongoing research,therapeutic application,unassigned 2,3,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29707331&form=6&db=m Expression of TGF-beta receptor 1 and Smads in the tissues of primary spontaneous pneumothorax. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,3,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30109203&form=6&db=m Thoracic Scoliosis in Patients with Primary Spontaneous Pneumothorax. causal interaction,diagnostic usage,ongoing research,unassigned 4,2,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30174837&form=6&db=m Seasonal and meteorological impacts on primary spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 3,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30225322&form=6&db=m Data on the epidemiology, diagnosis, and treatment of patients with pneumothorax. diagnostic usage,ongoing research,therapeutic application,unassigned 3,1,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30865105&form=6&db=m The influence of pleurodesis on the outcome of primary spontaneous pneumothorax in children. causal interaction,unassigned 1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30872304&form=6&db=m How should complete lung collapse secondary to primary spontaneous pneumothorax be managed??. diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,3,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30955098&form=6&db=m A novel dual-covering method in video-assisted thoracic surgery for pediatric primary spontaneous pneumothorax. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31065210&form=6&db=m A Mysterious Case of Spontaneous Cervical Epidural Hematoma and Bilateral Primary Spontaneous Pneumothorax Caused by a Rare Etiology. therapeutic application,unassigned 1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31089445&form=6&db=m A Prospective Randomized Trial Comparing Manual Needle Aspiration to Closed Thoracostomy as an Initial Treatment for the First Episode of Primary Spontaneous Pneumothorax. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31130791&form=6&db=m A Mysterious Case of Spontaneous Cervical Epidural Hematoma and Bilateral Primary Spontaneous Pneumothorax caused by a Rare Etiology. therapeutic application,unassigned 1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31525807&form=6&db=m Pneumothorax-Time for New Guidelines? causal interaction,diagnostic usage,unassigned 3,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31567476&form=6&db=m Recurrent primary spontaneous pneumothorax in a large Chinese family: a clinical and genetic investigation. unassigned - 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31600764&form=6&db=m Cannabinoids Identification in Lung Tissues of Young Cannabis Smokers Operated for Primary Spontaneous Pneumothorax and Correlation with Pathologic Findings. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31995686&form=6&db=m Conservative versus Interventional Treatment for Spontaneous Pneumothorax. diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32311952&form=6&db=m Comparison of tracheal intubation with controlled ventilation and laryngeal mask airway with spontaneous ventilation for thoracoscopic bullectomy. diagnostic usage,therapeutic application,unassigned 1,3,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32852262&form=6&db=m Comparison of single-port vs. two-port VATS technique for primary spontaneous pneumothorax. therapeutic application,unassigned 2,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33203804&form=6&db=m Correlation of Primary Spontaneous Pneumothorax and Air Pollution in Adolescents. diagnostic usage,ongoing research,unassigned 2,4,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33885029&form=6&db=m Is it a myth to perform blind apical wedge resection in primary spontaneous pneumothorax surgery to improve recurrence rates? therapeutic application,unassigned 1,0 3.1.3.3 Pneumothorax http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34123633&form=6&db=m High-Resolution CT Following Primary Spontaneous Pneumothorax in Adolescents: Useful Tool or Wasted Radiation? causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,1,3 3.1.3.3 Polydactyly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7329916&form=6&db=m Reappearance of the multiple trait semilethal mutation (psp) in the fowl. unassigned - 3.1.3.3 Polyneuropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9282819&form=6&db=m High prevalence of false-negative anti-HTLV type I/II enzyme-linked immunosorbent assay results in HIV type 1-positive patients. causal interaction,unassigned 3,0 3.1.3.3 Polyneuropathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34209067&form=6&db=m Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Polyradiculoneuropathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8319395&form=6&db=m [Clinical analysis of paralytic shellfish poisoning following ingestion of oysters] causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Pressure Ulcer http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29062513&form=6&db=m Exploring the challenge of health research priority setting in partnership: reflections on the methodology used by the James Lind Alliance Pressure Ulcer Priority Setting Partnership. ongoing research,unassigned 3,0 3.1.3.3 Primary Dysautonomias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11731878&form=6&db=m Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,unassigned 2,4,0 3.1.3.3 Primary Dysautonomias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17303592&form=6&db=m Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Primary Dysautonomias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18941145&form=6&db=m Predominant cortical dysfunction in Guadeloupean parkinsonism. causal interaction,unassigned 4,0 3.1.3.3 Primary Dysautonomias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28250027&form=6&db=m Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Primary Dysautonomias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30620042&form=6&db=m Electrophysiological and clinical assessment of dysautonomia in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP): a comparative study. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,1,0 3.1.3.3 Primary Progressive Nonfluent Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12584413&form=6&db=m Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. causal interaction,unassigned 4,0 3.1.3.3 Primary Progressive Nonfluent Aphasia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17117169&form=6&db=m Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases? causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,2,4 3.1.3.3 Prolactinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25921430&form=6&db=m Pituitary tumors contain a side population with tumor stem cell-associated characteristics. causal interaction,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1375876&form=6&db=m Two-site monoclonal antibody-based immunoradiometric assay for measuring prostate secretory protein in serum. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 3.1.3.3 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7694265&form=6&db=m Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma. causal interaction,diagnostic usage,unassigned 3,4,0 3.1.3.3 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21603625&form=6&db=m Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population. causal interaction,ongoing research,therapeutic application,unassigned 3,1,4,0 3.1.3.3 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22882676&form=6&db=m Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,1,0 3.1.3.3 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25129068&form=6&db=m Polysaccharopeptide enhanced the anti-cancer effect of gamma-tocotrienol through activation of AMPK. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,4 3.1.3.3 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27910783&form=6&db=m Recent Advances and Challenges in Studies of Control of Cancer Stem Cells and the Gut Microbiome by the Trametes-Derived Polysaccharopeptide PSP (Review). ongoing research,unassigned 4,0 3.1.3.3 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29654773&form=6&db=m Procyanidin from peanut skin induces antiproliferative effect in human prostate carcinoma cells DU145. diagnostic usage,ongoing research,unassigned 1,4,0 3.1.3.3 Prostatic Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30867828&form=6&db=m Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,3,1 3.1.3.3 Prostatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9629442&form=6&db=m Evaluation of seminal plasma parameters in patients with chronic prostatitis or leukocytospermia. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,2,1 3.1.3.3 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2615013&form=6&db=m In vitro immunoglobulin production by peripheral blood mononuclear cells as a prognostic factor in IgA nephropathy. causal interaction,unassigned 3,0 3.1.3.3 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7051750&form=6&db=m Renal glomerular changes associated with liver cirrhosis. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Proteinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9138338&form=6&db=m [Incidence, etiology and prognostic value of persistent significant proteinuria in kidney transplants] causal interaction,diagnostic usage,unassigned 2,4,0 3.1.3.3 Pseudobulbar Palsy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2676308&form=6&db=m [Palilalia associated with progressive supranuclear palsy] causal interaction,unassigned 2,0 3.1.3.3 Pseudobulbar Palsy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8060688&form=6&db=m [Widespread argentophilic structures in progressive supranuclear palsy--an autopsy case report] diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Pseudobulbar Palsy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8928621&form=6&db=m Progressive supranuclear palsy: a clinicopathological study of 21 cases. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Pseudobulbar Palsy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9577667&form=6&db=m [Progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Pseudobulbar Palsy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25732053&form=6&db=m Progressive Supranuclear Palsy: What do we know About it? causal interaction,unassigned 3,0 3.1.3.3 Pseudobulbar Palsy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31752626&form=6&db=m The Progressive Supranuclear Palsy: Past and Present Aspects. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Psoriasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31081461&form=6&db=m Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. therapeutic application,unassigned 1,0 3.1.3.3 Psychomotor Agitation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30103064&form=6&db=m Restless legs syndrome, leg motor restlessness and their variants in patients with Parkinson's disease and related disorders. diagnostic usage,unassigned 2,0 3.1.3.3 Pulmonary Atelectasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19231410&form=6&db=m Complete atelectasis of the lung in patients with primary spontaneous pneumothorax. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,3,0 3.1.3.3 Pulmonary Atelectasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29078445&form=6&db=m Uniportal video assisted thoracoscopic surgery bullectomy and double pleurodesis for primary spontaneous pneumothorax. therapeutic application,unassigned 3,0 3.1.3.3 Pulmonary Atelectasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29216862&form=6&db=m The incidence and risk factors of asymptomatic primary spontaneous pneumothorax detected during health check-ups. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Pulmonary Atelectasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30872304&form=6&db=m How should complete lung collapse secondary to primary spontaneous pneumothorax be managed??. diagnostic usage,ongoing research,therapeutic application,unassigned 4,2,3,0 3.1.3.3 Pulmonary Atelectasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34471541&form=6&db=m Conservative management of a complete primary spontaneous pneumothorax. diagnostic usage,ongoing research,unassigned 1,2,0 3.1.3.3 Pulmonary Disease, Chronic Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22217820&form=6&db=m Small-bore catheter versus chest tube drainage for pneumothorax. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Pulmonary Disease, Chronic Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26059238&form=6&db=m Neural versus pneumatic control of pressure support in patients with chronic obstructive pulmonary diseases at different levels of positive end expiratory pressure: a physiological study. diagnostic usage,unassigned 1,0 3.1.3.3 Pulmonary Disease, Chronic Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27164729&form=6&db=m Clinical Profile of Spontaneous Pneumothorax in Adults: A Retrospective Study. causal interaction,unassigned 4,0 3.1.3.3 Pulmonary Disease, Chronic Obstructive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33470654&form=6&db=m Neural control of pressure support ventilation improved patient-ventilator synchrony in patients with different respiratory system mechanical properties: a prospective, crossover trial. causal interaction,diagnostic usage,therapeutic application,unassigned 1,1,1,0 3.1.3.3 Rectal Prolapse http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20205956&form=6&db=m Functional outcome after perineal stapled prolapse resection for external rectal prolapse. diagnostic usage,ongoing research,unassigned 1,3,0 3.1.3.3 Rectal Prolapse http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26969880&form=6&db=m Perineal stapled prolapse resection for full thickness external rectal prolapse: a multicentre prospective study. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Rectal Prolapse http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27678400&form=6&db=m [Operative therapy of external rectal prolapse with a stapler]. therapeutic application,unassigned 4,0 3.1.3.3 Reflex, Abnormal http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11731878&form=6&db=m Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,unassigned 2,4,0 3.1.3.3 REM Sleep Behavior Disorder http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18328771&form=6&db=m Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: A prospective study. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,2,3,1 3.1.3.3 REM Sleep Behavior Disorder http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31484717&form=6&db=m Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension. causal interaction,diagnostic usage,unassigned 2,3,0 3.1.3.3 Renal Insufficiency, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25705419&form=6&db=m A validation of presepsin levels in kidney dysfunction patients: four case reports. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,4,1 3.1.3.3 Respiratory Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8319395&form=6&db=m [Clinical analysis of paralytic shellfish poisoning following ingestion of oysters] causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Respiratory Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21722681&form=6&db=m Alterations of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic produced in rat brain tissues after systemic administration of saxitoxin. therapeutic application,unassigned 1,0 3.1.3.3 Respiratory Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28683763&form=6&db=m New setting of neurally adjusted ventilatory assist for noninvasive ventilation by facial mask: a physiologic study. unassigned - 3.1.3.3 Respiratory Paralysis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32809126&form=6&db=m Shellfish contamination with marine biotoxins in Portugal and spring tides: a dangerous health coincidence. causal interaction,unassigned 3,0 3.1.3.3 Respiratory Tract Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16154793&form=6&db=m Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP). causal interaction,diagnostic usage,ongoing research,unassigned 1,3,2,0 3.1.3.3 Retinal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1316807&form=6&db=m Drosophila retinal degeneration C (rdgC) encodes a novel serine/threonine protein phosphatase. causal interaction,unassigned 1,0 3.1.3.3 Retinal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8446607&form=6&db=m Regulatory arrestin cycle secures the fidelity and maintenance of the fly photoreceptor cell. unassigned - 3.1.3.3 Retinal Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9430683&form=6&db=m Molecular cloning, expression, and characterization of a novel human serine/threonine protein phosphatase, PP7, that is homologous to Drosophila retinal degeneration C gene product (rdgC). ongoing research,unassigned 3,0 3.1.3.3 Rhinitis, Allergic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28608749&form=6&db=m Polypoid Change of the Middle Turbinate and Paranasal Sinus Polyposis Are Distinct Entities. causal interaction,unassigned 3,0 3.1.3.3 Root Resorption http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18547837&form=6&db=m Diagnosis of artificially induced external root resorption using conventional intraoral film radiography, CCD, and PSP: an ex vivo study. diagnostic usage,therapeutic application,unassigned 1,2,0 3.1.3.3 Root Resorption http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22981099&form=6&db=m Comparison of cone-beam computed tomography with intraoral photostimulable phosphor imaging plate for diagnosis of endodontic complications: a simulation study. therapeutic application,unassigned 1,0 3.1.3.3 Root Resorption http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23515150&form=6&db=m Diagnosis of Simulated External Root Resorption Using Conventional Intraoral Film Radiography, CCD, PSP, and CBCT: A Comparison Study. diagnostic usage,unassigned 2,0 3.1.3.3 Root Resorption http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25973149&form=6&db=m Diagnostic Accuracy of Charge-coupled Device Sensor and Photostimulable Phosphor Plate Receptor in the Detection of External Root Resorption In Vitro. unassigned - 3.1.3.3 Sarcoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24133614&form=6&db=m In vivo antioxidant, hypoglycemic, and anti-tumor activities of anthocyanin extracts from purple sweet potato. ongoing research,unassigned 3,0 3.1.3.3 Scoliosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16941460&form=6&db=m Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,1,1 3.1.3.3 Scoliosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19894336&form=6&db=m A comparison between the Cotrel-Dubousset and the pedicle screw-plate instrumentations in the adolescent idiopathic scoliosis. ongoing research,therapeutic application,unassigned 2,4,0 3.1.3.3 Scoliosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30109203&form=6&db=m Thoracic Scoliosis in Patients with Primary Spontaneous Pneumothorax. causal interaction,diagnostic usage,ongoing research,unassigned 4,2,2,0 3.1.3.3 Seizures http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2909902&form=6&db=m Seizures in progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Seizures http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17141473&form=6&db=m Lesion of the tuberomammillary nucleus E2-region attenuates postictal seizure protection in rats. ongoing research,unassigned 3,0 3.1.3.3 Seizures http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29621183&form=6&db=m Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models. causal interaction,unassigned 4,0 3.1.3.3 Seizures http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34472165&form=6&db=m Seizure prevalence in neurodegenerative diseases-a study of autopsy proven cases. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,2,1,3 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23531337&form=6&db=m Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23701994&form=6&db=m Concomitant assessment of PSP and NT-proCNP as predictive markers of sepsis in severe trauma patients under mechanical ventilation. causal interaction,diagnostic usage,unassigned 2,3,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24604486&form=6&db=m Pancreatic stone protein (PSP) and pancreatitis-associated protein (PAP): a protocol of a cohort study on the diagnostic efficacy and prognostic value of PSP and PAP as postoperative markers of septic complications in patients undergoing abdominal surgery (PSP study). causal interaction,diagnostic usage,unassigned 3,2,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25705419&form=6&db=m A validation of presepsin levels in kidney dysfunction patients: four case reports. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,4,1 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26065577&form=6&db=m Prognostication of Mortality in Critically Ill Patients With Severe Infections. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27687530&form=6&db=m Wip 1 inhibits intestinal inflammation in inflammatory bowel disease. unassigned - 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27689072&form=6&db=m The Role of Pancreatic Stone Protein in Diagnosis of Early Onset Neonatal Sepsis. diagnostic usage,therapeutic application,unassigned 4,3,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28155994&form=6&db=m Pancreatic stone protein and soluble CD25 for infection and sepsis in an emergency department. causal interaction,diagnostic usage,ongoing research,unassigned 4,4,3,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28358790&form=6&db=m Prognostic Value of High-Sensitivity C-Reactive Protein, Procalcitonin and Pancreatic Stone Protein in Pediatric Sepsis. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,2,3 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28415799&form=6&db=m The pancreas responds to remote damage and systemic stress by secretion of the pancreatic secretory proteins PSP/regI and PAP/regIII. ongoing research,unassigned 4,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28616918&form=6&db=m [Value of Procalcitonin, High Sensitivity C-reactive Protein and Pancreatic Stone Protein in Predicting Prognosis of Children with Sepsis]. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,4,1,1 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30672312&form=6&db=m Measurement of pancreatic stone protein in the identification and management of sepsis. diagnostic usage,therapeutic application,unassigned 4,2,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31408597&form=6&db=m [Inflammation markers and bloodstream infection (review of literature).] unassigned - 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31621373&form=6&db=m Prognostic performance of pancreatic stone protein in critically ill patients with sepsis. diagnostic usage,ongoing research,unassigned 4,1,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31972652&form=6&db=m Pancreatic Stone Protein Predicts Sepsis in Severely Burned Patients Irrespective of Trauma Severity: A Monocentric Observational Study. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32037128&form=6&db=m Pancreatic stone protein - sepsis and the riddles of the exocrine pancreas. causal interaction,ongoing research,unassigned 1,2,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32451625&form=6&db=m Expression of Pancreatic Stone Protein is Unaffected by Trauma and Subsequent Surgery in Burn Patients. unassigned - 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33272743&form=6&db=m Response of routine inflammatory biomarkers and novel Pancreatic Stone Protein to inhalation injury and its interference with sepsis detection in severely burned patients. causal interaction,unassigned 1,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33879189&form=6&db=m Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric study. causal interaction,diagnostic usage,therapeutic application,unassigned 2,3,2,0 3.1.3.3 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34442346&form=6&db=m Incidence and Time Point of Sepsis Detection as Related to Different Sepsis Definitions in Severely Burned Patients and Their Accompanying Time Course of Pro-Inflammatory Biomarkers. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Shock, Septic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26065577&form=6&db=m Prognostication of Mortality in Critically Ill Patients With Severe Infections. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,1,0 3.1.3.3 Shoulder Pain http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33469900&form=6&db=m Poststroke Pain. causal interaction,unassigned 1,0 3.1.3.3 Sick Sinus Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2348615&form=6&db=m [Various diagnostic criteria for abnormal signs of the artificial pacemaker examined by transesophageal electric stimulation of the left atrium] causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Sleep Apnea Syndromes http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18945638&form=6&db=m Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Sleep Apnea Syndromes http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26298782&form=6&db=m Predicting poor school performance in children suspected for sleep-disordered breathing. ongoing research,therapeutic application,unassigned 3,1,0 3.1.3.3 Sleep Deprivation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27544836&form=6&db=m Rest-activity rhythm disruption in progressive supranuclear palsy. unassigned - 3.1.3.3 Sleep Deprivation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29029214&form=6&db=m Sleepless Night and Day, the Plight of Progressive Supranuclear Palsy. unassigned - 3.1.3.3 Sleep Initiation and Maintenance Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24955381&form=6&db=m Sleep Disorders in Atypical Parkinsonism. causal interaction,unassigned 3,0 3.1.3.3 Sleep Initiation and Maintenance Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32326489&form=6&db=m Sleep Quality and Mental Disorder Symptoms among Canadian Public Safety Personnel. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Solitary Fibrous Tumors http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34039780&form=6&db=m Huge Pulmonary Sclerosing Pneumocytoma with Endobronchial Invasion: A Case Report with a Literature Review. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,1,0 3.1.3.3 Solitary Pulmonary Nodule http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27385997&form=6&db=m Pulmonary sclerosing pneumocytoma mimicking lung cancer: Case report and review of the literature. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Speech Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33205932&form=6&db=m [Parkinsonism-associated speech disorders]. unassigned - 3.1.3.3 Speech Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33719524&form=6&db=m Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Spinal Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18422568&form=6&db=m How do patients with parkinsonism present? A clinicopathological study. unassigned - 3.1.3.3 Spinocerebellar Degenerations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22019867&form=6&db=m [An autopsied case of progressive supranuclear palsy, initially diagnosed as spinocerebellar degeneration with severe olivopontocerebellar involvement]. therapeutic application,unassigned 1,0 3.1.3.3 Spinocerebellar Degenerations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23320789&form=6&db=m An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement. causal interaction,unassigned 3,0 3.1.3.3 Spinocerebellar Degenerations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31847511&form=6&db=m Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,4,0 3.1.3.3 Spondylitis, Ankylosing http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31081461&form=6&db=m Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. therapeutic application,unassigned 1,0 3.1.3.3 ST Elevation Myocardial Infarction http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28905041&form=6&db=m Presepsin (sCD14-ST): could it be a novel marker for the diagnosis of ST elevation myocardial infarction? causal interaction,diagnostic usage,ongoing research,unassigned 4,4,4,0 3.1.3.3 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1932625&form=6&db=m Effect of intravenous feeding on wound healing in starvation: an experimental study on the rabbit. unassigned - 3.1.3.3 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8134371&form=6&db=m Role of an Escherichia coli stress-response operon in stationary-phase survival. causal interaction,therapeutic application,unassigned 1,2,0 3.1.3.3 Stomach Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9457474&form=6&db=m A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,3,0 3.1.3.3 Stomach Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16201166&form=6&db=m [Resection of gastric carcinoma with preserving of the spleen and pancreas and functional clearance lymph nodes of the spleen hillus and splenic artery] causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Striatonigral Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8811682&form=6&db=m Progressive supranuclear palsy: MRI and pathological findings. ongoing research,unassigned 2,0 3.1.3.3 Striatonigral Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11458995&form=6&db=m Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy. ongoing research,unassigned 1,0 3.1.3.3 Striatonigral Degeneration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11921116&form=6&db=m Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3419596&form=6&db=m Risk factors for progressive supranuclear palsy. diagnostic usage,unassigned 2,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7372034&form=6&db=m [Echocardiographic evaluation of mitral stenosis: significance of Pc-To/Ac-Mo ratio (author's transl)] unassigned - 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964687&form=6&db=m Vascular progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,3,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8710059&form=6&db=m Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9191782&form=6&db=m Characterizing swallowing abnormalities in progressive supranuclear palsy. ongoing research,unassigned 2,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10025574&form=6&db=m A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy. diagnostic usage,unassigned 1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10584668&form=6&db=m Progression of falls in postmortem-confirmed parkinsonian disorders. diagnostic usage,therapeutic application,unassigned 4,2,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11176964&form=6&db=m Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. causal interaction,diagnostic usage,therapeutic application,unassigned 2,2,3,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12093930&form=6&db=m Effects of cerebral ischemia in mice deficient in Persephin. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12563380&form=6&db=m Progressive supranuclear palsy in a sample of Brazilian population: clinical features of 16 patients. unassigned - 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18195676&form=6&db=m Progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,3,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18541806&form=6&db=m Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18992014&form=6&db=m Progressive supranuclear palsy combined with Alzheimer's disease: A clinicopathological study of two autopsy cases. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19458322&form=6&db=m Familial aggregation of parkinsonism in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,4,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19508347&form=6&db=m Clinical heterogeneity in progressive supranuclear palsy: Problems of clinical diagnostic criteria of NINDS-SPSP in a retrospective study of seven Japanese autopsy cases. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23436751&form=6&db=m Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25997420&form=6&db=m Vascular Parkinsonism: deconstructing a syndrome. causal interaction,unassigned 3,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26886104&form=6&db=m Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26954800&form=6&db=m Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27424849&form=6&db=m Cough reflex attenuation and swallowing dysfunction in sub-acute post-stroke patients: prevalence, risk factors, and clinical outcome. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27430328&form=6&db=m Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,2,1 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27566745&form=6&db=m Association between nasogastric tubes, pneumonia, and clinical outcomes in acute stroke patients. therapeutic application,unassigned 1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28432758&form=6&db=m Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,2,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28702192&form=6&db=m Freezing of gait is an early clinical feature of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29467306&form=6&db=m Gait analysis in PSP and NPH: Dual-task conditions make the difference. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30831462&form=6&db=m Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,2,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31420309&form=6&db=m Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson's disease. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31665686&form=6&db=m Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,3,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31735079&form=6&db=m Risk stratification model for post-stroke pneumonia in patients with acute ischemic stroke. diagnostic usage,ongoing research,unassigned 4,4,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33761707&form=6&db=m Risk factors for and impact of poststroke pneumonia in patients with acute ischemic stroke. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34017242&form=6&db=m Case Report: Barely Able to Speak, Can't Stop Echoing: Echolalic Dynamic Aphasia in Progressive Supranuclear Palsy. ongoing research,therapeutic application,unassigned 2,1,0 3.1.3.3 Stroke http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34054712&form=6&db=m Usefulness of the Neutrophil-to-Lymphocyte Ratio as a Predictor of Pneumonia and Urinary Tract Infection Within the First Week After Acute Ischemic Stroke. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Subacute Sclerosing Panencephalitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3405368&form=6&db=m Descriptive epidemiology of some rare neurological diseases in Benghazi, Libya. unassigned - 3.1.3.3 Subclavian Steal Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6939274&form=6&db=m Progressive supranuclear palsy in the course of subclavian steal syndrome. causal interaction,unassigned 1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1552311&form=6&db=m Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2463046&form=6&db=m Selective decrease of large neurons in the neostriatum in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2816286&form=6&db=m Tremor in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3895032&form=6&db=m Treatment of progressive supranuclear palsy with tricyclic antidepressants. ongoing research,unassigned 2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7799001&form=6&db=m The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7955713&form=6&db=m [Adult-onset dementia with abundant neurofibrillary tangles resembling progressive supranuclear palsy] diagnostic usage,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964698&form=6&db=m Cognitive disturbances in progressive supranuclear palsy. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7984527&form=6&db=m [Progressive supranuclear paralysis. Quantification of dopamine D2 receptors using radionuclide tomography] causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7990846&form=6&db=m Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. diagnostic usage,therapeutic application,unassigned 2,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8208392&form=6&db=m Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8363349&form=6&db=m Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8627344&form=6&db=m Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. diagnostic usage,ongoing research,unassigned 1,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8648326&form=6&db=m Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. causal interaction,diagnostic usage,therapeutic application,unassigned 4,4,4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8673495&form=6&db=m What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features? causal interaction,ongoing research,unassigned 1,4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8679336&form=6&db=m [A 65-year-old man with Parkinsonism, gaze palsy, and dementia] therapeutic application,unassigned 2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8710059&form=6&db=m Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8780065&form=6&db=m Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9018027&form=6&db=m Cerebral oxygen metabolism in patients with progressive supranuclear palsy: a positron emission tomography study. diagnostic usage,unassigned 4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9055798&form=6&db=m Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,2 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9633705&form=6&db=m Progressive supranuclear palsy: a survey of the disease course. diagnostic usage,unassigned 2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9818850&form=6&db=m Caregiving in progressive supranuclear palsy. diagnostic usage,therapeutic application,unassigned 1,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9841787&form=6&db=m Structural and functional meta-analytic evidence for fronto-subcortical system deficit in progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10072441&form=6&db=m Association of an extended haplotype in the tau gene with progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10218631&form=6&db=m Progressive supranuclear palsy with dementia: cortical pathology. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10718204&form=6&db=m Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 1,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10830408&form=6&db=m Research goals in progressive supranuclear palsy. First International Brainstorming Conference on PSP. therapeutic application,unassigned 1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11295776&form=6&db=m Impairment of eyeblink classical conditioning in progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 1,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11346024&form=6&db=m Diagnosis and management of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11458995&form=6&db=m Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy. ongoing research,unassigned 1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11708994&form=6&db=m Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography. causal interaction,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11921116&form=6&db=m Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12112206&form=6&db=m Further extension of the H1 haplotype associated with progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,3,1 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12410387&form=6&db=m Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains. ongoing research,unassigned 2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12552038&form=6&db=m APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 4,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12584413&form=6&db=m Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. causal interaction,unassigned 4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12654952&form=6&db=m Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12654953&form=6&db=m Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 1,1,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14673883&form=6&db=m Health-related quality of life in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 2,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14978673&form=6&db=m Accuracy of clinical diagnosis of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15022178&form=6&db=m Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism? causal interaction,ongoing research,therapeutic application,unassigned 1,1,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15235807&form=6&db=m Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15365723&form=6&db=m Distribution of tuft-shaped astrocytes in the cerebral cortex in progressive supranuclear palsy. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15728291&form=6&db=m Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15754175&form=6&db=m Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study. diagnostic usage,ongoing research,unassigned 4,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15774434&form=6&db=m Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). causal interaction,diagnostic usage,ongoing research,therapeutic application 1,3,1,1 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15788542&form=6&db=m Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,1,1 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15965048&form=6&db=m A new noninvasive test to detect mitochondrial dysfunction of skeletal muscles in progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15985570&form=6&db=m New and reliable MRI diagnosis for progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16000317&form=6&db=m The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. causal interaction,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16093228&form=6&db=m Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16447770&form=6&db=m [MRI diagnosis of neurodegenerative disorders] causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16832075&form=6&db=m Measuring quality of life in PSP: the PSP-QoL. causal interaction,therapeutic application,unassigned 2,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16839689&form=6&db=m Effect of MAPT and APOE on prognosis of progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16897134&form=6&db=m Neuroimaging of PD, PSP, CBD and MSA-PET and SPECT studies. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17204917&form=6&db=m The ratio of square wave jerk rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease. causal interaction,unassigned 4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17587253&form=6&db=m Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. diagnostic usage,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17675576&form=6&db=m Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of parkinsonism-dementia complex of Guam but not alzheimer's disease or progressive supranuclear palsy. causal interaction,ongoing research,therapeutic application,unassigned 3,2,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17709703&form=6&db=m Frontal presentation in progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18195676&form=6&db=m Progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18283396&form=6&db=m The auditory startle response in parkinsonism may reveal the extent but not type of pathology. diagnostic usage,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18541806&form=6&db=m Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18561341&form=6&db=m Lack of trigemino-cervical reflexes in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18948373&form=6&db=m Balance and eye movement training to improve gait in people with progressive supranuclear palsy: quasi-randomized clinical trial. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19099114&form=6&db=m Clinical features of dystonia in atypical parkinsonism. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19158937&form=6&db=m Cortical Alzheimer Type Pathology Does Not Influence tau Pathology in Progressive Supranuclear Palsy. causal interaction,unassigned 1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19224319&form=6&db=m Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20198715&form=6&db=m Substantia nigra echogenicity in progressive supranuclear palsy. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20717064&form=6&db=m Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy. causal interaction,unassigned 2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20944816&form=6&db=m Behavioral changes as the earliest clinical manifestation of progressive supranuclear palsy. causal interaction,unassigned 4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21154980&form=6&db=m Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21207078&form=6&db=m In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21236720&form=6&db=m Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21412832&form=6&db=m Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22160214&form=6&db=m In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22160793&form=6&db=m Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22181323&form=6&db=m Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22277395&form=6&db=m The diagnosis of neurodegenerative disorders based on clinical and pathological findings using an MRI approach. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22488922&form=6&db=m Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22556362&form=6&db=m Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. causal interaction,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22892823&form=6&db=m Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy. diagnostic usage,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23127882&form=6&db=m Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23146616&form=6&db=m Electrophysiological features of lower motor neuron involvement in progressive supranuclear palsy. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23173978&form=6&db=m Transcranial brain sonography findings in two main variants of progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23300100&form=6&db=m [The genetics of corticobasal syndrome]. causal interaction,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23436751&form=6&db=m Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23746093&form=6&db=m Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. causal interaction,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24041972&form=6&db=m Microtubule-associated protein tau genetic variations are uncommon cause of frontotemporal dementia in south India. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24615741&form=6&db=m Rate of decline in progressive supranuclear palsy. diagnostic usage,unassigned 1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24868411&form=6&db=m Levodopa-induced facial dystonia in a case of progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 3,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24873720&form=6&db=m Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24888315&form=6&db=m Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study. therapeutic application,unassigned 1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25370486&form=6&db=m The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. causal interaction,diagnostic usage,therapeutic application,unassigned 1,1,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25666771&form=6&db=m Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25683763&form=6&db=m Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25814937&form=6&db=m Midbrain catecholaminergic neurons co-express ?-synuclein and tau in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 1,1,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26885623&form=6&db=m The Cure PSP Care Guide: A Telephonic Nursing Intervention for Individuals and Families Living With Progressive Supranuclear Palsy. therapeutic application,unassigned 2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26980757&form=6&db=m Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations. ongoing research,unassigned 1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27070344&form=6&db=m Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27132501&form=6&db=m Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy. diagnostic usage,unassigned 2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27245243&form=6&db=m Blood-Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy. diagnostic usage,unassigned 1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27364040&form=6&db=m Obsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential Tremor. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27411806&form=6&db=m MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome. diagnostic usage,ongoing research,unassigned 4,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27452874&form=6&db=m Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. diagnostic usage,ongoing research,unassigned 1,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27453032&form=6&db=m Cognitive impairment in progressive supranuclear palsy-Richardson's syndrome is related to white matter damage. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27747983&form=6&db=m Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 4,2,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28131191&form=6&db=m Potential multisystem degeneration in Asidan patients. diagnostic usage,ongoing research,unassigned 3,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28179466&form=6&db=m Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28207803&form=6&db=m Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms. diagnostic usage,therapeutic application,unassigned 2,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28415165&form=6&db=m Progressive Supranuclear Gaze Palsy with Predominant Cerebellar Ataxia: A Case Series with Videos. causal interaction,diagnostic usage,unassigned 2,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28467028&form=6&db=m Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,1,3 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28500751&form=6&db=m Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? causal interaction,diagnostic usage,unassigned 3,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28500752&form=6&db=m Which ante mortem clinical features predict progressive supranuclear palsy pathology? causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28706282&form=6&db=m Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetry. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28881351&form=6&db=m Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,2,1 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29336906&form=6&db=m Progression of white matter damage in progressive supranuclear palsy with predominant parkinsonism. diagnostic usage,therapeutic application,unassigned 1,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29460982&form=6&db=m Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,3,2 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29467306&form=6&db=m Gait analysis in PSP and NPH: Dual-task conditions make the difference. diagnostic usage,ongoing research,therapeutic application,unassigned 2,2,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29779682&form=6&db=m Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis. diagnostic usage,unassigned 1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29948175&form=6&db=m Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,4,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29958546&form=6&db=m Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30025721&form=6&db=m Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromes. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30062400&form=6&db=m Long-term treatment with rotigotine in drug-naïve PSP patients. causal interaction,diagnostic usage,therapeutic application,unassigned 1,3,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30066433&form=6&db=m Variation at the TRIM11 Locus Modifies Progressive Supranuclear Palsy Phenotype. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30363831&form=6&db=m Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology. causal interaction,unassigned 2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30712468&form=6&db=m Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status. diagnostic usage,unassigned 4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30726566&form=6&db=m Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy. causal interaction,diagnostic usage,unassigned 1,4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30796010&form=6&db=m Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy. diagnostic usage,unassigned 4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30884283&form=6&db=m The language profile of progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,2,1 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30894142&form=6&db=m Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation. diagnostic usage,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30989369&form=6&db=m Motor, cognitive and behavioral differences in MDS PSP phenotypes. causal interaction,diagnostic usage,ongoing research,unassigned 2,3,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31307919&form=6&db=m Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability. diagnostic usage,ongoing research,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31390857&form=6&db=m Increased Signal in the Superior Cerebellar Peduncle of Patients with Progressive Supranuclear Palsy. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31392246&form=6&db=m An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31414383&form=6&db=m CSF sAPP? and sAPP? levels in Alzheimer's Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis. causal interaction,unassigned 4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31432258&form=6&db=m Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31433871&form=6&db=m Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,2,4,1 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31527182&form=6&db=m Midbrain MRI assessments in progressive supranuclear palsy subtypes. diagnostic usage,unassigned 2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31552724&form=6&db=m Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes. diagnostic usage,therapeutic application,unassigned 3,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31559910&form=6&db=m Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy. diagnostic usage,unassigned 2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31603934&form=6&db=m Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31656263&form=6&db=m [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report]. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31665686&form=6&db=m Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31743601&form=6&db=m Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31779824&form=6&db=m Progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32019605&form=6&db=m Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity. causal interaction,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32142177&form=6&db=m Association of Tripartite Motif Containing 11 rs564309 with Tau Pathology in Progressive Supranuclear Palsy. causal interaction,unassigned 4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32259098&form=6&db=m Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32293067&form=6&db=m Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32536421&form=6&db=m Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study. diagnostic usage,ongoing research,unassigned 3,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32959131&form=6&db=m Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33011852&form=6&db=m Spinal cord stimulation therapy for gait dysfunction in progressive supranuclear palsy patients. ongoing research,therapeutic application,unassigned 1,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33165511&form=6&db=m Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33279909&form=6&db=m Pedunculopontine Nucleus Deep Brain Stimulation for Parkinsonian Disorders: A Case Series. therapeutic application,unassigned 2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33581485&form=6&db=m Association of PSP phenotypes with survival: A brain-bank study. diagnostic usage,unassigned 3,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33613435&form=6&db=m The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome-A Pilot Study. causal interaction,diagnostic usage,unassigned 1,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33632587&form=6&db=m Deciphering the saccade velocity profile of progressive supranuclear palsy: A sign of latent cerebellar/brainstem dysfunction? causal interaction,diagnostic usage,ongoing research,unassigned 3,1,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33704556&form=6&db=m Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes. unassigned - 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33744691&form=6&db=m Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33789283&form=6&db=m Association of Progressive Supranuclear Palsy Rating Scale with Progressive Supranuclear Palsy Quality of Life Scale. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34021393&form=6&db=m Feasibility of short imaging protocols for [18F]PI-2620 tau-PET in progressive supranuclear palsy. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34113306&form=6&db=m DescribePSP and ProPSP: German Multicenter Networks for Standardized Prospective Collection of Clinical Data, Imaging Data, and Biomaterials of Patients With Progressive Supranuclear Palsy. causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34177779&form=6&db=m Gait Analysis in Progressive Supranuclear Palsy Phenotypes. diagnostic usage,ongoing research,unassigned 4,1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34209067&form=6&db=m Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study. diagnostic usage,ongoing research,unassigned 4,2,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34296340&form=6&db=m Caregiver strain in progressive supranuclear palsy and corticobasal syndromes. ongoing research,unassigned 1,0 3.1.3.3 Supranuclear Palsy, Progressive http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34425331&form=6&db=m Sleep disturbances in the speech-language variant of progressive supranuclear palsy. unassigned - 3.1.3.3 Sweating, Gustatory http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16874962&form=6&db=m [Sixty-two cases report of surgical treatment of parotid pleomorphic adenoma] causal interaction,diagnostic usage,therapeutic application,unassigned 2,2,2,0 3.1.3.3 Sweating, Gustatory http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20728030&form=6&db=m Superficial parotidectomy versus retrograde partial superficial parotidectomy in treating benign salivary gland tumor (pleomorphic adenoma). causal interaction,unassigned 2,0 3.1.3.3 Sweating, Gustatory http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25621064&form=6&db=m Superficial parotidectomy versus partial superficial parotidectomy in treating benign parotid tumors. unassigned - 3.1.3.3 Sweating, Gustatory http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31446709&form=6&db=m [Partial superficial parotidectomy versus superficial parotidectomy for treatment of parotid benign tumors: evidence-based medicine analysis]. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Sweating, Gustatory http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32362539&form=6&db=m A meta-analysis of the pros and cons of partial superficial parotidectomy versus superficial parotidectomy for the treatment of benign parotid neoplasms. causal interaction,therapeutic application,unassigned 1,4,0 3.1.3.3 Sweating, Gustatory http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33043429&form=6&db=m Superficial or partial superficial parotidectomy for the treatment of primary benign parotid tumors. causal interaction,diagnostic usage,unassigned 3,2,0 3.1.3.3 Syndactyly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7329916&form=6&db=m Reappearance of the multiple trait semilethal mutation (psp) in the fowl. unassigned - 3.1.3.3 Synucleinopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16897136&form=6&db=m Pathologic changes of progressive supranuclear palsy, corticobasal degeneration, and multiple system atrophy : Prototype and clinicopathological diversity. unassigned - 3.1.3.3 Synucleinopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17675576&form=6&db=m Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of parkinsonism-dementia complex of Guam but not alzheimer's disease or progressive supranuclear palsy. causal interaction,ongoing research,therapeutic application,unassigned 3,2,2,0 3.1.3.3 Synucleinopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25249066&form=6&db=m Glucocerebrosidase mutations in primary parkinsonism. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Synucleinopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25258345&form=6&db=m Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis. causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Synucleinopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27495201&form=6&db=m Diagnostic Approach to Atypical Parkinsonian Syndromes. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Synucleinopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31070772&form=6&db=m Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Synucleinopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31897945&form=6&db=m Serum adiponectin levels between patients with Parkinson's disease and those with PSP. diagnostic usage,unassigned 4,0 3.1.3.3 Tachycardia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10066391&form=6&db=m Mechanical function and substrate oxidation in the neonatal pig heart subjected to pacing-induced tachycardia. causal interaction,unassigned 2,0 3.1.3.3 Tachycardia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14631166&form=6&db=m Performance of the neonatal pig heart subjected to oxygen insufficiency. unassigned - 3.1.3.3 Tachycardia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27181036&form=6&db=m Failing Left Ventricles Have an Enhanced Post-Stimulation Potentiation Despite Their Impaired Force Frequency Relationship. therapeutic application,unassigned 1,0 3.1.3.3 Tachycardia, Sinus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17659201&form=6&db=m Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing-induced congestive heart failure. unassigned - 3.1.3.3 Tachycardia, Ventricular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28461795&form=6&db=m Prolonged Sinus Pauses upon Termination of Paroxysmal Atrial Fibrillation: Abnormal Right Atrial Electrophysiologic and Electroanatomic Findings. diagnostic usage,unassigned 2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11912113&form=6&db=m Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,3,1,1 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12071638&form=6&db=m Argyrophilic grain disease is a sporadic 4-repeat tauopathy. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12784669&form=6&db=m [Amyotrophic lateral sclerosis-parkinsonism-dementia complex of the Kii Peninsula of Japan] causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12802605&form=6&db=m 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15050720&form=6&db=m Failure in heat-shock protein expression in response to UBB+1 protein in progressive supranuclear palsy in humans. causal interaction,unassigned 3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15266787&form=6&db=m Progressive supranuclear palsy--parkinsonian disorder with tau pathology. causal interaction,therapeutic application,unassigned 1,3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15390131&form=6&db=m Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration. causal interaction,diagnostic usage,unassigned 4,4,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15641585&form=6&db=m Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16361371&form=6&db=m Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16432153&form=6&db=m Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16823854&form=6&db=m Unexpected abundance of pathological tau in progressive supranuclear palsy white matter. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16897136&form=6&db=m Pathologic changes of progressive supranuclear palsy, corticobasal degeneration, and multiple system atrophy : Prototype and clinicopathological diversity. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17675576&form=6&db=m Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of parkinsonism-dementia complex of Guam but not alzheimer's disease or progressive supranuclear palsy. causal interaction,ongoing research,therapeutic application,unassigned 3,2,2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20512649&form=6&db=m Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20569300&form=6&db=m Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies. ongoing research,therapeutic application,unassigned 2,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21188269&form=6&db=m The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21568901&form=6&db=m Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21685912&form=6&db=m Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. diagnostic usage,unassigned 2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21690028&form=6&db=m [Progressive supranuclear palsy: what's new?]. diagnostic usage,therapeutic application,unassigned 3,3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21773886&form=6&db=m Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21856424&form=6&db=m Post mortem cerebrospinal fluid ?-synuclein levels are raised in multiple system atrophy and distinguish this from the other ?-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23428180&form=6&db=m Variation in tau isoform expression in different brain regions and disease states. diagnostic usage,unassigned 3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23432126&form=6&db=m Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. causal interaction,unassigned 1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24086739&form=6&db=m A Novel MAPT Mutation, G55R, in a Frontotemporal Dementia Patient Leads to Altered Tau Function. causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24479957&form=6&db=m Progressive Supranuclear Palsy in a family with TDP-43 pathology. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24955381&form=6&db=m Sleep Disorders in Atypical Parkinsonism. causal interaction,unassigned 3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25249066&form=6&db=m Glucocerebrosidase mutations in primary parkinsonism. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25469232&form=6&db=m [18F]-T807 tauopathy PET imaging in chronic traumatic encephalopathy. diagnostic usage,unassigned 1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25775028&form=6&db=m Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy. therapeutic application,unassigned 1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25974705&form=6&db=m Pathological and Clinical Spectrum of Progressive Supranuclear Palsy: With Special Reference to Astrocytic Tau Pathology. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26413239&form=6&db=m Genetics of Progressive Supranuclear Palsy. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26823029&form=6&db=m Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases. diagnostic usage,unassigned 3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26900156&form=6&db=m The Differential Diagnosis and Treatment of Atypical Parkinsonism. causal interaction,diagnostic usage,unassigned 3,3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27061067&form=6&db=m Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid. diagnostic usage,ongoing research,unassigned 2,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27495201&form=6&db=m Diagnostic Approach to Atypical Parkinsonian Syndromes. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27526039&form=6&db=m Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options. causal interaction,therapeutic application,unassigned 4,4,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27709663&form=6&db=m The MAPT gene is differentially methylated in the progressive supranuclear palsy brain. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27997036&form=6&db=m Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies. diagnostic usage,therapeutic application,unassigned 2,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28148553&form=6&db=m PERK activation mitigates tau pathology in vitro and in vivo. causal interaction,ongoing research,unassigned 3,4,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28271184&form=6&db=m Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28367478&form=6&db=m Central hypoventilation in progressive supranuclear palsy. causal interaction,therapeutic application,unassigned 1,3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28409749&form=6&db=m The Role of Stress as a Risk Factor for Progressive Supranuclear Palsy. causal interaction,unassigned 3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28500751&form=6&db=m Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? causal interaction,diagnostic usage,unassigned 3,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28568506&form=6&db=m PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins. diagnostic usage,unassigned 3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28867162&form=6&db=m DCTN1 variation in pathologically-confirmed PSP and CBD tauopathy. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29254097&form=6&db=m Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29281045&form=6&db=m Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease. diagnostic usage,ongoing research,unassigned 1,2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29304218&form=6&db=m Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study. diagnostic usage,ongoing research,unassigned 3,3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29339765&form=6&db=m Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29415231&form=6&db=m Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29502334&form=6&db=m Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29516660&form=6&db=m Tauopathy with Hippocampal 4-Repeat Tau Immunoreactive Spherical Inclusions in a Patient with PSP. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29902389&form=6&db=m The diagnosis of progressive supranuclear palsy: current opinions and challenges. causal interaction,diagnostic usage,unassigned 4,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29973911&form=6&db=m Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30193298&form=6&db=m Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review. ongoing research,therapeutic application,unassigned 3,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30201421&form=6&db=m Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations. causal interaction,unassigned 2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30326945&form=6&db=m ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans. causal interaction,diagnostic usage,unassigned 1,2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30348994&form=6&db=m APOE ?2 is associated with increased tau pathology in primary tauopathy. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30832741&form=6&db=m Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau). diagnostic usage,unassigned 2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31007097&form=6&db=m Emerging drugs for progressive supranuclear palsy. therapeutic application,unassigned 2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31515852&form=6&db=m Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration. causal interaction,unassigned 3,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31656263&form=6&db=m [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report]. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31695675&form=6&db=m Frontrunner in Translation: Progressive Supranuclear Palsy. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31727210&form=6&db=m Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration. causal interaction,unassigned 2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31826239&form=6&db=m Human tau pathology transmits glial tau aggregates in the absence of neuronal tau. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31953414&form=6&db=m Heavy metals contaminating the environment of a progressive supranuclear palsy cluster induce tau accumulation and cell death in cultured neurons. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31999351&form=6&db=m Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD. causal interaction,diagnostic usage,therapeutic application,unassigned 3,4,2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32096036&form=6&db=m Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease. causal interaction,unassigned 2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32293067&form=6&db=m Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases. causal interaction,diagnostic usage,therapeutic application,unassigned 1,4,2,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32585946&form=6&db=m Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies. therapeutic application,unassigned 1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32754109&form=6&db=m PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32961270&form=6&db=m Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32982676&form=6&db=m Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP). causal interaction,diagnostic usage,ongoing research,unassigned 1,3,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33089580&form=6&db=m Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33341150&form=6&db=m Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,2,2,4 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33522967&form=6&db=m Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers. unassigned - 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33754963&form=6&db=m Genetic pleiotropy and the shared pathological features of corticobasal degeneration and progressive supranuclear palsy: a case report and a review of the literature. causal interaction,therapeutic application,unassigned 4,1,0 3.1.3.3 Tauopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33809527&form=6&db=m Mechanisms of Neurodegeneration in Various Forms of Parkinsonism-Similarities and Differences. unassigned - 3.1.3.3 Tetanus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1680738&form=6&db=m Blockade of NMDA receptors unmasks a long-term depression in synaptic efficacy in rat prefrontal neurons in vitro. unassigned - 3.1.3.3 Tetanus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10995860&form=6&db=m Short-term synaptic plasticity contributes to the temporal filtering of electrosensory information. unassigned - 3.1.3.3 Tetralogy of Fallot http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33221863&form=6&db=m Three-step preoperative sequential planning for pulmonary valve replacement in repaired tetralogy of Fallot using computed tomography. unassigned - 3.1.3.3 Thiamine Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30131406&form=6&db=m Progressive supranuclear palsy responding to intravenous thiamine: superimposed Wernicke's encephalopathy? causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Thrombocytopenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2435204&form=6&db=m [Thrombopenia caused by pentosan polysulfate] causal interaction,therapeutic application,unassigned 1,4,0 3.1.3.3 Thrombosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15772370&form=6&db=m The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). unassigned - 3.1.3.3 Thrombosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29415486&form=6&db=m Impact of PSP Technique on Clinical Outcomes Following Bioresorbable Scaffolds Implantation. unassigned - 3.1.3.3 Thrombosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29730328&form=6&db=m Poor Subpleural Perfusion Predicts Failure After Balloon Pulmonary Angioplasty for Nonoperable Chronic Thromboembolic Pulmonary Hypertension. diagnostic usage,unassigned 3,0 3.1.3.3 Thrombosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30386494&form=6&db=m Undiscovered pathology of transient scaffolding t1remains a driver of failures in clinical trials. unassigned - 3.1.3.3 Tic Disorders http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26538289&form=6&db=m Premonitory urges are associated with decreased grey matter thickness within the insula and sensorimotor cortex in young people with Tourette syndrome. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Tics http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10388790&form=6&db=m Clinical genetics of familial progressive supranuclear palsy. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Tics http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14515942&form=6&db=m Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,4,0 3.1.3.3 Tics http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26538289&form=6&db=m Premonitory urges are associated with decreased grey matter thickness within the insula and sensorimotor cortex in young people with Tourette syndrome. causal interaction,therapeutic application,unassigned 4,2,0 3.1.3.3 Tourette Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14515942&form=6&db=m Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents. causal interaction,diagnostic usage,therapeutic application,unassigned 3,2,4,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2816286&form=6&db=m Tremor in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,2,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7723949&form=6&db=m Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. causal interaction,diagnostic usage,unassigned 4,2,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8679336&form=6&db=m [A 65-year-old man with Parkinsonism, gaze palsy, and dementia] therapeutic application,unassigned 2,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9014435&form=6&db=m [Progressive supranuclear palsy] causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10388790&form=6&db=m Clinical genetics of familial progressive supranuclear palsy. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10752576&form=6&db=m Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale. diagnostic usage,unassigned 2,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14502669&form=6&db=m Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. diagnostic usage,unassigned 3,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15480835&form=6&db=m Lewy body-related alpha-synucleinopathy in the aged human brain. ongoing research,unassigned 1,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17303592&form=6&db=m Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? causal interaction,diagnostic usage,unassigned 4,3,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18941145&form=6&db=m Predominant cortical dysfunction in Guadeloupean parkinsonism. causal interaction,unassigned 4,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19458322&form=6&db=m Familial aggregation of parkinsonism in progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 2,2,4,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22181323&form=6&db=m Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. unassigned - 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24868413&form=6&db=m Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy. unassigned - 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25683763&form=6&db=m Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. causal interaction,diagnostic usage,unassigned 1,3,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27039056&form=6&db=m Tremor in progressive supranuclear palsy. causal interaction,diagnostic usage,therapeutic application,unassigned 3,1,4,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28982612&form=6&db=m Brain regional iron contents in progressive supranuclear palsy. therapeutic application,unassigned 1,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29191439&form=6&db=m Effects of cerebellar neuromodulation in movement disorders: A systematic review. therapeutic application,unassigned 1,0 3.1.3.3 Tremor http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33045651&form=6&db=m The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25037224&form=6&db=m High Throughput Screen Identifies Small Molecule Inhibitors Specific for Mycobacterium tuberculosis Phosphoserine Phosphatase. causal interaction,diagnostic usage,ongoing research,therapeutic application 2,3,3,4 3.1.3.3 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25521849&form=6&db=m Characterization of M. tuberculosis SerB2, an essential HAD-family phosphatase, reveals novel properties. unassigned - 3.1.3.3 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25899163&form=6&db=m The Psp system of Mycobacterium tuberculosis integrates envelope stress-sensing and envelope-preserving functions. unassigned - 3.1.3.3 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27002134&form=6&db=m Rv2744c is a PspA ortholog that regulates lipid droplet homeostasis and non-replicating persistence in Mycobacterium tuberculosis. diagnostic usage,unassigned 3,0 3.1.3.3 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27758870&form=6&db=m Serine/Threonine Protein Phosphatase PstP of Mycobacterium tuberculosis Is Necessary for Accurate Cell Division and Survival of Pathogen. causal interaction,unassigned 3,0 3.1.3.3 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29140686&form=6&db=m Regulatory Mechanism of Mycobacterium tuberculosis Phosphoserine Phosphatase SerB2. unassigned - 3.1.3.3 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31958639&form=6&db=m Global discovery the PstP interactions using Mtb proteome microarray and revealing novel connections with EthR. ongoing research,unassigned 1,0 3.1.3.3 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31963843&form=6&db=m Identification and Repurposing of Trisubstituted Harmine Derivatives as Novel Inhibitors of Mycobacterium tuberculosis Phosphoserine Phosphatase. causal interaction,therapeutic application,unassigned 2,4,0 3.1.3.3 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32782143&form=6&db=m Biochemical characterization of phosphoserine phosphatase SerB2 from Mycobacterium marinum. causal interaction,therapeutic application,unassigned 3,4,0 3.1.3.3 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34304085&form=6&db=m Bilateral primary spontaneous pneumothorax with multiple bleb performed by VATS and wedge resection: A rare case in Indonesian adult and review article. causal interaction,therapeutic application,unassigned 3,1,0 3.1.3.3 Tuberculosis, Pulmonary http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16970292&form=6&db=m Aetiology and clinical profile of spontaneous pneumothorax in adults. causal interaction,unassigned 4,0 3.1.3.3 Urinary Incontinence http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24668247&form=6&db=m Nocturnal manifestations of atypical and vascular parkinsonism: How do they differ from Parkinson's disease? unassigned - 3.1.3.3 Uterine Cervical Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5062672&form=6&db=m [Evaluation of PSP excretion test in diagnosis of the upper urinary tract disturbances in cases of postoperative cervical cancer] diagnostic usage,therapeutic application,unassigned 4,2,0 3.1.3.3 Uterine Cervical Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16918926&form=6&db=m A novel design for estimating relative accuracy of screening tests when complete disease verification is not feasible. unassigned - 3.1.3.3 Uveitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31081461&form=6&db=m Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. therapeutic application,unassigned 1,0 3.1.3.3 Vascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964683&form=6&db=m The neuropathology of progressive supranuclear palsy. causal interaction,unassigned 3,0 3.1.3.3 Vascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7964687&form=6&db=m Vascular progressive supranuclear palsy. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,3,0 3.1.3.3 Vascular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12374498&form=6&db=m A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy. causal interaction,diagnostic usage,unassigned 3,4,0 3.1.3.3 Vascular System Injuries http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25997420&form=6&db=m Vascular Parkinsonism: deconstructing a syndrome. causal interaction,unassigned 3,0 3.1.3.3 Vasculitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17997742&form=6&db=m Poststeroid panniculitis. therapeutic application,unassigned 2,0 3.1.3.3 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7886949&form=6&db=m Serine/threonine protein phosphatase is required for tobacco mosaic virus-mediated programmed cell death. causal interaction,therapeutic application,unassigned 4,3,0 3.1.3.3 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23091130&form=6&db=m Pinon shell polysaccharide enhances immunity against H9N2 avian influenza virus in chickens. diagnostic usage,therapeutic application,unassigned 3,1,0 3.1.3.3 Virus Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31208426&form=6&db=m Respiratory virus associated with surgery in children patients. diagnostic usage,therapeutic application,unassigned 4,1,0 3.1.3.3 Wernicke Encephalopathy http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30131406&form=6&db=m Progressive supranuclear palsy responding to intravenous thiamine: superimposed Wernicke's encephalopathy? causal interaction,therapeutic application,unassigned 2,1,0 3.1.3.3 Williams Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9222972&form=6&db=m Phosphoserine phosphatase deficiency in a patient with Williams syndrome. causal interaction,unassigned 4,0 3.1.3.3 Xerostomia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32362539&form=6&db=m A meta-analysis of the pros and cons of partial superficial parotidectomy versus superficial parotidectomy for the treatment of benign parotid neoplasms. causal interaction,therapeutic application,unassigned 1,4,0